Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGRP,Agouti-related protein,42296,0.299619759315945,0.00495899123992799,0.289900136485686,0.309339382146204,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL27,C-C motif chemokine 27,42145,0.266709927947613,0.00635313408491108,0.254257785141187,0.279162070754039,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN1,CCN family member 1,42047,0.373649019395031,0.00704933723050722,0.359832318423237,0.387465720366826,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES1,Liver carboxylesterase 1,42163,0.369008440260961,0.00862457665216966,0.352104270022709,0.385912610499214,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCG,Pro-glucagon,41843,0.560200056417123,0.0125454926024377,0.535610890916345,0.584789221917901,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHR,Growth hormone receptor,39736,0.115283942189795,0.00285857735043429,0.109681130582944,0.120886753796646,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF9,Protein turtle homolog A,39958,0.374825160984106,0.00863439363201349,0.357901749465359,0.391748572502852,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LDLR,Low-density lipoprotein receptor,42170,0.405168305344994,0.00428243727065287,0.396774728294515,0.413561882395474,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPL,Lipoprotein lipase,42145,-0.206494499035678,0.00488715448093446,-0.216073321818309,-0.196915676253046,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFGE8,Lactadherin,42137,0.280160561975919,0.00427160288819162,0.271788220315064,0.288532903636775,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPY,Pro-neuropeptide Y,42262,0.374483329074745,0.00607306996506188,0.362580111943224,0.386386546206266,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTH,Parathyroid hormone,39649,0.328563946875688,0.00847020615439097,0.311962342813081,0.345165550938294,1.62727793595468e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRAP1,Proline-rich acidic protein 1,39966,0.154022301434723,0.00397862966702926,0.146224187287345,0.1618204155821,4.46993362079724e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FURIN,Furin,42181,0.12854398244584,0.00339829670080922,0.121883320912254,0.135204643979426,8.92537422545023e-298
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0837107119827489,0.00221110354400169,0.0793769490365056,0.0880444749289922,1.54380542823516e-295
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.124818099323758,0.00332739808319435,0.118296399080697,0.131339799566819,3.30503965564456e-293
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C9,Complement component C9,39990,-0.221120465748927,0.00587959688347587,-0.23264447564054,-0.209596455857315,7.07122695141912e-292
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,42230,0.185853315519517,0.00497675095926595,0.176098883639355,0.195607747399678,1.0677185718974e-290
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.293182891390112,0.00787013536112895,0.2777574260823,0.308608356697925,1.21377734455585e-286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F7,Coagulation factor VII,42194,0.117967900267479,0.00319710817753427,0.111701568239512,0.124234232295447,3.95895309332969e-284
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.306412860508558,0.00842414170044846,0.289901542775679,0.322924178241437,3.02375716318555e-276
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.156796937433822,0.00442948031710901,0.148115156012288,0.165478718855356,1.18939138237196e-262
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.526015368880956,0.0151520667419463,0.496317318066741,0.55571341969517,7.03383167399279e-253
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.301008835070994,0.00871506804659904,0.28392730169966,0.318090368442328,2.23973937957906e-250
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD4,T-cell surface glycoprotein CD4,42100,0.103540751333516,0.00301565949230107,0.0976300587286061,0.109451443938426,9.24738028003772e-248
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INHBC,Inhibin beta C chain,42137,0.141523535181776,0.00412357393285311,0.133441330273384,0.149605740090168,1.34144151453597e-247
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.451317274458777,0.0131633080213438,-0.477117358180611,-0.425517190736943,3.11323354230522e-247
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC39A5,Zinc transporter ZIP5,42119,0.185967192245487,0.00552025735043696,0.17514748783863,0.196786896652343,5.65513955342558e-239
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.298309109019975,0.00886584819646533,0.280932046554903,0.315686171485047,2.19642818115783e-238
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADIPOQ,Adiponectin,39979,-0.238434105816436,0.00711293666601584,-0.252375461681827,-0.224492749951045,5.05408768000553e-235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.209338223035725,0.00629126068202319,-0.221669093972491,-0.19700735209896,1.59862908358029e-233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLTP,Phospholipid transfer protein,42267,-0.1290924710614,0.00393908782913657,-0.136813083206508,-0.121371858916293,7.82063426098401e-227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.271800452286476,0.00832498245236243,0.255483486679846,0.288117417893107,4.36582721636536e-225
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR37,Prosaposin receptor GPR37,41900,0.220770050450022,0.00678266701788103,0.207476023094975,0.234064077805069,1.13029646951657e-223
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCHE,Cholinesterase,39806,0.0903131831569272,0.0027851469983853,0.084854295040092,0.0957720712737624,1.47094457201252e-220
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.112377151960587,0.00348402624683393,0.105548460516792,0.119205843404381,4.80099899159213e-220
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG2,Desmoglein-2,42137,-0.0892944992745646,0.002823670042395,-0.0948288925576588,-0.0837601059914704,8.05167047554327e-212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.105966798833281,0.00335826723505373,0.0993845950525756,0.112549002613986,6.2432828597754e-211
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MXRA8,Matrix remodeling-associated protein 8,39736,-0.100168011860967,0.00319453822417538,-0.106429306780351,-0.0939067169415833,6.74303961393612e-207
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL23,C-C motif chemokine 23,42185,0.13767789367371,0.00441621863662321,0.129022105145929,0.146333682201492,3.82135165107658e-206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS15,Enteropeptidase,42070,0.284638483116098,0.00918260667804405,0.266640574027132,0.302636392205065,7.6734184468131e-204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRP1,Neuropilin-1,42230,-0.0883503839796987,0.00285469933752202,-0.0939455946812419,-0.0827551732781556,2.59905318744216e-203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN3,Contactin-3,42137,0.0913660652872257,0.00296269528543034,0.0855591825277823,0.0971729480466692,6.98638220955401e-202
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFM,Afamin,39979,0.0649205143320171,0.00210248024639279,0.0607996530490872,0.0690413756149469,4.04827928587996e-201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACY1,Aminoacylase-1,42145,0.201934215144139,0.0065710520314511,0.189054953162495,0.214813477125783,1.55118266111039e-200
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPM,Carboxypeptidase M,42195,0.108786390955435,0.00355351881503944,0.101821494077957,0.115751287832912,4.24549128816126e-199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROC,Vitamin K-dependent protein C,42199,0.0818839518799949,0.00268433543922327,0.0766226544191172,0.0871452493408725,9.66922614430862e-198
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APCS,Serum amyloid P-component,39870,0.103446149101456,0.00338973982386827,0.0968022590466739,0.110090039156238,1.33138006229733e-196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.339475373168219,0.0111674638504099,0.317587144021415,0.361363602315022,2.2701213537847e-196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA4,Kallistatin,39802,0.0743355892611549,0.00243976312810683,0.0695536535300655,0.0791175249922443,5.89702425469713e-196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON3,Serum paraoxonase/lactonase 3,42185,-0.0932659997713297,0.00307274148305965,-0.0992885730781266,-0.0872434264645328,7.41870298673962e-196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAT,Tissue-type plasminogen activator,42272,0.16254048381423,0.00535620531845317,0.152042321390061,0.173038646238398,8.14752987704646e-196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.189774063715595,0.00627884931151464,0.177467519065027,0.202080608366164,4.09065566012399e-194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA5,Plasma serine protease inhibitor,39835,0.0950598939479077,0.00314019815924662,0.0889051055557843,0.101214682340031,1.39729678565973e-193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.216620828321203,0.00718606735119287,0.202536136312865,0.230705520329541,3.06660613325483e-193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTA3,Glutathione S-transferase A3,41843,0.242437904693818,0.00808570279521985,0.226589927215188,0.258285882172449,3.64515121673612e-191
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTR,Transthyretin,39862,0.0773516151705657,0.00258874103786789,0.0722776827363446,0.0824255476047867,7.44101610996792e-189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRIP2,Cysteine-rich protein 2,42016,0.112998163934983,0.00381386424716243,0.105522990010544,0.120473337859421,6.32759069976984e-187
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUSB,Beta-glucuronidase,42211,0.189490604695527,0.00639792540831212,0.176950670895235,0.202030538495818,7.06348766310416e-187
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GH1,Somatotropin,42129,-0.543620617443712,0.0186334180747181,-0.58014211687016,-0.507099118017265,1.60536528113815e-181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTA1,Glutathione S-transferase A1,42119,0.256902723056661,0.00888656225879358,0.239485061029425,0.274320385083896,2.31102635692475e-178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL6,C-X-C motif chemokine 6,42296,0.228917733038636,0.00792566333449615,0.213383432903024,0.244452033174249,4.02594787797955e-178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0623823244260298,0.00216178706636352,0.0581452217759573,0.0666194270761023,1.3591339561874e-177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHMP6,Charged multivesicular body protein 6,39958,0.173125965493572,0.00599064647132913,0.161384298409767,0.184867632577377,2.87109427960672e-177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0732404078659,0.00256476075226858,0.0682134767914536,0.0782673389403464,3.11887743806184e-174
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASGR1,Asialoglycoprotein receptor 1,42016,0.090490420943503,0.00318738587480794,0.0842431446288794,0.0967376972581266,3.13163932911733e-172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPB1,Beta-ureidopropionase,39958,0.269613656813315,0.0094846428706194,0.251023756786901,0.288203556839729,9.03600208775228e-172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNCA,Alpha-synuclein,39736,0.348372861376145,0.0123249798643842,0.324215900841952,0.372529821910338,8.27242237521619e-170
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF21,Fibroblast growth factor 21,42247,0.354217078047264,0.0126230086842493,0.329475981026136,0.378958175068393,1.68975816364359e-168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELN,Elastin,39958,0.102064579395308,0.0036383553192904,0.0949334029694992,0.109195755821118,1.76424341560357e-167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKB,Creatine kinase B-type,39966,-0.168557277838277,0.00601391062952845,-0.180344542672152,-0.156770013004401,3.32733724921353e-167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.056845362024721,0.00203815562108425,0.0528505770073958,0.0608401470420461,1.75876006877288e-166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHBG,Sex hormone-binding globulin,39990,-0.136248833182522,0.00490618444812042,-0.145864954700838,-0.126632711664205,2.69112975103632e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL16,C-C motif chemokine 16,42310,0.147306126448472,0.00540167141125869,0.136718850482405,0.15789340241454,1.64812846921745e-159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCS1,Neuronal calcium sensor 1,42262,0.0806444920477893,0.00297896211620102,0.0748057263000353,0.0864832577955433,2.90879975745802e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS3,"Nitric oxide synthase, endothelial",41839,0.143749365008977,0.0053346343904516,0.133293481603692,0.154205248414262,9.58551583769719e-156
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.244341709732826,0.00909113293119679,0.22652308918768,0.262160330277972,2.69577956319261e-154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.108930621711111,0.0040710530223486,-0.116909885634914,-0.100951357787308,9.25477153688133e-154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KYNU,Kynureninase,42296,0.127978092533102,0.00479180913034167,0.118586146637632,0.137370038428571,3.11331562174454e-153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,41843,0.314556596887827,0.0117783618580124,0.291471007646122,0.337642186129531,4.33934133184001e-153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.146450461729447,0.00549066498354877,0.135688758361691,0.157212165097203,7.81451627968076e-153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP5,Retinol-binding protein 5,42070,0.158175661100823,0.00593115038060615,0.146550606354835,0.169800715846811,9.70607475160221e-153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.201931490001319,0.00762091665418789,0.186994493359111,0.216868486643528,7.80852685370297e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO3,Beta-enolase,39638,0.175459724930132,0.00660422803626576,0.162515437979052,0.188404011881213,8.29670965037274e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.20355275241513,0.00770977319243922,0.188441596957949,0.218663907872311,8.4521470299921e-150
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0930349266425881,0.00353276264699289,-0.0999591414306941,-0.086110711854482,3.7962499817243e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL13,C-X-C motif chemokine 13,42249,0.159029297053007,0.0060626387491303,0.147146525104711,0.170912069001302,5.31293576014558e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0906465291692883,0.00345868583891934,0.0838675049250063,0.0974255534135702,1.04281524975283e-147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFH,Complement factor H,39418,0.0646481777194808,0.00246451527383156,0.0598177277827709,0.0694786276561906,4.33695295882201e-147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OXT,Oxytocin-neurophysin 1,42249,0.397863462199377,0.0152934055547204,0.367888387312125,0.427838537086629,1.14577168118557e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRP,Gastrin-releasing peptide,39638,0.146395593060246,0.00561578486520978,0.135388654724435,0.157402531396057,1.97447870986461e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORT1,Sortilin,42129,0.104402397237908,0.00402411792052776,0.0965151261136731,0.112289668362142,7.17263855768309e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0864103285713625,0.00335424454755777,0.0798360092581493,0.0929846478845758,6.11720984829973e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINF1,Pigment epithelium-derived factor,39815,0.0710897732878808,0.00276400885049743,0.0656723159409059,0.0765072306348558,8.62100285226548e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPY,Pancreatic prohormone,42089,0.277884842500031,0.0108694239014043,0.256580771653279,0.299188913346784,8.0597128393052e-141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAT2,Linker for activation of T-cells family member 2,42070,0.340444623846197,0.0133243038851313,0.31432898823134,0.366560259461055,1.1772205001711e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEG1,Protein HEG homolog 1,39736,0.0742448257426762,0.00289973314694697,0.0685613487746601,0.0799283027106922,1.52647544338253e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.177803729479267,0.00695271411080925,0.164176409822081,0.191431049136453,2.6975918266741e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTSS1,Protein MTSS 1,39930,0.300017909232803,0.0117413932305208,0.277004778500982,0.323031039964624,4.59709382113292e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F9,Coagulation factor IX,42199,0.0493493780272156,0.00193639036028348,0.0455540529210599,0.0531447031333712,5.40708443305007e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.175830379191879,0.00689836681304571,0.16230958023831,0.189351178145449,6.04959336475053e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAMR1,Inactive serine protease PAMR1,42137,0.0711598654183065,0.00279312463383108,0.0656853411359976,0.0766343897006154,6.86807118628802e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.332983806838584,0.0130935019121864,0.307320543090699,0.35864707058647,2.09018797698058e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFI,Complement factor I,39979,0.052057769343255,0.00204452068289017,0.0480505088047903,0.0560650298817197,3.90218248459736e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.190550752796186,0.00748696755284563,0.175876296392609,0.205225209199764,5.33744506199386e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR2,Cadherin-related family member 2,42070,0.176229964339579,0.0069550959899496,0.162597976199278,0.189861952479881,2.0595027334987e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPPC,C-type natriuretic peptide,42119,0.140793084933016,0.00557106011194427,0.129873807113605,0.151712362752427,9.9148516670491e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.110503764164121,0.00437365510690205,0.101931400154593,0.119076128173649,1.18922324516934e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUMB,Protein numb homolog,39657,0.223327685558781,0.00882922771554783,0.206022399236307,0.240632971881255,2.83090014494332e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300LG,CMRF35-like molecule 9,42137,-0.0994085683878699,0.00394476188821555,-0.107140301688772,-0.0916768350869674,5.5958125871616e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0691723954479985,0.00274746726010481,0.0637873596181931,0.0745574312778039,1.02961942089092e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.180537560024625,0.00722668331292728,0.166373260731288,0.194701859317963,1.22345543081637e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTYMK,Thymidylate kinase,39958,0.176990680587814,0.00709471343299729,0.163085042259139,0.190896318916489,8.86814363270458e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAMDC4,Apical endosomal glycoprotein,39919,0.148334247309368,0.00597144419846336,0.13663021668038,0.160038277938357,1.12325799585008e-132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0577046426785988,0.00232339380011209,0.0531507908303791,0.0622584945268185,1.41234605543186e-132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MME,Neprilysin,42070,0.203571361490973,0.00823357851566561,0.187433547600268,0.219709175381677,5.00108184009475e-132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADH1B,All-trans-retinol dehydrogenase,39736,0.198558187049023,0.00803811241483427,0.182803486715947,0.214312887382098,3.31957966877772e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF8,Immunoglobulin superfamily member 8,42145,0.0806629929352401,0.00328222602979859,0.0742298299168349,0.0870961559536454,1.62443958254249e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.148965634098102,0.00606405015568478,0.13708009579296,0.160851172403244,8.70821577205748e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,39657,0.224206853947572,0.00914532711539319,0.206282012801401,0.242131695093742,2.71634151800077e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0507447322273307,0.00207808028401658,0.0466716948706582,0.0548177695840032,6.08430247029547e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOMO1,Nodal modulator 1,42137,0.0600950944559478,0.00246335661447029,0.055266915491586,0.0649232734203095,1.11990568584311e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH9,Myosin-9,39966,0.292549094828903,0.0119924125115793,0.269043966306208,0.316054223351599,3.72876522035954e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFP,Properdin,39979,0.0608760192326191,0.00249845940511688,0.0559790387985901,0.0657729996666482,7.26409532105363e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPIND1,Heparin cofactor 2,39959,0.074964591443182,0.00307818705956083,0.0689313448064428,0.0809978380799213,9.7034096366568e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MVK,Mevalonate kinase,41913,0.21274668042093,0.00876001241659202,0.19557705608441,0.22991630475745,1.60135957031111e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGR3,Anterior gradient protein 3,41827,0.151923728854955,0.0062731201995205,0.139628413263895,0.164219044446015,8.0893688787131e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EEF1D,Elongation factor 1-delta,39958,0.232708218814438,0.00963431883312009,0.213824953901522,0.251591483727353,9.71542145854358e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.125115832720307,0.00519449519440422,0.114934622139275,0.135297043301339,1.61718924004032e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFR2,Fibroblast growth factor receptor 2,42181,0.0571042124396044,0.00238279438166167,0.0524339354515475,0.0617744894276613,2.40397213222892e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YES1,Tyrosine-protein kinase Yes,42070,0.289556059968178,0.0120864761890409,0.265866566637658,0.313245553298699,3.04467543086049e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORD,Sorbitol dehydrogenase,42204,0.174316795884912,0.00728029846846979,0.160047410886711,0.188586180883113,3.9141937728897e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.173103998668951,0.0072282921531736,0.158936546048731,0.187271451289171,1.38403832071431e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLA,Alpha-galactosidase A,39713,0.0989769440191385,0.00413382178369037,0.0908746533231053,0.107079234715172,1.41880936698487e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KHK,Ketohexokinase,39638,0.159149576493492,0.00665605721070425,0.146103704360512,0.172195448626473,3.13447636563218e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.130962301514077,0.00549300679195488,0.120196008201846,0.141728594826309,4.23249826038295e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP29,Synaptosomal-associated protein 29,42181,0.230575040423912,0.00969838540568065,0.211566205028778,0.249583875819046,1.91003053481771e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HJV,Hemojuvelin,39934,0.105915871593585,0.00444824838073042,0.0971973047673529,0.114634438419816,2.53357077781884e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEP,Leptin,42145,0.175052742278457,0.00737088391257904,0.160605809809802,0.189499674747112,3.46075798602756e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PYY,Peptide YY,39575,0.250698003680615,0.0105616557947962,0.229997158322814,0.271398849038415,1.68632884570351e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROS1,Vitamin K-dependent protein S,39979,0.0636531881843726,0.00268299521746442,0.0583945175581423,0.0689118588106029,1.73646898025591e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.139724788828517,0.00590156068566739,0.128157729884609,0.151291847772425,2.03922797616377e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATRN,"Attractin, Isoform 2",39979,0.0417111712433958,0.00176047324239472,0.0382606436883021,0.0451616987984894,3.54364495712506e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA1,Ephrin type-A receptor 1,42162,0.0806566693009206,0.00341985320328617,0.0739537570224797,0.0873595815793615,1.45090116874788e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL2,Angiopoietin-related protein 2,42140,0.0988870996216853,0.0041951726595298,0.0906645612090068,0.107109638034364,1.97457231086569e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KDR,Vascular endothelial growth factor receptor 2,42181,0.0626004333441259,0.00265915287897519,0.0573884937013345,0.0678123729869173,3.84760832497216e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCLY,Selenocysteine lyase,42224,0.12142862185608,0.00515847264455452,0.111318015472753,0.131539228239407,3.94463662562967e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM20A,Pseudokinase FAM20A,39958,0.0698221097114449,0.00297929746076301,0.0639826866883494,0.0756615327345404,1.1764268958238e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FYB1,FYN-binding protein 1,42115,0.229348610826706,0.00981194576257687,0.210117197132056,0.248580024521357,1.7179012197294e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0736822577016658,0.00314845741400875,0.0675112811702086,0.0798532342331229,2.46825408125905e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SARG,Specifically androgen-regulated gene protein,39915,0.272346845244844,0.011637458558813,0.249537426469571,0.295156264020118,2.53005381390752e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.346865122207989,0.0148375572476079,0.317783510002678,0.375946734413301,4.39715550838592e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.134242573018534,0.00581410269134061,0.122846931743507,0.145638214293562,1.15565591625611e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTN4R,Reticulon-4 receptor,42262,0.0825563533695096,0.00357748274244912,0.0755444871943093,0.0895682195447098,1.27399702031756e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPY30,Protein dpy-30 homolog,42216,0.14689019515119,0.00637388350125329,0.134397383488734,0.159383006813647,2.58245807341797e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAPIN,SNARE-associated protein Snapin,39934,0.141767710572303,0.00617439778093414,0.129665890921672,0.153869530222934,4.52075146356324e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFPI,Tissue factor pathway inhibitor,42152,0.0756373273549715,0.00330698515584052,0.0691556364495241,0.0821190182604189,1.23566355580326e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MLN,Promotilin,42119,0.217164777453147,0.00949647591208259,0.198551684665465,0.235777870240829,1.36729264050594e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD2AP,CD2-associated protein,42145,0.15306565217336,0.00669432118810659,0.139944782644671,0.166186521702049,1.44524429804723e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACE2,Angiotensin-converting enzyme 2,41900,0.132302984579369,0.00578695535008474,0.120960552093203,0.143645417065536,1.67683341953936e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F11R,Junctional adhesion molecule A,42137,0.134932974603965,0.0059145701359695,0.123340417137465,0.146525532070465,4.49246995568791e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0779349931861649,0.00341818038408833,0.0712353596333518,0.084634626738978,5.88165971483699e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS8,Prostasin,42080,0.100977408795421,0.00443555064353319,0.0922837295340962,0.109671088056746,1.32232112461878e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.191971136403073,0.00842142361289268,0.175465146121803,0.208477126684343,1.69247334983092e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F10,Coagulation factor X,39990,0.0698578135745422,0.00306788201225472,0.0638447648305229,0.0758708623185614,2.8123150951073e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YTHDF3,YTH domain-containing family protein 3,41913,0.206367877449171,0.00909454571990783,0.188542567838151,0.22419318706019,7.12106559584743e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABL1,Tyrosine-protein kinase ABL1,42070,0.162131451047372,0.00715995102480732,0.14809794703875,0.176164955055994,1.89113940674875e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL16,Pro-interleukin-16,42296,0.101651554391976,0.00449117105191455,0.0928488591302233,0.110454249653728,2.20642946649525e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISM1,Isthmin-1,42119,0.0947690748218331,0.00420052623101816,0.0865360434090375,0.103002106234629,1.13696408439659e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YOD1,Ubiquitin thioesterase OTU1,39575,0.144798076375559,0.00643142789761111,0.132192477696242,0.157403675054877,9.02735420965329e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAA80,N-alpha-acetyltransferase 80,39649,0.293863298229723,0.0130590843311874,0.268267492940596,0.319459103518851,1.11580631594991e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOST,Sclerostin,42129,0.0923415628363704,0.00411232859511396,0.0842813987899471,0.100401726882794,1.14560839163994e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLUL1,Clusterin-like protein 1,42123,-0.106021211526878,0.00474553347958687,-0.115322457146868,-0.0967199659068874,1.33976956739353e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.118218440619558,0.00528722953143191,0.107855470737951,0.128581410501164,2.33212626065523e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,P4HB,Protein disulfide-isomerase,42073,0.0911966982774783,0.00409953859214163,0.0831616026368807,0.0992317939180759,1.06946065889218e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0658420122194102,0.00296117866994947,0.0600381020263092,0.0716459224125111,1.32150520183394e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STC1,Stanniocalcin-1,42249,0.10795632967877,0.00486755963854802,0.0984159127872159,0.117496746570324,4.25168280340589e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSD,Cathepsin D,41225,0.0971631740899401,0.00439521819323196,0.0885485464312055,0.105777801748675,2.8006493195994e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES3,Carboxylesterase 3,42070,0.166403811333551,0.00754729395823185,0.151611115175417,0.181196507491686,7.34149581789542e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCXR,L-xylulose reductase,42181,0.127018892101122,0.00576463541467633,0.115720206688356,0.138317577513887,9.5580431961687e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.113400169287629,0.00514316488070257,0.103319566121452,0.123480772453806,1.74822641589574e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTSS2,Protein MTSS 2,39919,0.234672047418292,0.0106636809243486,0.213771232806569,0.255572862030016,3.91017761970779e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGF,Hepatocyte growth factor,42296,0.0802591249299447,0.0036693038134334,0.0730672894556152,0.0874509604042741,2.82792991852924e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.227069128256132,0.0103827524923459,0.206718933371134,0.24741932314113,3.24207616294365e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TJAP1,Tight junction-associated protein 1,42181,0.193014564045721,0.0088341365033717,0.175699656499112,0.210329471592329,4.90307713826316e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1R2,Interleukin-1 receptor type 2,42100,0.0464789904988224,0.00212878822037007,0.042306565586897,0.0506514154107477,6.92261755913744e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAB2,Stabilin-2,39966,0.0651301810616947,0.00298102822195908,0.0592873657466549,0.0709729963767345,1.08123081699297e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.230445284410162,0.0105816302501535,0.209705289119861,0.251185279700462,4.79543277216826e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.195868523752252,0.00899526636388773,0.178237801679032,0.213499245825472,5.82331008003872e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYAP1,Synapse-associated protein 1,39736,0.134810154886831,0.0062078088326143,0.122642849574907,0.146977460198755,1.89174396730468e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.207391869290426,0.00956961425830691,0.188635425344144,0.226148313236707,2.14936351899044e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.245414388032658,0.0113287158692547,0.223210104928919,0.267618671136397,2.49521054276813e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.262418565406318,0.0120940532341679,0.238714221067349,0.286122909745287,2.73406071409016e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0845155650145976,0.00391204224666608,0.0768479622111321,0.0921831678180631,8.72810185195571e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLKB1,Plasma kallikrein,39759,0.0562423470910611,0.00260003902784336,0.0511462705964881,0.0613384235856341,1.09869542611599e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXLNA,Alpha-taxilin,42016,0.201567912795433,0.00936079048981281,0.1832207634354,0.219915062155466,3.88553563357693e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",42070,0.194077772935229,0.00902805180363708,0.1763827914001,0.211772754470358,8.1069488082118e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FN1,Fibronectin,39979,0.0621053935782199,0.00289170809693687,0.0564376457082236,0.0677731414482162,2.4675548454194e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP3S2,AP-3 complex subunit sigma-2,39929,0.109827643635054,0.00511934739764883,0.0997937227356626,0.119861564534446,4.10019320050907e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.068373136024706,0.00318883115490963,0.0621230269610832,0.0746232450883289,5.25197497639063e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BECN1,Beclin-1,39638,0.135091244413533,0.00631197897657544,0.122719765619445,0.147462723207621,1.32177080941227e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.178001213860273,0.00832508342208603,0.161684050352984,0.194318377367562,1.82983847641976e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0935822590513117,0.00438198798657696,0.0849935625976209,0.102170955505003,3.04980948618607e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18R1,Interleukin-18 receptor 1,42296,0.0748598320454996,0.00351408406671352,0.0679722272747412,0.0817474368162581,4.30113313719803e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.227022571933261,0.010660349067902,0.206128287760173,0.247916856106349,5.19179164730089e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0809500630579417,0.00380287152943853,-0.0884036912556413,-0.0734964348602422,6.30592903582524e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.120119679165989,0.00565603697632265,0.109033846692396,0.131205511639581,3.49750146592967e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MASP1,Mannan-binding lectin serine protease 1,41997,0.0519709026628641,0.00245296108930508,0.0471630989278262,0.0567787063979021,5.0634182995528e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.165033385230421,0.00780094879701363,0.149743525588274,0.180323244872567,1.00704630434098e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP85,Centrosomal protein of 85 kDa,41843,0.146299293384246,0.00693584441090407,0.132705038338874,0.159893548429618,3.60990351309431e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL10,C-X-C motif chemokine 10,42185,0.147601897970399,0.00701680204421698,0.133848965963734,0.161354829977064,1.0733291368362e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A4,Protein S100-A4,42181,0.125362744715834,0.00596336309316257,0.113674553053235,0.137050936378432,1.41065351370691e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EZR,Ezrin,42249,0.0543382089001544,0.00258698655126252,0.0492677152596799,0.059408702540629,1.99007854789541e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFX1,Transcriptional repressor NF-X1,39575,0.150529205653437,0.00717196986497278,0.136472144718091,0.164586266588784,6.30853246046599e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA3F,Semaphorin-3F,42145,0.0594335597602936,0.00283741669710054,0.0538722230339765,0.0649948964866106,6.66654530252646e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP20,Centrosomal protein 20,41843,0.167521502766657,0.00801191732097017,0.151818144817555,0.183224860715758,1.53767704916804e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.136438253712668,0.00653160636505959,0.123636305237151,0.149240202188185,2.31441559322575e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.121491377717839,0.00582631776305004,0.110071794902261,0.132910960533418,4.78001550625677e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD63,CD63 antigen,41992,0.111869932052604,0.00537069698443452,0.101343365963112,0.122396498142096,7.38331298784743e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.180693696817467,0.00867640816436165,0.163687936815319,0.197699456819616,7.46621811027024e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA2,Apolipoprotein A-II,39990,-0.109351041647943,0.00524601341457253,-0.119633227940505,-0.0990688553553809,9.89208239430262e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUOM,Fucose mutarotase,39736,0.142665244074523,0.00684294455470271,0.129253072747306,0.156077415401741,1.00062208993365e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.116351499145523,0.00559481883047804,0.105385654237786,0.12731734405326,1.44105414677407e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN1,Dynactin subunit 1,42262,0.141410869178854,0.00680272063711176,0.128077536730115,0.154744201627593,1.62352854259693e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR5,Cadherin-related family member 5,42145,0.085632700579357,0.00412154699637022,0.0775544684664714,0.0937109326922426,2.06741615845439e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARF6,ADP-ribosylation factor 6,39930,0.240043493769188,0.0115518843608646,0.217401800421894,0.262685187116483,3.72893516902468e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AXIN1,Axin-1,42119,0.213284137278648,0.0102951650249045,0.193105613829835,0.233462660727461,6.95938618528986e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.116481304412352,0.00562223652005208,0.10546172083305,0.127500887991654,7.30458862181514e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFB1,BPI fold-containing family B member 1,42098,-0.142716223425782,0.00689080194271113,-0.156222195233495,-0.129210251618068,7.86142869472287e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.146554500838387,0.00708071125283071,0.132676306782839,0.160432694893935,1.09654995976202e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPK9,Mitogen-activated protein kinase 9,42119,0.0944514886054996,0.00456923851080851,0.085495781124315,0.103407196086684,1.74621627692507e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCN2,Ficolin-2,42116,0.089099985012693,0.00431553926720081,0.0806415280489794,0.0975584419764065,2.87773846913387e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17RB,Interleukin-17 receptor B,41934,-0.118396153376779,0.00576931103807416,-0.129704003011404,-0.107088303742153,3.63375460341902e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.061656539205372,0.00300349913356277,0.055769680903589,0.0675433975071551,5.61711123539743e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFC,Platelet-derived growth factor C,41843,0.0610534777886671,0.00297849454004783,0.0552156284901733,0.0668913270871608,5.94663648643497e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGRN,Agrin,42185,0.0781710096754677,0.00381989420727065,0.0706840170292172,0.0856580023217181,1.07767113274483e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK1,Dickkopf-related protein 1,42249,0.12838802144235,0.00627856874272214,0.116082026706614,0.140694016178085,1.4476551872572e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.158629718952823,0.00776847132360071,0.143403515158566,0.17385592274708,2.58718018928891e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NHLRC3,NHL repeat-containing protein 3,39481,0.0700725479815298,0.00342939138251993,0.0633509408717907,0.0767941550912689,4.31264533614007e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANG,Angiogenin,42152,0.0710947633759963,0.0034918840999616,0.0642506705400716,0.077938856211921,8.58857801891521e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEP1A,Meprin A subunit alpha,39930,0.164247660235885,0.00808859455551619,0.148394014907073,0.180101305564697,4.50816644962724e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.178620867322919,0.00881336351444524,0.161346674834607,0.195895059811232,1.03185977185368e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KAZN,Kazrin,39930,0.225294611132011,0.0111589474923613,0.203423074046983,0.247166148217039,4.41539606224843e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.124977867859409,0.00620222317956549,-0.137134225291357,-0.11282151042746,5.49548295333238e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAXX,Protein PAXX,39736,0.0992411774698878,0.0049185413337902,0.089600836455659,0.108881518484117,6.00756315465804e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EHBP1,EH domain-binding protein 1,39958,0.160752653520281,0.00797599437635483,0.145119704542626,0.176385602497937,8.67427204981718e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0507526870232207,0.0025227450236133,0.0458081067769387,0.0556972672695028,9.98563034658533e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTD,Biotinidase,39979,0.0437547975681323,0.00218244499890488,0.0394772053702787,0.0480323897659858,6.78578869643888e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0848892455182327,0.00424577677859449,-0.0932109680042779,-0.0765675230321875,1.14330350558177e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBIN,Erbin,42070,0.21806613346934,0.0109185309433418,0.19666581282039,0.23946645411829,1.76863627305925e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0826426323295753,0.0041400710264624,0.074528093117709,0.0907571715414416,2.07328909658571e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0795961447981915,0.0039808879510453,0.0717936044141427,0.0873986851822403,2.07878208783609e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNA4,Plexin-A4,42119,0.171506024788178,0.0085912185487446,0.154667236432639,0.188344813143718,2.0919981052696e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.194935552086666,0.0097677328515782,0.175790795697573,0.21408030847576,2.45605807775342e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,41839,0.168415246577426,0.00843877249488805,0.151875252487446,0.184955240667407,2.47813195133761e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH2,Cadherin-2,42145,0.0749959834669693,0.00376057350752493,0.0676252593922205,0.0823667075417182,3.083588344113e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.23139713874956,0.0115920715633404,0.208676678485413,0.254117599013708,3.70469924165535e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL17,C-X-C motif chemokine 17,42296,0.0902463971306569,0.00454081547227986,0.0813463988049883,0.0991463954563254,1.12233292544107e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELE,E-selectin,42310,0.106745479921319,0.0053823468555607,0.0961960800844204,0.117294879758218,2.52112684854956e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.156911238451623,0.00795433533333651,0.141320741198283,0.172501735704962,3.77814091272017e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCR,Breakpoint cluster region protein,42119,0.193929964332251,0.00986433563421563,0.174595866489188,0.213264062175314,7.28461296862852e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASAH2,Neutral ceramidase,42016,0.111428478119758,0.0056728986646228,0.100309596737097,0.122547359502418,1.03883584737022e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC1B,C-type lectin domain family 1 member B,42249,0.199978726246222,0.0101839770731464,0.180018131182855,0.219939321309589,1.10551824087856e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.220409233663663,0.0112483675777601,0.198362433211253,0.242456034116072,2.55459161642881e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCTN3,Tectonic-3,39958,0.0635515351378395,0.00323917968610569,0.0572027429530724,0.0699003273226067,2.59425145289546e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL22,C-C motif chemokine 22,41991,0.108388424378651,0.0055342869288817,0.0975412219980426,0.119235626759259,3.12496609018156e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IKBKG,NF-kappa-B essential modulator,42119,0.190844323887432,0.00976391126804371,0.171707057802066,0.209981589972798,6.41291877124276e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.228765537848811,0.0117274480421851,0.205779739686129,0.251751336011494,2.23669133737167e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0556778965181098,0.00286374950089287,0.0500649474963598,0.0612908455398598,4.59902741373635e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,42310,0.13747005818718,0.00708657961304528,0.123580362145612,0.151359754228749,1.01409724684932e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F13B,Coagulation factor XIII B chain,39925,0.0529101490582695,0.00272745691742195,0.0475643335001224,0.0582559646164165,1.70101649163696e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE4,Ribonuclease 4,39645,0.0572898778041877,0.00295356959544868,0.0515008813971082,0.0630788742112671,1.91515713479933e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDLIM7,PDZ and LIM domain protein 7,42185,0.259028405790849,0.013378636594275,0.23280627806607,0.285250533515628,2.10087862315752e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP10,Stromelysin-2,42124,-0.118954012958749,0.00614871636064851,-0.13100549702562,-0.106902528891878,2.83067166167937e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0410470055663565,0.00212605496260558,0.0368799378396495,0.0452140732930634,6.021678901413e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD6,T-cell differentiation antigen CD6,42284,0.107149833762512,0.00555896895978618,0.0962542546013306,0.118045412923692,1.04845590856291e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.214377727109663,0.0111214795008839,0.19257962728793,0.236175826931395,1.0624782531518e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KITLG,Kit ligand,42145,-0.0784703363259546,0.00407329829312542,-0.0864540009804804,-0.0704866716714287,1.3112418323871e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF3,Immunoglobulin superfamily member 3,42070,0.0760381277090611,0.00394901762450186,0.0682980531650375,0.0837782022530847,1.5928477393803e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP5,Microfibrillar-associated protein 5,42310,0.0828578330219678,0.00431348709937366,0.0744033983071954,0.0913122677367401,3.61362878285481e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSP1,Lymphocyte-specific protein 1,42119,0.0830554233246159,0.00432782155246156,0.0745728930817913,0.0915379535674406,5.23553919384966e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.10795470382323,0.00562913486456077,0.0969215994886912,0.118987808157769,6.73585534513218e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSO,Cathepsin O,42296,0.0626082204975735,0.00326561750984703,0.0562076101782733,0.0690088308168737,7.25647062452125e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.145136707623527,0.00756932192091225,0.130300836658539,0.159972578588515,7.43287514672476e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,42070,0.280367340805798,0.0146237961267989,0.251704700397272,0.309029981214324,7.54589358379723e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R9B,Neurabin-2,42296,0.19373429538014,0.0101144051408812,0.173910061304012,0.213558529456267,1.00954332085399e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,42119,0.134632800426337,0.00703003901588073,0.120853923955211,0.148411676897463,1.10619151404314e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATG16L1,Autophagy-related protein 16-1,39930,0.176047826860502,0.00918881879357542,0.158037742025094,0.19405791169591,1.52149494232518e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.183020685802935,0.00956592232901206,0.164271478038071,0.201769893567798,2.48407821933458e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.142364382074764,0.00744375390646866,0.127774624418085,0.156954139731442,2.84087119233399e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLA2,Src-like-adapter 2,39934,0.21702930359751,0.0113722434559437,0.19473970642386,0.239318900771159,6.09783236395607e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP23,Synaptosomal-associated protein 23,42145,0.176622982155876,0.00927073939966715,0.158452332932529,0.194793631379224,7.03189781197043e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNIP1,TNFAIP3-interacting protein 1,39929,0.179642996952656,0.00941911119213483,0.161181539016072,0.198104454889241,7.61813263782055e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THOP1,Thimet oligopeptidase,42081,0.0635310047220919,0.00334336985690061,0.0569779998025667,0.0700840096416171,1.78633584825397e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMOT,Angiomotin,39736,0.0776109895325882,0.0040807723007535,0.0696126758231113,0.085609303242065,2.15079009999763e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BACH1,Transcription regulator protein BACH1,42119,0.15202353219137,0.00801944496524426,0.136305420059492,0.167741644323249,4.10373497473046e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PXN,Paxillin,41839,0.103879042827127,0.0054790601482493,0.0931400849365581,0.114618000717695,4.12140377202918e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELP,P-selectin,42217,0.112847690779461,0.0059533485974155,0.101179127528527,0.124516254030396,4.152106615354e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOF,Apolipoprotein F,39990,-0.0523253957862016,0.00275951502583735,-0.0577340452368428,-0.0469167463355604,5.77089960044007e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.099716536721071,0.00527362956094823,0.0893802227816124,0.11005285066053,1.05257976350109e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C19orf12,Protein C19orf12,41839,0.134617013629902,0.00713494913948074,0.12063251331652,0.148601513943284,2.25413533006774e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPL,N-acetylneuraminate lyase,39958,0.0935298724443394,0.0049526184691592,0.0838227402447874,0.103237004643891,2.39201609974729e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.113059779167141,0.00599517079378559,0.101309244411321,0.124810313922961,2.57071162315174e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSME1,Proteasome activator complex subunit 1,42002,0.0730857351115237,0.00387570192199054,0.0654893593444223,0.0806821108786252,2.62748979790634e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH1A1,Retinal dehydrogenase 1,42137,0.107000564301977,0.00568520949214573,0.0958575536973715,0.118143574906583,5.03342234724952e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5E,5'-nucleotidase,42181,0.107607115896235,0.00574348514102086,0.0963498850198337,0.118864346772635,2.39386939616578e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.189856540585585,0.0101370375223667,0.169987947041746,0.209725134129424,2.69706286845065e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOE,Apolipoprotein E,39979,0.139300360179957,0.0074429831317335,0.124712113241759,0.153888607118155,5.25787843630759e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.214970642152338,0.0114900777778652,0.192450089707723,0.237491194596954,5.93832896611723e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.145497392731489,0.00777540857331997,0.130257591927782,0.160737193535196,6.03452706893486e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP2B,DNA topoisomerase 2-beta,39657,0.160081076465414,0.00857214839001308,0.143279665620989,0.17688248730984,1.19716678827707e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CMIP,C-Maf-inducing protein,39919,0.166607902194864,0.00895532644024371,0.149055462371987,0.184160342017742,4.0230945689006e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAT,Linker for activation of T-cells family member 1,42296,0.150413022329096,0.0080955072887886,0.13454582804307,0.166280216615122,4.0260688592213e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD5,Programmed cell death protein 5,42249,0.113607195863923,0.00611580475562576,0.101620218542897,0.12559417318495,4.34650317449589e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.136169229604649,0.00732041511671275,0.121821215975892,0.150517243233406,4.53597501461937e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAB2,Disabled homolog 2,42262,0.219898307934718,0.0118401215149777,0.196691669765362,0.243104946104074,4.63932126757383e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMBP,Protein AMBP,42239,0.0399398879473696,0.00215229384396992,0.0357213920131886,0.0441583838815507,6.15914315729677e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRPK2,SRSF protein kinase 2,42119,0.168708310708815,0.0091080415217316,0.150856549326221,0.186560072091409,1.16019046805563e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLSCR3,Phospholipid scramblase 3,39911,0.113989076181016,0.00615114991205023,0.101932822353398,0.126045330008634,1.50723800777476e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINF2,Alpha-2-antiplasmin,39786,0.026510752208093,0.00143118931488654,0.0237056211509154,0.0293158832652706,1.78312174549016e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.225577489025511,0.0121851150158826,0.201694663594381,0.249460314456641,2.11157416567633e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXO1,Forkhead box protein O1,42119,0.170851756928577,0.00927261960581376,0.152677422501182,0.189026091355972,6.76960150316855e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.125440848037096,0.00681545642536235,0.112082553443385,0.138799142630806,1.01433333894597e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLIN1,Perilipin-1,41839,0.0667716071806571,0.0036279588199277,0.0596608078935988,0.0738824064677154,1.02631035202064e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINH1,Serpin H1,39757,0.252828110862243,0.0137361462037323,0.225905264302928,0.279750957421558,1.48361726765706e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FETUB,Fetuin-B,42199,0.0631318507252349,0.00343490823005625,0.0563994305943246,0.0698642708561451,1.52885562706266e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFC,Vascular endothelial growth factor C,42181,0.108632802885802,0.00591791046451299,0.0970336983753564,0.120231907396247,2.31258405737535e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0391729616315917,0.00213886960537903,0.0349807772050488,0.0433651460581346,4.96955118284613e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMPR,GMP reductase 1,42296,0.0927917352067071,0.00508783737526294,0.0828195739511917,0.102763896462222,1.90480165560698e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.144555022490835,0.00792053201667425,0.129030779738153,0.160079265243516,2.43633399449963e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.129470401549589,0.00710888931885652,0.11553697848463,0.143403824614548,3.21154902106145e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGF,Placenta growth factor,42296,0.0509371718282893,0.00279842720781565,0.0454522545009706,0.056422089155608,3.6131068241452e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCK2,Cytoplasmic protein NCK2,42185,0.207872601669034,0.0114215495047737,0.185486364639678,0.230258838698391,3.8068772539822e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.163897900335844,0.0089994332787356,0.146259011109523,0.181536789562166,4.54284552101541e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.190000956231635,0.0104469924273969,0.169524851073937,0.210477061389333,4.71406908984343e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSNK2A1,Casein kinase II subunit alpha,39934,-0.086536075858244,0.00475547105527163,-0.0958567991265764,-0.0772153525899117,5.91344137018307e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0465487909804662,0.00256581095823805,0.0415198015023196,0.0515777804586128,1.07766091933363e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0720972157803846,0.00398075062244517,0.0642949445603921,0.0798994870003772,1.83956977379691e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.219060538483383,0.01210072985472,0.195343107968132,0.242777968998634,2.15316626970579e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.161794603910612,0.00894257085179398,0.144267165041096,0.179322042780128,2.60987117558373e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.149097814302296,0.00823179530489252,0.132963495504707,0.165232133099885,2.63560548317607e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL5,C-C motif chemokine 5,42217,0.194790037857211,0.0107754557523527,0.173670144582599,0.215909931131822,3.3592509762297e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL32,Interleukin-32,42119,-0.0859561395772445,0.00475898781256374,-0.0952837556898694,-0.0766285234646196,4.46876845266705e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.134981910918078,0.0074790493265523,0.120322974238036,0.149640847598121,5.88028633179084e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN2,CCN family member 2,42146,0.108884900548155,0.00603605599136266,0.0970542308050839,0.120715570291226,6.65864564192322e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUCB2,Nucleobindin-2,42231,0.0722346702409924,0.00400532323120399,0.0643842367078326,0.0800851037741522,7.11373158988036e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEFTY2,Left-right determination factor 2,42247,0.0991498336264251,0.00550826347566196,0.0883536372141276,0.109946030038723,1.30433146324255e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCBP2,Poly(rC)-binding protein 2,39934,0.140185847072045,0.00779374229400789,0.124910112175789,0.1554615819683,2.40909598964786e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.12020112291953,0.00668663337067373,0.10709532151301,0.133306924326051,2.88990472505309e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.148556136001766,0.00828761355196054,0.132312413439923,0.164799858563608,5.01353592862274e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0808144944378979,0.00451436255680837,0.0719663438265535,0.0896626450492423,7.38472047967091e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.077685714283559,0.00434310778667293,0.0691732230216801,0.086198205545438,1.38317704802751e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC13,Mucin-13,41839,0.100685692376308,0.00563737360063047,0.0896364401190724,0.111734944633544,1.60930601077066e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP43,Centrosomal protein 43,41797,0.134022576063538,0.00751764423884304,0.119287993355405,0.14875715877167,2.86479893765853e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH2B3,SH2B adapter protein 3,41843,0.18778337114458,0.0105479923990767,0.16710930604239,0.20845743624677,4.40141431961737e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.205426652329294,0.0115643964739729,0.182760435240307,0.228092869418281,1.18330243884782e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL5,C-X-C motif chemokine 5,42101,0.212348984028109,0.0120416698409624,0.188747311139823,0.235950656916396,7.89764331008552e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MINK1,Misshapen-like kinase 1,39929,0.175677255774047,0.00995513414093324,0.156165192857818,0.195189318690276,8.91244025211892e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTBS,Di-N-acetylchitobiase,39860,0.051702484166188,0.00294145676691255,0.0459372289030394,0.0574677394293366,2.99393806900807e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREG1,Protein CREG1,41960,0.0758397783822612,0.00432064495310229,0.0673713142741807,0.0843082424903417,3.28897029110769e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFRP4,Secreted frizzled-related protein 4,39736,0.0749478520636371,0.00427068212351381,0.06657731510155,0.0833183890257242,4.93241542867785e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC27,Cell division cycle protein 27 homolog,41843,0.114309595600331,0.00652383408919451,0.10152288078551,0.127096310415153,5.69525284234762e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.177625646238327,0.0101475038195034,0.1577365387521,0.197514753724554,7.51865754830808e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.178075279099904,0.0101732467478183,0.15813571547418,0.198014842725628,7.64417029387024e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0957584411067977,0.00546487101289574,0.0850472939215221,0.106469588292073,8.00912942694855e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.192354733953915,0.0109837284270279,0.17082662623694,0.213882841670889,9.41158698735505e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYTL4,Synaptotagmin-like protein 4,39958,0.136089149354872,0.00777581131191678,0.120848559183515,0.151329739526229,1.07345707695857e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM5,Tripartite motif-containing protein 5,42119,0.162547353983951,0.00929830699110181,0.144322672281392,0.180772035686511,1.10084659860166e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOK2,Docking protein 2,42145,0.229489563765714,0.013139414757961,0.203736310840111,0.255242816691318,1.43510222625287e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.154161714741465,0.00883062771335761,0.136853684423285,0.171469745059646,1.71351884172012e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SULT2A1,Bile salt sulfotransferase,42119,0.109854890659871,0.00630040501058153,0.097506096839131,0.122203684480611,2.38889557530609e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NIT2,Omega-amidase NIT2,39903,0.135809146272345,0.00780361022989401,0.120514070221753,0.151104222322938,5.78586648251628e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIP,Gastric inhibitory polypeptide,39638,0.0939891852042802,0.00540849132421032,0.083388542208828,0.104589828199732,9.32144637943295e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP3B1,AP-3 complex subunit beta-1,39930,0.143082926107475,0.00823829698417027,0.126935864018502,0.159229988196449,1.04994915657061e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRP14,Signal recognition particle 14 kDa protein,42070,0.11067278554032,0.0063938596710908,0.0981408205849823,0.123204750495658,2.09231782379888e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.11840903140611,0.00684152009063521,0.104999652028465,0.131818410783755,2.93268755689954e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0902352676953509,0.00522452289381528,0.0799952028234729,0.100475332567229,4.0817204127625e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3GLB2,Endophilin-B2,39929,0.121416892469736,0.00702996416225561,0.107638162711715,0.135195622227757,5.39595474052179e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0994544234101732,0.00576299617795726,0.0881589509013769,0.110749895918969,7.02847116086065e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL13,C-C motif chemokine 13,42275,0.12550205534282,0.00728864421229149,0.111216312686729,0.139787797998911,9.44999370391237e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOLM2,Protein GOLM2,42249,0.0418662168100283,0.00243343783901767,0.0370966786455537,0.0466357549745029,1.20682998625452e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFB,Platelet-derived growth factor subunit B,42185,0.157776046362871,0.00917102823630848,0.139800831019707,0.175751261706036,1.23252004136377e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.20566792484464,0.0119588729213534,0.182228533918788,0.229107315770493,1.39001108345445e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEXIM1,Protein HEXIM1,42119,0.148625341960027,0.00865086473999237,0.131669647069642,0.165581036850412,1.841939993334e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTUD7B,OTU domain-containing protein 7B,39934,0.116033156973247,0.00675567583874118,0.102792032329315,0.12927428161718,2.70087303053026e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAO1,Hydroxyacid oxidase 1,42262,0.226863652775643,0.0132256348757494,0.200941408419174,0.252785897132112,2.86002948387885e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,39736,0.141126800896041,0.0082273269860834,0.125001240003317,0.157252361788764,4.05449973873034e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.105834827279159,0.00617793664844407,0.0937260714482082,0.117943583110109,4.27782779754098e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0357270555838946,0.0020922225230964,-0.0398278117291636,-0.0316262994386257,1.07025184996143e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP2,Methionine aminopeptidase 2,42247,0.101842567763956,0.00596548700728654,0.0901502132296742,0.113534922298237,1.12491706932699e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USO1,General vesicular transport factor p115,42070,0.162257697270715,0.00952389257019082,0.143590867833141,0.180924526708289,2.06449010867389e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYN,Tyrosine-protein kinase Lyn,42070,0.154635148507039,0.0090784278174163,0.136841429984903,0.172428867029175,2.19479113287766e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0498786159075086,0.00293146093120873,0.0441329524823395,0.0556242793326777,2.96368795680565e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0535047838426505,0.00314500931023986,0.0473405655945804,0.0596690020907206,3.18347456476766e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPD52L2,Tumor protein D54,39736,0.197639237877647,0.0116296254229818,0.174845172048603,0.220433303706691,5.76065099352897e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPHN1,Oligophrenin-1,39929,0.197084095192146,0.0116008956273088,0.174346339762621,0.219821850621671,6.14642734697297e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0968997022221229,0.00571504600602786,0.0856982120503083,0.108101192393937,8.29349196318448e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.185705998148927,0.0109605965757311,0.164223228860494,0.20718876743736,9.73524502868311e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL17,C-C motif chemokine 17,42107,0.165760562483753,0.0097920605684417,0.146568123769607,0.184953001197898,1.26399151437867e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIT1,ARF GTPase-activating protein GIT1,39657,0.175502822440852,0.0103615855496548,0.155194114763529,0.195811530118176,1.49346744266782e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEC31A,Protein transport protein Sec31A,39638,0.140233314488554,0.0082820775115726,0.124000442565871,0.156466186411236,1.64625367276627e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK11,Serine/threonine-protein kinase STK11,41900,0.131748134878451,0.00780459888646979,0.116451121060971,0.147045148695932,2.83388438507724e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPB2,Carboxypeptidase B2,39959,0.0405693244588176,0.00240310158896448,0.0358592453444473,0.045279403573188,3.58220472033687e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.114198459217272,0.00677145899351297,0.100926399589986,0.127470518844557,3.72811417710443e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.146277177198565,0.00866850033030289,0.129286916551171,0.163267437845959,4.07053583640282e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.111580637845127,0.00661367821234331,0.0986178285489343,0.12454344714132,4.30640216876732e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.130290127278238,0.00772571620171635,0.115147723522874,0.145432531033602,4.81990911394818e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NSFL1C,NSFL1 cofactor p47,42249,0.11326296496544,0.00672891366494647,0.100074294182145,0.126451635748735,6.09804666670412e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.141584102331479,0.00841170738912708,-0.158071048814168,-0.12509715584879,6.20208062004533e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGLN1,Egl nine homolog 1,42119,0.10079664179231,0.00599328126312018,0.0890498105165945,0.112543473068026,7.7949753322686e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.184765539842557,0.0109807325709151,0.163243304003564,0.206287775681551,9.02426785459187e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNST,Consortin,42145,0.195835745130408,0.0116567048588253,0.172988603607111,0.218682886653706,1.04671119956256e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LBR,Delta(14)-sterol reductase LBR,42249,0.122354728072902,0.00728422605892052,0.108077644997418,0.136631811148387,1.08875193619468e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRAP,BRCA1-associated protein,39813,0.197641759992315,0.0117789755510179,0.17455496791232,0.22072855207231,1.99510509073226e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AZI2,5-azacytidine-induced protein 2,39934,0.0997883232343004,0.00594777410032865,0.0881306859976563,0.111445960470945,2.01670447482639e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.186450555437901,0.0111352053842366,0.164625552884798,0.208275557991005,2.62551493571701e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.102948985801114,0.00617036472829604,0.0908550709336538,0.115042900668574,6.99508950409873e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0680209273859571,0.00407729060802596,0.0600294377942262,0.0760124169776879,7.2474389396835e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSTN,Growth/differentiation factor 8,41900,0.096198761334063,0.00577734880383075,0.0848751576785547,0.107522364989571,1.24989617426589e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0428029793501544,0.00257288384113247,0.0377601270215347,0.047845831678774,1.58719747562156e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMN,Protein amnionless,41913,0.0840713481767908,0.00506070951442298,0.0741523575285218,0.0939903388250599,2.34098320000006e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLK1,Protein delta homolog 1,42310,0.102725620614803,0.00619399070647929,0.0905853988301039,0.114865842399503,3.54158450358691e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.138783958886572,0.0083675942496594,0.122383474157239,0.155184443615904,4.61172585873471e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0784570596694182,0.0047409495287122,0.0691647985931423,0.0877493207456941,6.51376726018052e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0979430496014999,0.00591902951592203,0.0863417517502927,0.109544347452707,6.5431927524595e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDUA,Alpha-L-iduronidase,42262,0.0833564914021285,0.00504779413504597,0.0734628148974384,0.0932501679068186,1.13572813194086e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFASC,Neurofascin,42296,0.0514994486300694,0.00312142399737005,0.0453814575952241,0.0576174396649147,1.43831950943026e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AAMDC,Mth938 domain-containing protein,39638,0.0936100232538497,0.00566871503329159,0.0824993417885982,0.104720704719101,1.55848918835067e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0920233978186155,0.00559160165355993,0.081063858577638,0.102982937059593,2.84446500273985e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GASK1A,Golgi-associated kinase 1A,39575,0.075279867554752,0.00457125840768385,0.0663202010756917,0.0842395340338124,3.27325257679662e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNMBP,Dynamin-binding protein,42016,0.106789913806026,0.00649387701935769,0.0940619148480845,0.119517912763967,3.54705020369308e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAX1BP1,Tax1-binding protein 1,39929,0.10934001988174,0.006643478864122,0.0963188013080609,0.122361238455419,3.64532239907225e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAMBP,STAM-binding protein,41997,0.110805730100092,0.00674663713017005,0.0975823213249589,0.124029138875226,4.97949188969018e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA5,Integrin alpha-5,42137,0.043729644431082,0.00266340695395422,0.0385093668013317,0.0489499220608322,5.33839575440479e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.127652431192517,0.00777252104568207,0.11241828994298,0.142886572442054,6.35069673942896e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTDH,Protein LYRIC,39657,0.166809178573967,0.0101925536061179,0.146831773505976,0.186786583641958,1.67620788459554e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COCH,Cochlin,39958,0.0804121993630925,0.00491657818970778,0.0707757061112653,0.0900486926149198,1.90133146748261e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAG1,Dystroglycan,42185,0.0830636081992689,0.00508528605179201,0.0730964475377566,0.0930307688607813,2.07716669896669e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL4A1,Collagen alpha-1(IV) chain,42145,-0.06858128840774,0.00420728781593,-0.0768275725269628,-0.0603350042885172,3.57196624971694e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.190848211347428,0.0117091742400466,0.167898229836937,0.21379819285792,3.64880028466026e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOLGA3,Golgin subfamily A member 3,39934,0.135392959064021,0.00831157602681548,0.119102270051463,0.151683648076579,5.45423675523838e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGCC,Regulator of cell cycle RGCC,39934,0.133368363549535,0.00819487338507715,0.117306411714784,0.149430315384287,6.93894924095425e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.165452606742708,0.0101800069524053,0.145499793115993,0.185405420369422,7.87622855856632e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.147443086569382,0.00908049679981428,0.129645312841746,0.165240860297018,9.81924451732048e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBKS,Ribokinase,41830,0.0860403132804101,0.00530546426762174,0.0756416033158715,0.0964390232449487,1.39609422313492e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGBP1,Immunoglobulin-binding protein 1,39934,0.104176078807048,0.0064195664969292,0.0915937284730664,0.116758429141029,1.46106360045761e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CMC1,COX assembly mitochondrial protein homolog,39958,0.158709560695238,0.0097861444178721,0.139528717636209,0.177890403754267,1.71089919542032e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0986541149402411,0.0060900432902038,0.0867176300914416,0.11059059978904,2.4018006090916e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.157206981826377,0.0097136514492712,0.138168224985806,0.176245738666949,3.04077445941095e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM13A,Protein FAM13A,39930,0.117702305383984,0.00727442948012464,0.10344442360294,0.131960187165029,3.11644801290346e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESM1,Endothelial cell-specific molecule 1,42123,-0.0601370281636983,0.00372040337394738,-0.0674290187766351,-0.0528450375507614,3.17028761969684e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NIT1,Deaminated glutathione amidase,39638,0.0767859473147597,0.00475391723386527,0.0674682695363838,0.0861036250931356,5.06234280006463e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX15,Sorting nexin-15,39736,0.093196375701487,0.00577096647167472,0.0818852814170046,0.104507469985969,5.23571129878632e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.191093775539516,0.0118517590953627,-0.214323223366427,-0.167864327712605,6.01926565243124e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.146898221245126,0.00910356948410581,0.129055225056279,0.164741217433974,6.50126065131024e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.175955904786595,0.0109224633936891,0.154547876534964,0.197363933038226,7.54921547372257e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QDPR,Dihydropteridine reductase,42081,0.0725958131437155,0.00451448039071156,0.0637474315779208,0.0814441947095101,1.19748067268034e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCG2,Secretogranin-2,42193,0.0568382564629888,0.00353582116012327,0.0499080469891472,0.0637684659368304,1.29705164786166e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT5,ADP-sugar pyrophosphatase,42137,0.0858624903258781,0.00534872929822496,0.0753789809013572,0.096345999750399,1.84940469134444e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0755768613928782,0.004715535079037,0.0663344126379656,0.0848193101477907,2.83095182468703e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.0967027607941851,0.00603076680204022,0.0848824578621863,0.108523063726184,3.10650470766821e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELOA,Elongin-A,42070,0.092039292087599,0.0057617513606543,0.0807462594207166,0.103332324754481,6.43789458977848e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EREG,Proepiregulin,41997,0.136820831901779,0.00859608110944873,0.11997251292726,0.153669150876299,1.59988172369881e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0564907890487588,0.00355211870830057,0.0495286363804897,0.0634529417170279,1.9330697189828e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.112738620239907,0.00708463392276096,0.0988527377512956,0.126624502728518,2.09378072092253e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.104321503172843,0.00656545811492691,0.0914532052675865,0.1171898010781,2.42457677788969e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0522866222944377,0.00328814180792074,0.045841864350913,0.0587313802379623,2.65448239835387e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUS,RNA-binding protein FUS,41831,0.0676572428733227,0.00425912062138378,0.0593093664554105,0.0760051192912349,2.65490279298079e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB27B,Ras-related protein Rab-27B,39958,0.140395751159657,0.00884157834857473,0.12306625759645,0.157725244722863,3.55408873272037e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.13158247864606,0.00829673019088992,0.115320887471916,0.147844069820205,3.9640115603978e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP3,Metalloproteinase inhibitor 3,42185,0.216022027856802,0.013694354082533,0.189181093855037,0.242862961858567,1.44902694467619e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0468659848840205,0.00297772278419741,0.0410296482269936,0.0527023215410475,2.53006846741884e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTBDN,Retbindin,42070,0.0505044536623783,0.00321139008036574,0.0442101291048614,0.0567987782198951,3.07632447236336e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARSB,Arylsulfatase B,42070,0.0935522929176795,0.00595019012347767,0.0818899202756633,0.105214665559696,3.27781764794245e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RLN2,Prorelaxin H2,39709,0.0867077384077824,0.00551075929133226,0.0759066501967711,0.0975088266187936,3.46649387525099e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0690580829981484,0.00439232737578869,0.0604491213416026,0.0776670446546942,4.14786498006386e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MITD1,MIT domain-containing protein 1,42016,0.162640238667288,0.0103558647925414,0.142342743673907,0.182937733660669,4.31382613781959e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOC1,Apolipoprotein C-I,39959,0.0648913210132302,0.00412975020997725,0.0567970106016748,0.0729856314247856,4.66397820263574e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIAE,Sialate O-acetylesterase,42147,0.0782034367051749,0.00498216485656438,0.0684383935863087,0.0879684798240411,4.86443421906494e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS8,Galectin-8,42249,0.102268013614161,0.00652284147868956,0.0894832443159295,0.115052782912393,6.39681377590137e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.122333757098113,0.00780417862574883,0.107037566991645,0.137629947204581,6.77396120799591e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST13,Hsc70-interacting protein,39736,0.0912554799308274,0.00581821315739951,0.0798517821423243,0.10265917771933,7.45213647958173e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDRKH,Tudor and KH domain-containing protein,41839,0.1426368487403,0.00912552480811297,0.124750820116399,0.160522877364202,1.3858069335805e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST3,Cystatin-C,42184,0.0479959376818621,0.00307261068607779,0.0419736207371497,0.0540182546265746,1.57094084667014e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0774078028626743,0.00496214299517204,0.0676820025921371,0.0871336031332115,2.1754036281447e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PENK,Proenkephalin-A,39736,0.0517510451188821,0.00331879488474004,0.0452462071447916,0.0582558830929725,3.02244212938241e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.126151820939727,0.00810792000215239,0.110260297735509,0.142043344143946,4.08801015031208e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH2D1A,SH2 domain-containing protein 1A,42119,0.0998669174352834,0.00642673512082805,0.0872705165984605,0.112463318272106,5.50657028012029e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERMAP,Erythroid membrane-associated protein,39657,0.0742279954506702,0.00477387969060255,0.0648711912570892,0.0835847996442512,6.03080595641743e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0815171788139764,0.00524468122266102,0.0712376036175608,0.091796754010392,6.40985943279136e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDLIM5,PDZ and LIM domain protein 5,39934,0.197595387937554,0.0127131015192346,0.172677708959854,0.222513066915254,6.41581451718678e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBNL,Drebrin-like protein,42185,0.154304556596615,0.00994033771503687,0.134821494675143,0.173787618518087,7.0242149273339e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRKL,Crk-like protein,42143,0.175519447933447,0.0113087511334046,0.153354295711974,0.19768460015492,7.31044709220128e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHACTR2,Phosphatase and actin regulator 2,39934,0.190050027227733,0.0122386908185051,0.166062193223463,0.214037861232003,7.94961799985864e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STIP1,Stress-induced-phosphoprotein 1,42105,0.106259110332074,0.00685108795154439,0.0928309779470475,0.119687242717102,8.6580311571235e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0793594625739966,0.00512081226750626,0.0693226705296843,0.0893962546183088,1.27977602730588e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0479056659590757,0.00309742340378379,0.0418347160876595,0.053976615830492,2.10083208545247e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.174604311759013,0.0112947257253057,0.152466649337414,0.196741974180613,2.34435914811771e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF2,TNF receptor-associated factor 2,42119,0.114884028182473,0.00745118551267374,0.100279704577633,0.129488351787314,3.49864122842387e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.142629471264892,0.0092454599934909,0.12450836967765,0.160750572852134,3.74076728673668e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.129337190837724,0.00838415429405542,0.112904248421375,0.145770133254072,3.76823256059505e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,41900,0.126928821139455,0.00823874036499826,0.110780890024058,0.143076752254851,4.26315499128273e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0971840728583442,0.00632350253779682,0.0847900078842625,0.109578137832426,7.42269374445318e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNB3,Plexin-B3,42099,0.0791472342293769,0.00515192148877013,0.0690494681113875,0.0892450003473664,8.14773495181478e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.148826394096465,0.00969558157194521,0.129823054215452,0.167829733977477,1.19944099920653e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCAM,Cell surface glycoprotein MUC18,42217,-0.0526330703868695,0.00343305279771801,-0.0593618538703968,-0.0459042869033422,1.2993801313902e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0462372415655489,0.00301873954968789,0.0403205120481606,0.0521539710829371,1.63664654029349e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.102922877879487,0.00671433247415121,0.0897627862301505,0.116082969528823,1.7138123768755e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBPL,FK506-binding protein-like,39930,0.0974791499913021,0.00636181050863985,0.085010001394368,0.109948298588236,1.81269863249277e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADD1,Alpha-adducin,39736,0.114069949624684,0.00746724012757056,0.0994341589746456,0.128705740274722,3.72576845216853e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYDGF,Myeloid-derived growth factor,39958,0.162780356373296,0.0106709423384426,0.141865309389949,0.183695403356643,5.02750882909374e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IST1,IST1 homolog,39850,0.16095660198634,0.0105616168490847,0.140255832962134,0.181657371010546,6.34588961459666e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0839228584636327,0.00551530007703033,0.0731128703126533,0.0947328466146122,8.93642963515279e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.108579155559356,0.00713676230438851,0.0945911014427547,0.122567209675958,9.24696759043709e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREH,Trehalase,39966,0.122781121155061,0.00807036810792923,0.10696319966352,0.138599042646603,9.25060180284066e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.173563179593256,0.0114122840628672,0.151195102830037,0.195931256356476,1.005730177476e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL4,C-C motif chemokine 4,42148,0.101406906980893,0.00667602628308724,0.0883218954660416,0.114491918495744,1.10212899897814e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.144609694027116,0.00951469518049893,0.125960891473338,0.163258496580894,1.16661141394927e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN3,Ataxin-3,39929,0.0993737049310796,0.00654548220190449,0.0865445598153468,0.112202850046812,1.49390849172495e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D23,TBC1 domain family member 23,42070,0.146494102940742,0.00965736253967611,0.127565672362976,0.165422533518507,1.50807390641748e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFA,Vascular endothelial growth factor A,42253,0.0920886178040053,0.00607458492844454,0.080182431344254,0.103994804263757,1.71639725080816e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD1,Sushi domain-containing protein 1,41900,0.0790778401569967,0.00521629460529735,0.0688539027306139,0.0893017775833795,1.75733128980694e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0623266364898807,0.00411125299407064,0.0542685806215022,0.0703846923582591,1.75901461847612e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN2L,Ataxin-2-like protein,39934,0.0782102583364295,0.0051556939253207,0.0681050982428009,0.0883154184300581,1.7954795080017e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BID,BH3-interacting domain death agonist,42119,0.107776491673988,0.00711547990873768,0.0938301510528626,0.121722832295114,2.10141621707714e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0957988752382672,0.00633734561638908,0.0833776778301446,0.10822007264639,3.3707074418433e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCC,Tubulin-specific chaperone C,42016,0.130343018891987,0.008623692091833,0.113440582391994,0.147245455391979,3.42687348177091e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGFR,Opioid growth factor receptor,42070,0.0519911648246814,0.00344226111110687,0.0452443330469119,0.0587379966024509,4.00726725310835e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.113334786616332,0.00752112992066717,0.0985933719718248,0.12807620126084,8.28938646418301e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,39735,0.10652867649706,0.00707420150727978,0.0926632415427918,0.120394111451329,9.54299966379891e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.11638092351703,0.00773049088622751,0.101229161380024,0.131532685654036,1.01196326357015e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP2B1,AP-2 complex subunit beta,39649,0.078566690482311,0.00521932358144686,0.0683368162626752,0.0887965647019469,1.04784829494189e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDHD2,Phospholipase DDHD2,39934,0.106995893858209,0.00711128384121148,0.0930577775294349,0.120934010186984,1.13132461162585e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGA,Protein O-GlcNAcase,39930,0.115160830857048,0.00765676939211156,0.100153562848509,0.130168098865586,1.22852416268124e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP5,Fatty acid-binding protein 5,42218,0.107235851001448,0.00714341299668762,0.0932347615279404,0.121236940474956,1.55697725202092e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0536386264875144,0.00357595945802928,0.046629745949777,0.0606475070252517,1.87476587748606e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0477235637407515,0.00318245045919845,0.0414859608407225,0.0539611666407805,1.96156462947758e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.134875168825565,0.00899343625219687,0.117248033771259,0.152502303879871,2.33426706874971e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.234763847968448,0.0156592056587428,0.204071804877312,0.265455891059584,2.51051083268361e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS2,Trypsin-2,42217,0.0915518287996151,0.00612959393866077,0.0795378246798399,0.10356583291939,4.78088403539274e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0692014342281604,0.00463222382648939,0.0601222755282412,0.0782805929280797,5.48332118740143e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0717251312433569,0.00480522867268876,0.0623068830448869,0.0811433794418268,5.64674797824041e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GTPBP2,GTP-binding protein 2,39649,0.131455950842172,0.00881405884127732,0.114180395513268,0.148731506171075,8.10479936607335e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.186680976457348,0.0125313890733046,0.162119453873671,0.211242499041025,8.57453954790324e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0724415225415906,0.00486342743817269,0.0629092047627721,0.081973840320409,8.81919379872821e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.135992603238536,0.0091517024228972,0.118055266489657,0.153929939987414,1.50576372752209e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD207,C-type lectin domain family 4 member K,41832,0.0620438855119079,0.00418367705932224,0.0538438784756363,0.0702438925481794,2.33385052833436e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0946198548437002,0.00638721736176995,0.0821009088146311,0.107138800872769,2.93616489841651e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0738437848581378,0.00499974594838467,-0.0836432869169717,-0.0640442827993038,5.50089937992793e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",39934,0.100554452116357,0.0068080753271424,0.0872106244751579,0.113898279757556,6.52093228681893e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6AP2,Renin receptor,41843,0.062334446427161,0.00422693590010141,0.0540496520629622,0.0706192407913598,7.84752486647843e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YJU2,Splicing factor YJU2,39919,0.0523373231926208,0.00355019044281447,0.0453789499247045,0.0592956964605372,9.7780989335753e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD36,Platelet glycoprotein 4,39657,0.0735113348606747,0.00498845955446667,0.06373395413392,0.0832887155874294,1.09050603658002e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON2,Serum paraoxonase/arylesterase 2,41900,0.0554973697024929,0.00377073986163888,0.0481067195736807,0.0628880198313051,1.19361755864581e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.195174835203238,0.0132733843436498,0.169159001889685,0.221190668516792,1.4728555356158e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.102076477969582,0.00694963109737113,0.0884552010187345,0.115697754920429,1.80298303605006e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGKA,Diacylglycerol kinase alpha,39657,0.087160249223216,0.00593521885976519,0.0755272202580762,0.0987932781883557,2.2843939055687e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAT2,Signal transducer and activator of transcription 2,39657,0.123460793837454,0.00842652937762764,0.106944796257304,0.139976791417604,3.7247148945229e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VNN1,Pantetheinase,39990,0.114697779197405,0.00784689365367588,0.0993178676362003,0.13007769075861,5.94467666090106e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0612116889899471,0.00419253949224149,0.0529943115851538,0.0694290663947404,6.46117323723148e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMMD1,COMM domain-containing protein 1,39638,0.0956070037125912,0.0065459680291793,0.0827769063753998,0.108437101049783,7.23808061968653e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD5,T-cell surface glycoprotein CD5,42239,0.0556755712559995,0.00381840308655882,0.0481915012063442,0.0631596413056548,8.5080057570016e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL11,Eotaxin,42296,0.0584242240143242,0.00401092655015165,0.0505628079760269,0.0662856400526214,1.04635560468823e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0886136476518717,0.0060838177691099,0.0766893648244163,0.100537930479327,1.08829536460344e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPACT,Protein IMPACT,39929,0.0847449896068903,0.00581718760026408,0.0733433019103727,0.0961466773034079,1.2084586772297e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS1BP3,HCLS1-binding protein 3,39638,0.142605693841637,0.00979523720653553,0.123407028916827,0.161804358766446,1.41832201775653e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.078875887884091,0.00542492351089463,0.0682430378027375,0.0895087379654444,1.55285685956361e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",41900,0.144626359197873,0.00995599826964915,0.125112602589361,0.164140115806385,1.89794296011113e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0584037118726285,0.00403609591241813,0.050492963884289,0.0663144598609681,4.20597651402258e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GET3,ATPase GET3,39958,0.0839899410289111,0.00580202240830329,0.0726179771086366,0.0953619049491855,4.50643245110022e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.113056038598673,0.00782354213490424,0.0977218960142605,0.128390181183085,5.55119982223818e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.161909398108512,0.0112116492116274,0.139934565653722,0.183884230563302,6.36517617728363e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL3,C-X-C motif chemokine 3,42129,0.147832656192402,0.0102377483402121,0.127766669445586,0.167898642939218,6.47310397539874e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXJ3,Forkhead box protein J3,39657,0.0701075614175405,0.00485360552171799,0.0605944945949732,0.0796206282401078,7.25186115787694e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,39736,0.128662609614727,0.00891116074224463,0.111196734559928,0.146128484669527,7.85167291352325e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNMT,Histamine N-methyltransferase,41961,0.0741280767639016,0.00514008194320981,0.0640535161552103,0.0842026373725928,8.50029690624951e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.112896523793921,0.00782740257288714,0.0975548147510627,0.12823823283678,9.81131238076195e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPSE,Heparanase,39866,0.147731639073145,0.0102460337198498,0.12764941298224,0.167813865164051,1.03143202291648e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0395542967021337,0.00274476376721565,0.034174559718391,0.0449340336858764,1.17178877851993e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.122626280400145,0.00851632277919709,0.105934287752918,0.139318273047371,1.18204807637619e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASC3,Protein CASC3,39649,0.0667426628111466,0.00463573330908104,0.0576566255253477,0.0758287000969454,1.41586713069808e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,39934,0.117591734068112,0.00819537963438546,0.101528789984717,0.133654678151508,2.76524820254618e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF19,Fibroblast growth factor 19,42185,0.119515458408033,0.00834224998414778,0.103164648439103,0.135866268376962,3.24313347853225e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPP,Lipoma-preferred partner,39575,0.10152390081189,0.00708295419488585,0.0876413105899135,0.115406491033866,3.52280702372525e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLB,Beta-klotho,41839,-0.115029048589822,0.00803237376983433,-0.130772501178697,-0.0992855960009466,3.59466200037706e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.086879295089905,0.00606637617735204,-0.098769392397515,-0.074989197782295,4.15758490498215e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FMNL1,Formin-like protein 1,41839,0.0971292754571917,0.00679277071332897,0.083815444859067,0.110443106055317,4.89190107454169e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD226,CD226 antigen,39657,0.0653338473196911,0.00456589378151705,0.0563846955079176,0.0742829991314645,4.94148835420817e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL7,Angiopoietin-related protein 7,42262,0.0563838739183338,0.00394615167609828,0.0486494166331811,0.0641183312034864,5.54773602703011e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,41843,0.139216543851709,0.00974415784250545,0.120117994480398,0.158315093223019,5.77401427328248e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOK1,Docking protein 1,39929,0.210162687362901,0.0147315852744895,0.181288780224902,0.239036594500901,8.85786881760925e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.105220229770711,0.00738478524338777,0.0907460506936711,0.119694408847751,9.77895393760859e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TWF2,Twinfilin-2,39966,0.130264847331321,0.00914239460492064,0.112345753905677,0.148183940756966,1.13289071304271e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TALDO1,Transaldolase,39948,0.0675665830680149,0.00474305368186339,0.0582701978515627,0.0768629682844672,1.18443340052937e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLG4,Disks large homolog 4,39929,0.110173125896006,0.0077427484890173,0.0949973388575324,0.12534891293448,1.48900488951371e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0519364052520152,0.00365364779890408,0.0447752555661632,0.0590975549378671,1.56927109108346e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0489270705579245,0.00344378851197642,-0.0556768960413983,-0.0421772450744507,1.74446883234355e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMPR2,GMP reductase 2,39736,0.10122174125291,0.00712544583084189,0.0872558674244595,0.11518761508136,2.10380763274106e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.127901505769316,0.00902213747099454,0.110218116326166,0.145584895212465,2.76049955791688e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSNL1,Visinin-like protein 1,39929,0.059025910605898,0.00416125536374428,0.0508698500929592,0.0671819711188368,2.7819456369147e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RWDD1,RWD domain-containing protein 1,42249,0.0947333308582048,0.00668581801513041,0.0816291275485492,0.10783753416786,2.96980006762873e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.130939945117546,0.0092346543811732,0.112840022530447,0.149039867704646,3.05424572029005e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIRBP,Cold-inducible RNA-binding protein,39930,0.146750649592559,0.0103528708541415,0.126459022718441,0.167042276466676,3.18929217483312e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.132158115236418,0.00934540288221273,0.113841125587281,0.150475104885555,4.42674805055039e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASHC3,WASH complex subunit 3,39929,0.115368339936229,0.00815413666563711,0.0993862320715802,0.131350447800878,4.61585760621699e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MGLL,Monoglyceride lipase,42166,0.132442617305746,0.00937026583315364,0.114076896272765,0.150808338338728,4.8682013396626e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXO3,Forkhead box protein O3,41843,0.145963095027589,0.0103285405547714,0.125719155540237,0.166207034514941,5.12000515306506e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEPR,Leptin receptor,42145,-0.0476913666002885,0.00337539887413912,-0.0543071483936012,-0.0410755848069758,5.24489171893346e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TADA3,Transcriptional adapter 3,39919,0.0613717997295883,0.00434599379453008,0.0528536518923094,0.0698899475668673,6.7318225383623e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0442702906235222,0.00313579416149505,0.0381241340669919,0.0504164471800525,7.12301726898255e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0741816699991842,0.00525498516066609,0.0638818990842786,0.0844814409140897,7.38148256245591e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSC22D1,TSC22 domain family protein 1,39934,0.099943846004429,0.0070849031718371,0.0860574357876283,0.11383025622123,8.27304643778508e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.119750178497589,0.0084895619065979,0.103110637160657,0.136389719834521,8.59454685860133e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.106183269700181,0.00754680590226753,0.0913915301317362,0.120975009268625,1.19686044540994e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.086871008011826,0.00617282707263992,0.0747722669494517,0.0989697490742002,1.33811315754658e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEMIP2,Cell surface hyaluronidase,39657,0.0489031674935494,0.00347491636796963,0.0420923314123289,0.0557140035747698,1.34530397056277e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.064906272404002,0.0046187681559455,0.0558534868183489,0.0739590579896552,1.53350470614931e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPC5,Glypican-5,42016,0.0849754320663766,0.00604873262304627,0.073119916125206,0.0968309480075473,1.62704570278166e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL3,Angiopoietin-related protein 3,42189,0.0518890441316613,0.00369609830840311,0.0446446914471912,0.0591333968161314,1.84255080272148e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0916276621673602,0.00653294949668744,0.0788230811538529,0.104432243180868,2.220869480837e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA11,Annexin A11,42087,0.0998574824623326,0.00712199454666754,0.0858983731508642,0.113816591773801,2.37468606941884e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RFC4,Replication factor C subunit 4,39919,0.0333155193966341,0.00238143269519278,0.0286479113140563,0.0379831274792119,4.19419674796303e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF23,Fibroblast growth factor 23,42250,0.075856931329232,0.00542707552289411,0.0652198633043596,0.0864939993541045,4.30511960926831e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAMP8,Vesicle-associated membrane protein 8,39657,0.131965145244561,0.00944014310090094,0.113462464766795,0.150467825722327,4.94900002358107e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG4,BAG family molecular chaperone regulator 4,39657,0.0758418378225389,0.00542910369585863,0.0652007945786559,0.0864828810664218,5.65415246980615e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.069025972749965,0.00494660068353683,0.0593306354102329,0.0787213100896972,6.93615696667776e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPB1,Carboxypeptidase B,42310,0.0928666343376303,0.00666280072857346,0.0798075449096263,0.105925723765634,7.40402801933553e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPART,Spartin,39736,0.116279765422552,0.00834452782405251,0.0999244908874089,0.132635039957695,9.05947605989366e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPT1,Angiopoietin-1,42085,0.124935934643175,0.00897549625939898,0.107343961974753,0.142527907311597,9.65501058699617e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0707019610354371,0.00508371595640629,0.0607378777608808,0.0806660443099934,1.30054576969028e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.140820285567697,0.0101315956545121,0.120962358084854,0.160678213050541,1.4594032160914e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP6,Bone morphogenetic protein 6,41886,0.0597094172358564,0.00429941938887636,0.0512825552336587,0.068136279238054,1.51344760844853e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CETN2,Centrin-2,41839,0.101540530351671,0.00731815891823813,0.0871969388719242,0.115884121831418,1.80520764648799e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0799150272273963,0.00576109860591473,0.0686232739598034,0.0912067804949892,1.87581007786648e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.107059396317999,0.00771824542035297,0.0919316352941069,0.122187157341891,1.87931747424622e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOD,Apolipoprotein D,39468,-0.0631770437256681,0.00455165932165683,-0.0720982959961155,-0.0542557914552207,1.96432183519455e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEXN,Nexilin,39990,0.103838307602326,0.00748611386525769,0.0891655244264207,0.118511090778231,2.14441837332824e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0766968565350388,0.00553283418636307,0.0658525015297672,0.0875412115403104,2.47364303601255e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK10,Kallikrein-10,42138,0.0607364390352193,0.00438946954583563,0.0521330787253815,0.0693397993450572,3.00791764038125e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0561010903660978,0.00405512425259545,0.0481530468310107,0.0640491339011849,3.13688852571889e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.142486027859891,0.0103035376855706,0.122291093996172,0.162680961723609,3.36007298238792e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNPY4,Protein canopy homolog 4,42070,0.111410926716289,0.00806907144709517,0.0955955466799829,0.127226306752596,4.53329676953663e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UROD,Uroporphyrinogen decarboxylase,39736,0.100477089384803,0.00727374542884495,0.0862205483442672,0.114733630425339,4.77087147285457e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0380716428066621,0.0027595575290882,0.0326629100496493,0.043480375563675,5.24101271345386e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0717175684162972,0.00519517206189329,0.0615350311749863,0.0819001056576081,5.31072668201358e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53I3,Quinone oxidoreductase PIG3,39513,0.0786775594354654,0.00569917056758327,0.0675071851230021,0.0898479337479286,5.45226907008781e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA1,Carboxypeptidase A1,42310,0.0958311187413052,0.00694897277903551,0.0822111320943956,0.109451105388215,5.61263982244952e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRAS,Ras-related protein R-Ras,39649,0.194976663495344,0.0141363041151955,0.167269507429561,0.222683819561127,6.39778992749839e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBXN1,UBX domain-containing protein 1,39736,0.101841375570398,0.00738703327041961,0.0873627903603756,0.11631996078042,6.90990951113842e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0523792561004587,0.00380183988366732,0.0449276499284707,0.0598308622724466,7.72781813087025e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSG,Alpha-2-HS-glycoprotein,39990,0.0394851484196483,0.00286886834456983,0.0338621664642914,0.0451081303750051,9.3081470901733e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAX,Protein max,41839,0.156838979583758,0.0114145272360689,0.134466506201063,0.179211452966453,1.14244713212822e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18,Interleukin-18,42069,0.0653924253849121,0.00476258003886023,0.0560577685087461,0.0747270822610782,1.29132865958873e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNLR1,Interferon lambda receptor 1,42119,0.0537261254314352,0.00391651671068156,0.0460497526784993,0.061402498184371,1.52971538178015e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP10,Caspase-10,41839,0.105162421862684,0.00766668746219205,0.0901357144367874,0.12018912928858,1.57282099966231e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDC,Nuclear migration protein nudC,42296,0.0935299260538178,0.00682018686611696,0.0801623597962286,0.106897492311407,1.6048805461129e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGF,Pro-epidermal growth factor,42081,0.153272114306817,0.0111790246217585,0.131361226048171,0.175183002565464,1.68890145195459e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,42145,0.118594024753247,0.0086523874553938,0.101635345340675,0.135552704165819,1.78212280399585e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0768029634820842,0.0056005513961129,0.0658258827457029,0.0877800442184655,1.84116263358797e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINE2,Glia-derived nexin,39958,0.095556607576794,0.00696923199347187,0.0818969128695891,0.109216302283999,1.89327858042318e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAS6,Growth arrest-specific protein 6,42236,-0.0371303985510472,0.00271005007858519,-0.0424420967050742,-0.0318187003970202,1.91235816959047e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.130541937096621,0.0095269281772578,0.111869157869195,0.149214716324046,2.13296542775451e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMPER,BMP-binding endothelial regulator protein,39736,0.0339591825983117,0.00247951271884491,0.0290993376693757,0.0388190275272477,2.36534850140048e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WDR46,WD repeat-containing protein 46,39919,0.0538686990972893,0.00393555009297108,0.046155020915066,0.0615823772795126,2.60965679964549e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICA1,Islet cell autoantigen 1,41913,0.117455296370574,0.00859475628697342,0.100609574048106,0.134301018693042,3.12580163221332e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2,Microtubule-associated protein 2,39929,0.0687319340125662,0.00503065658706798,0.0588718471019129,0.0785920209232194,3.66201188874484e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53,Cellular tumor antigen p53,41843,0.0653016783817976,0.00478357726969756,0.0559258669331904,0.0746774898304048,3.82746060711661e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0830429820717617,0.00609035579872439,0.0711058847062619,0.0949800794372615,4.69129733332542e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNCG,Gamma-synuclein,42016,0.0978426389530306,0.00717618294778477,0.0837773203753725,0.111907957530689,4.76819688888519e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFA,Platelet-derived growth factor subunit A,42310,0.104971419227657,0.00771796219724674,0.0898442133210538,0.120098625134261,7.38798470886895e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMG3,Proteasome assembly chaperone 3,42119,0.0722951652549228,0.00531807133742095,0.0618717454335777,0.0827185850762679,8.1554109776454e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CETN3,Centrin-3,39930,0.11493198544954,0.00845017087558749,0.0983696505333886,0.131494320365692,8.38809337782357e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0714698283664431,0.00525484411904,0.0611703338931247,0.0817693228397615,8.43022429342731e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,A1BG,Alpha-1B-glycoprotein,39979,0.0241044709774133,0.001774831396267,0.02062580144073,0.0275831405140966,1.0921772647689e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRAP2,GRB2-related adapter protein 2,42145,0.188143193929774,0.0138679084185964,0.160962093429325,0.215324294430223,1.17883323704988e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.111067969499579,0.00818696586743427,0.0950215163994081,0.127114422599751,1.20152784202545e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0387094082303125,0.00285716715463767,-0.0443094558534023,-0.0331093606072226,1.70291788264008e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNM3,Dynamin-3,39934,0.0801830334470571,0.00591875971905547,0.0685822643977084,0.0917838024964058,1.72879239409517e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM17,Splicing factor 45,39934,0.111713223352268,0.00825656210861888,0.0955303616193753,0.127896085085161,2.1719123555537e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMT,Catechol O-methyltransferase,41740,0.120860256956628,0.00894582302978345,0.103326443818253,0.138394070095004,2.56748168336939e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHMP1A,Charged multivesicular body protein 1a,42016,0.115083996556214,0.00852447250319456,0.0983760304499528,0.131791962662476,2.89080652661024e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEPH,Hephaestin,39958,0.0404524033675476,0.0029990165462468,0.0345743309369038,0.0463304757981913,3.78563092563111e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EHD3,EH domain-containing protein 3,39638,0.171042228121928,0.0126865891656077,0.146176513357337,0.195907942886519,4.21163315220866e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LARP1,La-related protein 1,39919,0.0901611687145286,0.00669436030550296,0.0770402225157428,0.103282114913314,4.9770333368594e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESYT2,Extended synaptotagmin-2,39929,0.120568516924046,0.00895841804995266,0.103010017546139,0.138127016301953,5.64831661776368e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.084258599416917,0.00626313838340386,0.0719828481854455,0.0965343506483886,6.19270873939785e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRY2,Protein sprouty homolog 2,41913,0.134030766404323,0.00998358726806042,0.114462935358925,0.153598597449721,7.94115795039196e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0717567177711061,0.00534940233764697,0.061271889189318,0.0822415463528941,1.03488932890205e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PF4,Platelet factor 4,39914,0.140487469283552,0.0104769757501799,0.119952596813199,0.161022341753905,1.09213494346509e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLB1,Beta-galactosidase,42016,0.0619012974549649,0.00463189917839314,0.0528227750653143,0.0709798198446155,1.77769529501826e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0964806852587366,0.00721550667188105,0.0823382921818498,0.110623078335623,1.82426697009248e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PQBP1,Polyglutamine-binding protein 1,41843,0.0812336565763145,0.00608331551331354,0.06931035817022,0.093156954982409,2.06201752531894e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL2,ADAMTS-like protein 2,39966,0.0497871055406784,0.00372678662890483,0.0424826037480249,0.0570916073333318,2.10873986551322e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH9,Protocadherin-9,39930,0.0485546112262467,0.00363758255592455,0.0414249494166346,0.0556842730358588,2.45112803885952e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCT5,T-complex protein 1 subunit epsilon,41843,0.0648957801083548,0.00486769509517802,0.0553550977218059,0.0744364624949037,2.74407596923347e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGL1,Fibrinogen-like protein 1,39990,-0.0928052635468264,0.0069596870036947,-0.106446250074068,-0.0791642770195848,2.91332341388446e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATG4A,Cysteine protease ATG4A,41843,0.0832471229731878,0.00626004798883637,0.0709774289150685,0.0955168170313071,4.28726145038229e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPARC,SPARC,42181,0.099792914219467,0.0075117503286783,0.0850698835752575,0.114515944863676,5.03241564955512e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0666258719524106,0.00501258329236585,0.0568012086993736,0.0764505352054477,5.24523965753749e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHRL,Appetite-regulating hormone,42145,0.118455354718031,0.00892758400628713,0.100957290065708,0.135953419370354,6.2595234566027e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0609786462317829,0.0046013624909396,0.0519599757495413,0.0699973167140246,7.72071713704642e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NACC1,Nucleus accumbens-associated protein 1,39919,0.0789835578252758,0.00595696904597848,0.0673078984951579,0.0906592171553936,7.92375959385256e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDT,D-dopachrome decarboxylase,39966,0.0579517530642809,0.00437143967648844,0.0493837312983635,0.0665197748301982,8.12405545609846e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.117353856011765,0.00886468073816981,0.0999790817649527,0.134728630258578,9.3017612560989e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0361347359171685,0.00274306042794662,0.0307583374783931,0.0415111343559438,2.17412589766388e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.138502877787674,0.0105185225043048,0.117886573679236,0.159119181896111,2.3841758364476e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0740939277898994,0.00562595851167967,0.0630670491070072,0.0851208064727915,2.56764360351011e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.10863969706543,0.00825622435171783,0.0924574973360631,0.124821896794797,2.64919886987624e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0453503866300826,0.00344730754149333,-0.0521071094114095,-0.0385936638487556,2.74370102337832e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNDP1,Beta-Ala-His dipeptidase,42217,0.0652656512703809,0.00496119631218368,0.0555417064985009,0.074989596042261,2.7568447039871e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK24,Serine/threonine-protein kinase 24,41839,0.0878997927235566,0.00668923330700452,0.0747888954418278,0.101010690005285,3.39411679955751e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HYOU1,Hypoxia up-regulated protein 1,42310,0.032322656245687,0.00246171715881931,0.0274976906144012,0.0371476218769729,3.81141098071526e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0484139985792568,0.00368859846455209,0.0411843455887347,0.0556436515697789,4.09155583173996e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0524725525896053,0.00399562560839363,0.0446411263971538,0.0603039787820568,4.14051700314204e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MENT,Protein MENT,39736,-0.0334735310051632,0.00255243475591382,-0.0384763031267543,-0.0284707588835721,5.29830135919888e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PVR,Poliovirus receptor,42249,0.0526542534406774,0.00401921494990981,0.0447765921388542,0.0605319147425007,5.61040149492941e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0864827438486099,0.00660192709322106,0.0735429667458966,0.0994225209513231,5.71404364303167e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTF1,Cardiotrophin-1,41900,0.118855908121313,0.00908002194838808,0.101059065102472,0.136652751140153,6.54830842715406e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F12,Coagulation factor XII,39979,0.0580400143001825,0.00443201984171772,0.0493532554104158,0.0667267731899492,6.66364044144885e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0639512299684658,0.00488443120860156,0.0543777447996068,0.0735247151373249,6.93902336617163e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNRD2,Protein ZNRD2,39930,0.0981888767048084,0.00750015570033918,0.0834885715321436,0.112889181877473,7.04113701523457e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0854273536379861,0.00653945411899357,0.0726100235647587,0.0982446837112135,9.25348068193132e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DFFA,DNA fragmentation factor subunit alpha,42296,0.0936749951637692,0.0071796026445447,0.0796029739804616,0.107747016347077,1.11830521826585e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0933244674525126,0.0071669833620212,0.0792771800629511,0.107371754842074,1.76176811116809e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.052561480390969,0.00404291605099364,0.0446373649310215,0.0604855958509166,2.07280886907279e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0784121285510698,0.00603217712534202,0.0665890613853994,0.0902351957167402,2.09566439528973e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.105639349436517,0.00813391434243936,0.0896968773253355,0.121581821547698,2.74637619011459e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POSTN,Periostin,39966,-0.0527715967485283,0.00406720760990215,-0.0607433236639365,-0.04479986983312,3.17155072908385e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FIS1,Mitochondrial fission 1 protein,42125,0.106824578099132,0.00824959320338426,0.0906553754204987,0.122993780777765,4.00641904813077e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RILP,Rab-interacting lysosomal protein,42224,0.0815090617656098,0.00630004866351765,0.0691609663851152,0.0938571571461044,4.61135217799577e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPBP,Platelet basic protein,39908,0.119248038749674,0.00921126985842249,0.101193949827166,0.137302127672182,4.61849403046151e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0900505843406913,0.0069626901500623,0.0764037116465692,0.103697457034813,4.88407739901129e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTF2,Transcription termination factor 2,39649,0.069305894488115,0.00535545488336125,0.058809202916727,0.0798025860595031,4.97725112738429e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0414268892547417,0.00320439962730685,0.0351462659852203,0.0477075125242631,5.23245354412187e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMVK,Phosphomevalonate kinase,41832,0.151184685059767,0.0116948198011979,0.128262838249419,0.174106531870115,5.34791375781182e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0699000990214395,0.00540884202946035,0.0592987686436972,0.0805014293991818,5.54119055491147e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKG1,cGMP-dependent protein kinase 1,39736,0.174946933997483,0.0135638024878663,0.148361881121265,0.201531986873701,8.60088573251731e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA11,Integrin alpha-11,42119,-0.0469051156951762,0.00364654167608598,-0.0540523373803047,-0.0397578940100476,1.20998744213515e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0639208861606397,0.00496766175614887,0.054184269118588,0.0736575032026915,1.2780574481437e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0351964998882255,0.00273769933538239,0.0298306091908761,0.040562390585575,1.44982263971489e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.109013366632506,0.00848863606050733,0.0923756399539119,0.125651093311101,1.58091956040184e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1S,Complement C1s subcomponent,39979,0.0291183270648199,0.00226729716132585,0.0246744246286212,0.0335622295010185,1.71970053532358e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0865753153965652,0.0067457804641664,0.073353585686799,0.0997970451063313,1.74856903687744e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL3,C-C motif chemokine 3,42119,0.0819874773444914,0.00639040322205304,0.0694622870292674,0.0945126676597153,1.84688120157591e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL7,Interleukin-7,42119,0.0891315385033597,0.0069546762230011,0.0755003731062775,0.102762703900442,2.19986484488985e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINC1,Antithrombin-III,39959,0.0199247028986425,0.00155485093019407,0.0168771950754621,0.0229722107218228,2.46456684933822e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RILPL2,RILP-like protein 2,39958,0.136144358717127,0.0106291600313233,0.115311205055733,0.15697751237852,2.65892923512214e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED8,Protein TMED8,39930,0.142145149010185,0.0111106220003196,0.120368329889559,0.163921968130811,3.21909769470924e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP7,Caspase-7,39929,0.116197067362779,0.0090892173048713,0.0983822014452309,0.134011933280326,3.63471433487143e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUB1,NEDD8 ultimate buster 1,42119,0.115479855946062,0.00906127564957687,0.0977197556728912,0.133239956219233,5.47220324348286e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FEN1,Flap endonuclease 1,41843,0.0881988023553569,0.00692292812754273,0.0746298632253731,0.101767741485341,5.83180092647498e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD69,Early activation antigen CD69,42082,0.119888378215883,0.00941667739401318,0.101431690523618,0.138345065908149,6.44629824707298e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.104216526952099,0.0081869394889279,0.0881701255537999,0.120262928350397,6.58230708608771e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0670622340610887,0.00527261031489727,0.0567279178438901,0.0773965502782874,8.39529497479108e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.11881142132814,0.00934266287061058,0.100499802101744,0.137123040554537,8.56297235623641e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASSF2,Ras association domain-containing protein 2,41843,0.0780436115435867,0.0061444335513658,0.0660005217829098,0.0900867013042637,9.49922908936487e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.134999930988906,0.01064043357345,0.114144681184944,0.155855180792868,1.23166560108118e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XCL1,Lymphotactin,42262,0.0743653518426904,0.00586549914501801,0.0628689735184551,0.0858617301669257,1.25213138344304e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0631219990847682,0.00498070451426085,0.0533598182368169,0.0728841799327194,1.33634330323137e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSZ,Cathepsin Z,42168,0.0438359017783839,0.00346691279594437,0.0370407526983329,0.0506310508584348,1.93622455353653e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARA5,Scavenger receptor class A member 5,42249,0.0414675248598346,0.00328126547763806,0.035036244523664,0.0478988051960052,2.09292096062298e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0770285873583298,0.00610596160210786,0.0650609026181983,0.0889962720984612,2.78829273345498e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F2,Prothrombin,39979,0.0201685061603422,0.00159829155529762,0.0170358547119588,0.0233011576087255,2.90901762818903e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0884566694897198,0.0070220906629013,0.0746933717904332,0.102219967189006,3.53961830586182e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN4,CCN family member 4,42262,0.0529533570237437,0.00420659569365572,0.0447084294641785,0.0611982845833089,3.89214008516964e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JAM3,Junctional adhesion molecule C,39736,0.0687220763999139,0.00546420748834821,0.0580122297227514,0.0794319230770764,4.97825486281578e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA1,GDNF family receptor alpha-1,42247,0.0385546842240585,0.00306981026999873,0.032537856094861,0.0445715123532561,5.58749435293016e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0885824097213577,0.00704882802438663,0.0747667067935599,0.102398112649155,5.6716033224919e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0551577437503603,0.00439250309867655,0.0465484376769543,0.0637670498237663,5.78606832031684e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0739548097172294,0.00589635482840083,0.0623979542535638,0.0855116651808951,6.97380455166832e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NID1,Nidogen-1,42189,0.0485833668133048,0.0038739816367652,0.040990362805245,0.0561763708213646,7.04106258708534e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0410930818532743,0.00327975999152979,0.0346647522698759,0.0475214114366727,8.12995969813822e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0894638641832405,0.00713609694127813,0.0754771141783354,0.103450614188146,8.2570313097294e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMA,Granzyme A,42296,0.0456638504644579,0.00364854611783525,0.0385127000735009,0.052815000855415,9.61841025023888e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0360719290948076,0.00288531842464311,0.0304167049825071,0.0417271532071081,1.2504854026319e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,39649,0.106826979924309,0.00854427351944304,0.0900802038262002,0.123573756022417,1.2557106844559e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.114434264050416,0.00915875849731506,0.0964830973956784,0.132385430705153,1.37178883712157e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.113294845213686,0.00907308405940259,0.0955116004572567,0.131078089970115,1.39566391556136e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0529753927635614,0.00424773559588984,0.0446498309956173,0.0613009545315055,1.67191074317637e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0532872944160992,0.00427656095993173,0.044905234934633,0.0616693538975654,1.91164172920446e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCB,Tubulin-folding cofactor B,42016,0.133882665150868,0.0107571413264142,0.112798668151096,0.154966662150639,2.30652337573415e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIABLO,"Diablo homolog, mitochondrial",42107,0.146569675988454,0.0117781489843782,0.123484503979073,0.169654847997836,2.349410683708e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL8,C-C motif chemokine 8,42239,0.0808896204764456,0.00651599990974787,0.0681182606533398,0.0936609802995514,3.39888120221802e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,39736,0.159799188430938,0.0128695425554787,0.1345748850222,0.185023491839677,3.61751232194587e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL2,C-C motif chemokine 2,41992,0.0691932750846043,0.00557897535553027,0.058258483387765,0.0801280667814437,3.94858352688612e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGCT,Gamma-glutamylcyclotransferase,39952,0.0633495378539064,0.00511405130611579,0.0533259972939195,0.0733730784138933,5.14999525792053e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK13,Kallikrein-13,41839,0.0597256565012915,0.00482912342987925,0.0502605745787281,0.0691907384238548,6.08629162028023e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB33A,Ras-related protein Rab-33A,39575,0.0884117612098124,0.00714576145694382,0.0744060687542025,0.102417453665422,6.28242941967046e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0424404320932471,0.00343139341198581,0.035714901005755,0.0491659631807393,6.60600438318238e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.101288927130554,0.00819799558748341,0.0852208557790867,0.117356998482022,7.63020494513879e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADM,Pro-adrenomedullin,42262,0.0347539211863122,0.0028146050803308,0.0292372952288638,0.0402705471437605,7.68741690985599e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APPL2,DCC-interacting protein 13-beta,39736,0.149889837927187,0.012135925050585,0.126103424828041,0.173676251026334,8.13649152108834e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.148195849195744,0.0120094350212096,0.124657356554173,0.171734341837314,8.57123563133564e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YWHAQ,14-3-3 protein theta,39736,0.098309282335079,0.00796904494176548,0.0826899542492187,0.113928610420939,9.72189880250114e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0417912197593346,0.00339547513449753,0.0351360884957194,0.0484463510229497,1.25729611508148e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0659419859473939,0.00535768054400614,0.0554409320811419,0.076443039813646,1.26928695678964e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.12384750022727,0.01006609250439,0.104117958918665,0.143577041535874,1.3336056276529e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPB1,Heat shock protein beta-1,41949,0.0927153319211038,0.00754075377739986,0.0779354545174,0.107495209324808,1.47756507427567e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA1,Apolipoprotein A-I,39979,-0.0362467235247424,0.002949403886722,-0.0420275551427175,-0.0304658919067673,1.7060353090788e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRDL2,Chordin-like protein 2,42145,0.0603608389452503,0.00491711081110565,0.0507233017554832,0.0699983761350174,1.86534864989638e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMOX2,Heme oxygenase 2,41839,0.0631485311390512,0.00514644448810606,0.0530614999423633,0.0732355623357391,2.01066241950511e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REEP4,Receptor expression-enhancing protein 4,39934,0.0823506841766685,0.00670918437251029,0.0692006828065483,0.0955006855467887,2.05738101646152e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD22,B-cell receptor CD22,42296,0.0562532691499863,0.00458753714253804,0.0472616963506118,0.0652448419493609,2.18905831635359e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATOX1,Copper transport protein ATOX1,42181,0.093605375521151,0.00764409490723418,0.078622949502972,0.10858780153933,2.69456320146447e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.137970938709205,0.0112603169936133,0.115900717401723,0.160041160016687,2.69620408801108e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIFBP,KIF-binding protein,42070,0.10866854907129,0.00887789049796257,0.0912678836952833,0.126069214447297,2.87687518894671e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRG1,Scrapie-responsive protein 1,39958,0.03601783902468,0.00294118098776963,0.0302531242886515,0.0417825537607085,2.90012281704838e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGR1,Prostaglandin reductase 1,39958,0.110188094995959,0.00900139006997859,0.0925453704588012,0.127830819533117,3.07506843292257e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA4D,Semaphorin-4D,42249,0.0395682972358407,0.00323576345329894,0.0332262008673748,0.0459103936043067,3.30875882626948e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.130175088793706,0.0106483051313056,0.109304410736347,0.151045766851065,3.81015471813832e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,39922,0.026378244015618,0.00215919349013447,0.0221462247749544,0.0306102632562815,4.14865268262456e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,39930,0.109635955261477,0.00897992278720678,0.0920353065985512,0.127236603924402,4.55353398737128e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPON2,Spondin-2,42070,-0.0457511788401257,0.00375425722851623,-0.0531095230080175,-0.0383928346722339,5.5390961142707e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.104841509136556,0.00860415654595182,-0.121705655966622,-0.0879773623064909,5.62777812570251e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSNAX,Translin-associated protein X,39575,0.0515179437477626,0.00422585006892373,0.0432352776126721,0.0598006098828531,5.74403004001585e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THTPA,Thiamine-triphosphatase,39897,0.115045327135022,0.00944827932494939,0.0965266996581214,0.133563954611923,6.77511691583416e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0971344653485447,0.00798053672685131,0.0814926133639161,0.112776317333173,7.23308875071269e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0879368271061144,0.0072351918404957,0.0737558510987428,0.102117803113486,8.26345911139376e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BIN2,Bridging integrator 2,42137,0.116449701455227,0.00960063853816559,0.0976324499204223,0.135266952990031,1.10366418751643e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0875434282668663,0.00722445935377672,0.0733834879334639,0.101703368600269,1.27122471279592e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAP18,Chromatin complexes subunit BAP18,39929,0.0886574923760679,0.00733310989351386,0.0742845969847807,0.103030387767355,1.91531919878117e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL1,Growth-regulated alpha protein,42117,0.120810064192849,0.0100087315405003,0.101192950373469,0.140427178012229,2.24581305819635e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTUD6B,Deubiquitinase OTUD6B,39930,0.0753362498998792,0.00623873444558746,0.0631083303865277,0.0875641694132306,2.27847745544103e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0936709895336771,0.00776387991245363,0.078453784905268,0.108888194162086,2.41898267853847e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRADD,Death domain-containing protein CRADD,41997,0.096871626940981,0.00803089485123246,0.0811310730325654,0.112612180849397,2.4840388432618e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APP,Amyloid-beta precursor protein,42112,0.0857415061624399,0.00711884285881461,0.0717885741591633,0.0996944381657165,3.0753935760999e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0479221796975888,0.00398300077260516,0.0401154981832827,0.0557288612118949,3.57476083677186e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACYBP,Calcyclin-binding protein,39713,0.134215756465291,0.0111545843350329,0.112352771168626,0.156078741761955,3.85913446375601e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNGR2,Interferon gamma receptor 2,42016,0.0682888862413773,0.00568028842759809,0.057155520923285,0.0794222515594695,4.02521588393467e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MATN2,Matrilin-2,42144,0.0382649600553862,0.00318978839004759,0.032012974810893,0.0445169452998795,5.4737162065056e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0719776949338885,0.00600128863398542,0.0602151692112771,0.0837402206564999,5.63237185332423e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNMA1,Paraneoplastic antigen Ma1,39638,0.0739316773575265,0.00616386321109195,0.0618505054637863,0.0860128492512667,6.09176007973336e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.083089487316873,0.00693044987725627,0.0695058055574507,0.0966731690762953,6.41349133145304e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.116489353412738,0.00971933829072513,0.0974394503629166,0.135539256462559,6.78054954319855e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD164,Sialomucin core protein 24,42137,0.0347635012220279,0.00290665928352989,0.0290664490263093,0.0404605534177465,8.42608973504696e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD72,B-cell differentiation antigen CD72,39736,0.0558585036501681,0.00466839470208716,0.0467084500340773,0.065008557266259,8.58196526326786e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARK7,Parkinson disease protein 7,42137,0.0650413164476519,0.00544755280278582,0.0543641129541917,0.0757185199411121,1.0743093599893e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.115164870387259,0.00964335493239371,0.0962638947197678,0.134065846054751,1.11585860451297e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CERT,Ceramide transfer protein,41839,0.0789169823910813,0.00661164347394846,0.0659581611821423,0.0918758036000203,1.12928458165464e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA12,Serpin A12,41751,0.139070466319245,0.0116586626907137,0.116219487445446,0.161921445193044,1.23851639702926e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS9,Galectin-9,42129,0.0402715916110897,0.00338026583628751,0.0336462705719662,0.0468969126502132,1.46033664344589e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L1,Bcl-2-like protein 1,39929,0.127766142599913,0.0107265174931279,0.106742168313382,0.148790116886443,1.61673226601971e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0686169262109687,0.0057654121271443,0.0573167184417659,0.0799171339801716,1.81487764401857e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYO9B,Unconventional myosin-IXb,41913,0.0841680138243449,0.00709918817565832,0.0702536050000546,0.0980824226486352,2.9105799408337e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0500513699011086,0.0042198926284043,0.0417803803494362,0.058322359452781,2.93208122374473e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0780251514392211,0.00657917043612109,0.0651299773844238,0.0909203254940184,3.01757894098159e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDF2,Growth/differentiation factor 2,42145,0.0450625957756503,0.00380286919815832,0.03760897214726,0.0525162194040406,3.11834789272212e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD244,Natural killer cell receptor 2B4,42296,0.0350622959532117,0.00296178540237848,0.0292571965645499,0.0408673953418735,3.553357998194e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.123483863476574,0.0104292639675046,0.103042506100265,0.143925220852883,3.78761395837797e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB1,Leukocyte elastase inhibitor,42093,0.11396737100974,0.00963338567839936,0.0950859350800777,0.132848806939403,3.91553024386756e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0935108898639141,0.00791262146418027,0.0780021517941208,0.109019627933707,4.91741128188423e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRLF1,Cytokine receptor-like factor 1,42185,0.0316109154399902,0.0026777182222997,0.0263625877242828,0.0368592431556976,5.26147082686105e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEP1B,Meprin A subunit beta,42145,0.145541170085735,0.0123368797720113,0.121360885732593,0.169721454438878,5.7817247456561e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0877346979736203,0.00743460551583455,0.0731628711625845,0.102306524784656,6.02528096379354e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIF1,Allograft inflammatory factor 1,41843,0.0663422023528961,0.00563047614647263,0.0553064691058097,0.0773779355999824,6.9154834518727e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB9,Serpin B9,42016,0.0415730929818812,0.00353278533213787,0.034648833730891,0.0484973522328714,8.19891517114447e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NBN,Nibrin,41913,0.0688572529959378,0.00585230686128304,0.057386731547823,0.0803277744440526,8.41320334389143e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPI,Glucose-6-phosphate isomerase,39990,0.0605356499050164,0.00514482849072576,0.0504517860631939,0.0706195137468389,8.88983499701756e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0420711868902735,0.00357822146374135,0.0350578728213405,0.0490845009592066,9.18184756802304e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0927018584602362,0.00788348958551607,0.0772502188726247,0.108153498047848,9.68536038379125e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRB1,Chymotrypsinogen B,42137,0.0737899468051759,0.00628683493351461,0.0614677503354873,0.0861121432748646,1.1694040159114e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MIF,Macrophage migration inhibitory factor,42105,0.0845404634336586,0.00720562730125399,0.0704174339232008,0.0986634929441164,1.2358982031746e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4G,C-type lectin domain family 4 member G,42119,0.0423029554961868,0.00360565733557288,0.0352358671184639,0.0493700438739096,1.23801645243915e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCOF1,Treacle protein,39958,0.0409624331803809,0.00349428616278162,0.034113632301329,0.0478112340594329,1.48183346255642e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D5,TBC1 domain family member 5,42119,0.0983430863603169,0.00840674068523185,0.0818658746172625,0.114820298103371,1.84726111548259e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL18,C-C motif chemokine 18,42020,0.0882994733003402,0.00755470607433767,0.0734922493946384,0.103106697206042,2.08376207098616e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.114144941452307,0.00977330912308703,0.0949892555710563,0.133300627333558,2.48670965050136e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP2,Retinol-binding protein 2,42070,-0.0978723741777484,0.0083851699873611,-0.114307307352976,-0.0814374410025207,2.50528382994074e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM106A,Transmembrane protein 106A,39919,0.0901261072600756,0.00772092726864538,0.0749930898135307,0.105259124706621,2.6474193977062e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP2,Caspase-2,42119,0.0859162551035267,0.00736646979664693,0.0714779743020987,0.100354535904955,2.77605422705356e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0537962903822445,0.00461294160408591,0.0447549248382361,0.0628376559262528,3.02585001483902e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0668841161325563,0.0057431084616337,0.0556276235477543,0.0781406087173584,3.41345660391921e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,39915,0.109864281383795,0.00943821947187973,0.0913653712189108,0.128363191548679,3.86510580852755e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRG2,Bone marrow proteoglycan,39966,-0.0642273600409758,0.00551837845862641,-0.0750433818198836,-0.053411338262068,3.92802644744057e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STXBP1,Syntaxin-binding protein 1,39934,0.0976432190456075,0.00839212601764857,0.0811946520510163,0.114091786040199,4.10522885438669e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.118676433771511,0.010199909555547,0.0986846110426393,0.138668256500383,4.10988050997368e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.130245072698465,0.0111966424965488,0.108299653405229,0.152190491991701,4.23071262536891e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0803356678262665,0.00690987025260679,0.0667923221311572,0.0938790135213758,4.55036332803996e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0599172083476875,0.00515390050370147,0.0498155633604326,0.0700188533349424,4.58221554197578e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.124340734777062,0.0107080478246565,0.103352961040736,0.145328508513389,5.03244195855161e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA14,Carbonic anhydrase 14,42262,-0.0458579640371224,0.0039510845867453,-0.0536020898271432,-0.0381138382471016,5.34274356923349e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0838436516102269,0.00722132454524183,0.0696898555015529,0.0979974477189009,5.50938320942626e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.119774543085917,0.010328757515644,0.0995301783552546,0.140018907816579,6.02817133041603e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0691544869131426,0.00596068372849212,0.0574715468052981,0.0808374270209872,6.09653542467905e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACYP1,Acylphosphatase-1,39701,0.0811628382533396,0.00699694773665898,0.067448820689488,0.0948768558171912,6.23040969529205e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB6,Serpin B6,42216,0.0730273354085916,0.00629962599235879,0.0606800684635684,0.0853746023536149,6.29621367110987e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0584522663923786,0.00504351800960469,0.0485669710935534,0.0683375616912038,6.94779360411013e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0767568135393445,0.00662812404663163,0.0637656904079465,0.0897479366707425,7.71096946148311e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA3,Annexin A3,42224,0.0865442268020416,0.00747828150703983,0.0718867950482435,0.10120165855584,7.89357325937153e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0942998866088504,0.00815855658957969,0.0783091156932742,0.110290657524427,9.95262670990917e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0717244327137841,0.00621247271825459,0.0595479861860051,0.0839008792415631,1.08955302528638e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIAPIN1,Anamorsin,42181,0.0760399374284009,0.00659794907659798,0.0631079572382688,0.0889719176185329,1.37305311104761e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MICALL2,MICAL-like protein 2,39649,0.0850725388002621,0.00738179098623669,0.0706042284672382,0.0995408491332861,1.4815023733147e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OCLN,Occludin,39934,0.0548610235589185,0.00476201130904594,0.0455274813931885,0.0641945657246486,1.53719412912705e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS1,Galectin-1,42145,0.0433738494511538,0.0037678590887655,0.0359888456371734,0.0507588532651342,1.60019192098262e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MESD,LRP chaperone MESD,42137,0.15097882643858,0.0131166401042758,0.1252702118342,0.176687441042961,1.62004223407949e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.133861234551332,0.0116254700173852,0.111075313317257,0.156647155785407,1.64901441633912e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGXT,Serine--pyruvate aminotransferase,42145,0.0950725244194966,0.00826166870777278,0.0788796537522619,0.111265395086731,1.67292546462763e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C3,Complement C3,39445,0.0569866786237663,0.00495756679755783,0.047269847700553,0.0667035095469797,2.09898908819315e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0338789264264044,0.00294776008488619,0.0281013166600275,0.0396565361927813,2.12543258278665e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX8,Syntaxin-8,42119,0.0592144642279912,0.00515827248056291,0.0491042501660879,0.0693246782898945,2.31177937265154e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],41874,0.058466262639722,0.00510169416793673,0.048466942070566,0.068465583208878,2.90184967356409e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUGT1,Protein SGT1 homolog,41843,0.0986316091508241,0.00860708272593171,0.0817617270079979,0.11550149129365,2.93114461874169e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3BP1,SH3 domain-binding protein 1,39930,0.0609751533921192,0.00532070940959342,0.0505465629493161,0.0714037438349223,3.07532597347619e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0710675788685367,0.00621009478453253,0.058895793090853,0.0832393646462205,3.4979559670648e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLF4,Krueppel-like factor 4,39586,0.0499833831913473,0.00436865106063967,0.0414208271124936,0.0585459392702011,3.84686829276474e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX4,Syntaxin-4,42070,0.0724800333157508,0.00634876198253965,0.0600364598299731,0.0849236068015286,4.759248117581e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX1,Peroxiredoxin-1,41742,-0.112889990881816,0.00989011866567536,-0.132274623466539,-0.0935053582970918,4.90643742927543e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP1,Metalloproteinase inhibitor 1,42032,0.0353313295394524,0.0030999484623961,0.0292554305531561,0.0414072285257488,5.9144209756768e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STXBP3,Syntaxin-binding protein 3,41843,0.0533664730373923,0.00468453524324217,0.0441847839606376,0.0625481621141469,6.31291360724006e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSPN,Persephin,42119,0.106140930845724,0.00932153066766892,0.087870730737093,0.124411130954355,6.66984329087208e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0788817558044548,0.0069388581337497,0.0652815938623054,0.0924819177466042,8.2853651336742e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.112192110179735,0.00987539742366452,0.0928363312293524,0.131547889130117,8.94679048609747e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LACTB2,Endoribonuclease LACTB2,42145,0.080541982013947,0.00709436828955069,0.0666370201664276,0.0944469438614663,9.77061156693901e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.029879298857172,0.00263275986880611,0.024719089514312,0.035039508200032,1.0223129903046e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0747578537810102,0.0065946820662077,0.0618322769312431,0.0876834306307773,1.26708484889955e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0412144450975321,0.00363725691935323,0.0340854215355997,0.0483434686594644,1.32675052413562e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRIB,Protein scribble homolog,39638,0.10685569987498,0.00943063533784142,0.0883716546128112,0.12533974513715,1.34695058652611e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0920900142224412,0.00813221040941039,0.0761508818199969,0.108029146624886,1.43711994948044e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA2,Annexin A2,39492,0.085898683391383,0.00759486244910565,0.0710127529911359,0.10078461379163,1.70755527248703e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F11,Coagulation factor XI,39822,0.038247987821289,0.00338338596444121,0.0316165513309842,0.0448794243115937,1.79585578473826e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCA,Calcitonin,41997,0.0844121679576822,0.0074779569952761,0.0697553722469411,0.0990689636684234,2.03918880332421e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.138157576208919,0.0122402391811596,0.114166707413847,0.162148445003992,2.05216223642501e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSS,Cathepsin S,39358,0.0294947719891344,0.00261194662198073,0.0243753566100522,0.0346141873682167,2.09720171414504e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD99L2,CD99 antigen-like protein 2,42137,0.0298608662927346,0.00264797742963452,0.024670830530651,0.0350509020548183,2.30803802848817e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.101418948506183,0.00899422277947503,0.083790271858412,0.119047625153954,2.470070882593e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0514230033049341,0.00456416094465874,0.042477247853403,0.0603687587564652,2.76842182123968e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0366429408263487,0.00325482358132573,0.0302634866069503,0.0430223950457472,2.85213583544794e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0740403770449388,0.00657779730244027,0.0611478943321559,0.0869328597577217,2.91606663155845e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0639645394446645,0.00568159060212041,0.0528286218645085,0.0751004570248205,3.04491711140998e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0720715882440413,0.00640620508254065,0.0595154262822616,0.084627750205821,3.31752626071495e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0373739243554201,0.00332504622295033,0.0308568337584374,0.0438910149524027,3.69476244240196e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLG,Plasminogen,39742,0.0264188809500521,0.00235331899196843,0.021806375725794,0.0310313861743102,4.34240933667874e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12A_IL12B,Interleukin-12,42070,0.09291196395623,0.00828678896946743,0.0766698575760738,0.109154070336386,4.78444801423575e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THPO,Thrombopoietin,41900,0.0470290822486436,0.00419457311797068,0.0388077189374211,0.0552504455598661,4.81168334758432e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL16,C-X-C motif chemokine 16,42295,0.0280955668956956,0.00251076410542897,0.0231744692490548,0.0330166645423364,6.09076770621421e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFL7,Epidermal growth factor-like protein 7,41843,0.0467757322747852,0.00418025587010904,0.0385824307693715,0.054969033780199,6.17589058164959e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.134743022741071,0.0120442112393881,0.11113636871187,0.158349676770271,6.329539110878e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP7,Matrilysin,41881,0.0624195150841827,0.00558015881906566,0.051482403798814,0.0733566263695514,6.43152960055172e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0972781423582613,0.00869586320839827,0.0802342504698007,0.114322034246722,6.76906835219486e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0416757725997464,0.00373163619994702,0.0343617656478502,0.0489897795516426,7.77814864011518e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMFG,Glia maturation factor gamma,39958,0.0865913435945235,0.00775819775259852,0.0713852759994305,0.101797411189617,8.90320387918803e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0244763438803536,0.00219493276045946,-0.0287784120908542,-0.0201742756698531,9.40665718402714e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG6,Large proline-rich protein BAG6,41900,0.044279132447941,0.00397289565957005,0.0364922569551837,0.0520660079406983,1.0117147633136e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL15,C-C motif chemokine 15,42310,0.0522095130334539,0.00468719715706574,0.0430226066056051,0.0613964194613028,1.07885599896285e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA9,Serpin A9,42025,0.086641425080668,0.00778064421767215,0.0713913624140306,0.101891487747305,1.12517001981541e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0870528903321211,0.00782566998529417,0.0717145771609445,0.102391203503298,1.34674289472835e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKD2,Polycystin-2,39575,0.0700427690868805,0.006297854490605,0.0576989742852947,0.0823865638884664,1.39835884219491e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0740725845391615,0.00666351627576975,0.0610120926386528,0.0871330764396702,1.484063282292e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JPT2,Jupiter microtubule associated homolog 2,39930,0.105212382611739,0.00946848433724802,0.0866541533107326,0.123770611912745,1.54249499472401e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ING1,Inhibitor of growth protein 1,41820,0.0570363185402402,0.00513721965392271,0.0469673680185517,0.0671052690619287,1.62933436909711e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.152697840575813,0.0137585626896385,0.125731057704122,0.179664623447505,1.79029001717381e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP1,Guanylate-binding protein 1,39911,0.0772472226026538,0.0069625582251228,0.0636006084814131,0.0908938367238945,1.86689626384759e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS3BP,Galectin-3-binding protein,39979,0.0372555726427443,0.00336161009337272,0.0306668168597337,0.0438443284257548,2.12762789734854e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM2,Paralemmin-2,39929,0.0462458262406992,0.00417492860581591,0.0380629661733,0.0544286863080984,2.26733317849931e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCN1,Ficolin-1,39978,0.0664039038725432,0.00600033769590653,0.0546432419885664,0.07816456575652,2.53790362364083e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.117447172928391,0.0106154506221997,0.0966408897088799,0.138253456147903,2.62193435846558e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA4,Protein disulfide-isomerase A4,39966,0.0730247503391799,0.00660085049339174,0.0600870833721321,0.0859624173062277,2.64645664300438e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPLAH,5-oxoprolinase,39638,0.0827113951748089,0.00747744398939152,0.0680556049556015,0.0973671853940163,2.71644517132795e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0782911636422095,0.00707925008215403,0.0644158334811876,0.0921664938032314,2.75882382557459e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0994888211834298,0.00900873291531082,0.0818317046694206,0.117145937697439,3.1043801133844e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0518896188637635,0.00470302696846224,0.0426716860055775,0.0611075517219495,3.70528537237681e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0758499626236498,0.00687596691696459,0.0623730674663992,0.0893268577809004,3.78062531881497e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLO1,Lactoylglutathione lyase,41900,0.0669945596493768,0.00607904955526302,0.0550796225210613,0.0789094967776924,4.02471735419074e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOM,Apolipoprotein M,42199,0.0336386259672031,0.00305296662811688,0.027654811376094,0.0396224405583121,4.09932443794717e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA2,Carboxypeptidase A2,42205,0.0789101463574659,0.00716217523514698,0.0648722828965779,0.092948009818354,4.13134069551712e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMB1,Laminin subunit beta-1,39638,0.0372209303174578,0.00338046374036013,0.0305952213863519,0.0438466392485636,4.75364256758885e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP3,Caspase-3,42310,0.103998107618527,0.00947830040211244,0.0854206388303863,0.122575576406667,6.78868781424579e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP3,Stromelysin-1,42137,-0.0587008384201871,0.00535215160752116,-0.0691910555709286,-0.0482106212694456,7.15803458449845e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAP,Prolyl endopeptidase FAP,42310,0.0324961311761678,0.00296350786248532,0.0266876557656966,0.038304606586639,7.31439880737114e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPPK1,Epiplakin,39638,0.0874970939417813,0.00797655119950098,0.0718630535907594,0.103131134292803,7.47564947319911e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2,Complement C2,42199,0.026601989210337,0.00243222008845677,0.0218348378369617,0.0313691405837123,9.96967504741928e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0623887569804767,0.00570636414522031,0.0512042832558449,0.0735732307051085,1.09966272310751e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.141494353060301,0.012970496029919,0.11607218084166,0.166916525278942,1.35956634537436e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARSA,Arylsulfatase A,42137,0.052952436216367,0.00485928176273309,0.0434282439614101,0.0624766284713238,1.54699313289887e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYBB1,Beta-crystallin B1,39958,0.0777021061923882,0.00712805802482766,0.063731112463726,0.0916730999210504,1.56229849880033e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0421833302280821,0.00387413710443003,0.0345900215033992,0.049776638952765,1.8079001510895e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDC4,Syndecan-4,42145,0.0554912836075864,0.00509904029480197,0.0454971646297746,0.0654854025853983,1.81084135906927e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.047132471846317,0.00433041307022358,0.0386448622286787,0.0556200814639552,1.87571487677068e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.102363514420901,0.00941254715454965,0.083914921997984,0.120812106843819,2.07740182011119e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPI,Mannose-6-phosphate isomerase,42070,0.0994851374357546,0.00916609298463083,0.0815195951858782,0.117450679685631,2.48740212339889e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.109487796495515,0.0100973422027116,0.0896970057782004,0.12927858721283,2.78358238596555e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASS1,Argininosuccinate synthase,39575,0.0899786451039019,0.00832573479394064,0.0736602049077782,0.106297085300026,4.35119336016639e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRK5,G protein-coupled receptor kinase 5,41900,0.0597639731434742,0.00553736475366203,0.0489107382262966,0.0706172080606518,4.81519104229766e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0675499088341099,0.0062642006013403,0.0552720756554829,0.0798277420127369,5.33850920993073e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RP2,Protein XRP2,42070,0.0494485208444411,0.0045861280197261,0.040459709925778,0.0584373317631043,5.38449129160515e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0408213637370263,0.00378866473438544,0.0333955808576308,0.0482471466164218,5.83525456699451e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.100785931823409,0.00935893496358478,0.0824424192947824,0.119129444352035,6.5114736252709e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTD,Deoxycytidylate deaminase,39736,0.110851378359807,0.0103116230643084,0.0906405971537629,0.131062159565852,8.01071533300259e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.140564789887599,0.013118580797807,0.114852371523897,0.1662772082513,1.10837262223861e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0800592330056849,0.00747137254683067,0.0654153428138968,0.094703123197473,1.16652457567125e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0383630419750978,0.00358319445958992,0.0313399808343015,0.045386103115894,1.21421749882659e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLIT2,Slit homolog 2 protein,41839,0.0596404371969127,0.00557098524143938,0.0487213061236915,0.0705595682701338,1.23203938530477e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCS,Copper chaperone for superoxide dismutase,42016,0.0533829131335717,0.00499022531704186,0.0436020715121696,0.0631637547549737,1.33847688181929e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0325833688087994,0.00304934961342379,0.0266066435664888,0.0385600940511101,1.51781686847815e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0796563660040541,0.00745296763325145,0.0650485494428812,0.0942641825652269,1.56293717123757e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNB2,Plexin-B2,42255,0.0281445408822262,0.0026353190108674,0.0229793156209261,0.0333097661435263,1.6112094117933e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBI,Acyl-CoA-binding protein,42085,0.089449175311534,0.00838500637490594,0.0730145628167183,0.10588378780635,1.83685428428067e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G4A,Cytosolic phospholipase A2,42185,0.101346570575215,0.00950436254444755,0.0827180199880974,0.119975121162332,1.92559987983102e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0951271563074042,0.00892914969073109,0.0776260229135713,0.112628289701237,2.13587900052391e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0590104503057919,0.00553943241411492,0.0481531627741267,0.0698677378374572,2.25300498175076e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0422231470398485,0.00397160019354796,0.0344388106604945,0.0500074834192025,2.8349011891486e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKN3,Serine/threonine-protein kinase N3,39757,0.0840558541941025,0.00792718821060598,0.0685185653013148,0.0995931430868902,3.82251200762963e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.083004770639384,0.00783450547863729,0.0676491399012549,0.0983604013775131,3.99651579447183e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNAS,Neuroendocrine secretory protein 55,39934,0.0987188173435437,0.009315017992203,0.0804613820788258,0.116976252608262,4.04130551097571e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRGN,Neurogranin,39990,0.105369988942514,0.00995076293977953,0.0858664935805457,0.124873484304481,4.42382429081054e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.114153216267128,0.0107811036437694,0.0930222531253402,0.135284179408916,4.47077075457542e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPA,Apolipoprotein(a),39775,-0.208080671412607,0.0196600247800067,-0.24661431998142,-0.169547022843794,4.6983158433592e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.116185924231447,0.0109791722394758,0.0946667466420739,0.137705101820819,4.7928480277897e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPL14,60S ribosomal protein L14,39638,0.0445029018499043,0.00420836173467876,0.0362545128499339,0.0527512908498746,5.18904771176826e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLN4,Cerebellin-4,42262,0.0361275245301032,0.00341920752445854,0.0294258777821645,0.0428291712780419,5.39338947290406e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL7,C-C motif chemokine 7,42119,0.0640219716669877,0.00606267325573104,0.0521391320857549,0.0759048112482206,5.76219253521247e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0320312711541685,0.00303258336540115,0.0260874077579822,0.0379751345503547,5.9307875010566e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.123135780127681,0.0116632225007852,0.100275864026142,0.14599569622922,6.26080941702295e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0701058275026906,0.00665066853967699,0.0570705171649237,0.0831411378404575,7.05620667514158e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0315689798734433,0.0030036965873188,0.0256817345622984,0.0374562251845881,9.73049026681092e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DXO,Decapping and exoribonuclease protein,39929,0.0513454796677165,0.00488402543583937,0.0417727898134714,0.0609181695219617,9.89101532510561e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCA,Tubulin-specific chaperone A,39736,0.0950394946082467,0.00904735079576113,0.0773066870485549,0.112772302167939,1.08384510902335e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0560285208103294,0.00534220864068139,0.0455577918745939,0.0664992497460649,1.30307193842242e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0514048901952092,0.00490991068362399,0.0417814652553062,0.0610283151351123,1.49655984417666e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.065472721184732,0.00625666545665941,0.0532096568896796,0.0777357854797845,1.58174351960982e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0688390310853223,0.00658563222809753,0.0559311919182511,0.0817468702523935,1.77842921954082e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0387415701039608,0.0037085406201768,0.0314728304884143,0.0460103097195074,1.90016553720067e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0355815385239431,0.00341001866536778,0.0288979019398222,0.0422651751080639,2.16606074982081e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0334305471625854,0.00320301248420317,0.0271526426935472,0.0397084516316236,2.18363662511626e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.041912768633912,0.00401867579250577,0.0340361640806007,0.0497893731872233,2.37915033496738e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX6,Peroxiredoxin-6,42262,-0.0674164003224945,0.00646963084534306,-0.0800968767793669,-0.0547359238656221,2.48889620238852e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLRX,Glutaredoxin-1,42057,0.062315193928907,0.00598502055455478,0.0505845536419796,0.0740458342158344,2.73085238598425e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0454903573713681,0.00436969722487104,0.0369257508106208,0.0540549639321153,2.76317327045874e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC3B,Tetranectin,39726,0.0235579626290808,0.00226346386777558,0.0191215734482406,0.0279943518099209,2.97897745204918e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN6,Dynactin subunit 6,41839,0.0810363332175968,0.00778941591585933,0.0657690780225125,0.0963035884126811,2.99354981949746e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLTA,Clathrin light chain A,41900,0.052391806230405,0.00503827579956806,0.0425167856632516,0.0622668267975584,3.13827168644733e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGR,Tyrosine-protein kinase Fgr,41839,0.0658415439702619,0.00633193497617906,0.0534309514169509,0.0782521365235729,3.15549926616022e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB10,Ras-related protein Rab-10,39958,0.0599470508817892,0.00576314263510144,0.0486512913169904,0.071242810446588,3.15781011667366e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SWAP70,Switch-associated protein 70,39930,0.041075841598885,0.00395065420994201,0.0333325593473987,0.0488191238503714,3.31368747004115e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0337419046965647,0.00325161986239834,0.0273687297662639,0.0401150796268654,3.92180644075486e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0331312353611696,0.00319748979588823,0.0268641553612287,0.0393983153611105,4.60946053897398e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0494440167184124,0.00477695047443811,0.0400811937885137,0.0588068396483111,5.37744143810854e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.043263541374408,0.00418194240177649,0.0350669342669261,0.0514601484818899,5.4314080546516e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BGLAP,Osteocalcin,39966,0.0938618591257989,0.00907499382338343,0.0760748712319674,0.11164884701963,5.81413589465061e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGRN,Neugrin,39929,0.0249843345866269,0.00241630293827011,0.0202483808276175,0.0297202883456363,6.00287950441011e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TST,Thiosulfate sulfurtransferase,41809,0.0839777817527307,0.00814330630621804,0.0680169013925433,0.0999386621129181,7.68635211480861e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNC79,Protein unc-79 homolog,39560,0.0618824862030161,0.00601052903177751,0.0501018493007322,0.0736631231053,9.55270055656372e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSE,Cathepsin E,39736,0.0588058978624113,0.00571364690855381,0.0476071499216459,0.0700046458031768,9.86255905317805e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0513134495451754,0.00498944457502032,0.0415341381781356,0.0610927609122153,1.02629841843555e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBN1,Drebrin,39657,0.0565107204847868,0.00549500604923336,0.0457405086282894,0.0672809323412842,1.07463856481502e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRMD4B,FERM domain-containing protein 4B,39575,0.0778727270651971,0.00757589722569928,0.0630239685028265,0.0927214856275677,1.13350414813353e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0549765821589764,0.00535950088254255,0.044471960429193,0.0654812038887598,1.34284497961055e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0686635670789241,0.00670317437970846,0.0555253452946955,0.0818017888631527,1.55351006877985e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFC1,Cryptic protein,41843,0.0527530943238311,0.00516262995512141,0.0426343396117931,0.062871849035869,2.02372667285833e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,39575,0.07398853348005,0.0072419324413363,0.0597943458950309,0.0881827210650692,2.1466071678336e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLNK,B-cell linker protein,39657,0.0460281623945678,0.00450553320864104,0.0371973173056314,0.0548590074835042,2.15943935981527e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BDNF,Brain-derived neurotrophic factor,39966,0.0923763142030843,0.00905061777752218,0.0746371033591408,0.110115525047028,2.35838283079402e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0937749309970595,0.0091892056820671,0.075764087860208,0.111785774133911,2.41657000725296e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0433828623663128,0.00426651905947193,-0.0517452397228778,-0.0350204850097479,3.3594002424867e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPAG1,Sperm-associated antigen 1,39934,0.0639928622408359,0.0062958189170503,0.0516530571634173,0.0763326673182545,3.63100178814533e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F2R,Proteinase-activated receptor 1,42166,0.0627425832211764,0.0061764498295231,0.0506367415553111,0.0748484248870416,3.71135769924282e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLMH,Bleomycin hydrolase,42310,0.0337732007954367,0.00332990149904811,0.0272465938573024,0.0402998077335709,4.35614709113802e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF6,SLAM family member 6,41843,0.0423040743269248,0.00417076845274768,0.0341293681595393,0.0504787804943102,4.35992726178471e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0469872192918215,0.00463280429825132,-0.0560675157163941,-0.037906922867249,4.36717142188463e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0776853551127233,0.0076595966925311,0.0626725455953624,0.0926981646300843,4.54338621363852e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NADK,NAD kinase,42145,0.0596665844153279,0.00589063047741868,0.0481209486795873,0.0712122201510686,4.99980372850308e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0429260681704825,0.00424783209500972,0.0346003172642634,0.0512518190767015,6.60098294628125e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.122337215474701,0.0121461698492742,-0.146143708379278,-0.0985307225701233,8.91741938561708e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.106354788644355,0.0105651490275999,0.0856470965502588,0.12706248073845,9.41376907294491e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0529916778949991,0.00528557741737009,0.0426319461569537,0.0633514096330445,1.42041294991138e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNF,Tumor necrosis factor,41880,0.0392189381282716,0.00391827399806123,0.0315391210920716,0.0468987551644716,1.68157845019502e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES2,Cocaine esterase,42070,0.0596537199075622,0.0059977857301558,0.0478980598764568,0.0714093799386675,3.15812134980271e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0620663956790872,0.00624875098647703,0.0498188437455923,0.0743139476125822,3.61008660881374e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMMT,MICOS complex subunit MIC60,39919,0.0477060770149956,0.00480970663053576,0.0382790520191455,0.0571331020108457,4.28785411024644e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHPS,Deoxyhypusine synthase,39919,0.0431056265368729,0.00434666941858725,0.0345861544764419,0.0516250985973039,4.36414466429032e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN9,Septin-9,42070,0.0306970641773393,0.00309892866606294,0.024623163991856,0.0367709643628227,4.71424448706345e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12B,Interleukin-12 subunit beta,42296,0.0584090142803247,0.00590671330168012,0.0468318562090317,0.0699861723516177,5.5707911277867e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMTN,Smoothelin,39897,0.0987012022198673,0.00998995906561149,0.0791208824512688,0.118281521988466,6.29336379992558e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TF,Serotransferrin,39979,0.0227783051684715,0.00230990699525615,0.0182508874577694,0.0273057228791735,7.57496434168973e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0441446965197208,0.00448154627835737,0.0353608658141403,0.0529285272253012,8.48927455554807e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0284363384727087,0.00288998458418956,0.0227719686876971,0.0341007082577202,9.42657366406429e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,39930,0.10491094021765,0.0106667865078719,0.0840040386622215,0.125817841773079,9.78326215685056e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0395228112378137,0.00401998802133512,0.0316436347159969,0.0474019877596306,1.01471848646946e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDCP1,CUB domain-containing protein 1,42016,0.0592641891417457,0.00603609550912318,0.0474334419438642,0.0710949363396271,1.11977004815283e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARF1,Scavenger receptor class F member 1,42310,0.0449450494389615,0.00457846010066791,0.0359712676416524,0.0539188312362706,1.13405705472312e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0480367885829534,0.00489512511861096,0.038442343350476,0.0576312338154309,1.17683695213889e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1R,Complement C1r subcomponent,39979,0.0198911165240979,0.00202654788200745,0.0159190826753634,0.0238631503728325,1.19030616359554e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.126261732573098,0.0128698000315144,0.10103692451133,0.151486540634866,1.20442768368577e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFB,Complement factor B,39794,0.0346420580669508,0.00353229463742229,0.0277187605776031,0.0415653555562985,1.29244739672736e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH15,Cadherin-15,42230,0.0729017424026106,0.007455680411544,0.0582886087959844,0.0875148760092369,1.65920409871912e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX16,Syntaxin-16,41843,0.0601175343472247,0.00615854383514187,0.0480467884303467,0.0721882802641028,1.95750226655627e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0383510725156831,0.00392739155616146,0.0306533850656067,0.0460487599657596,1.95988849532488e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAP3,Cytosol aminopeptidase,41913,0.0505323959972463,0.00517777671078035,0.0403839536441168,0.0606808383503758,1.99771356132837e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.126419994043164,0.0129625406779455,0.101013414314391,0.151826573771937,2.12877353051649e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0928667332882014,0.00954822399885361,0.0741522142504484,0.111581252325955,2.86659736430316e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",39929,0.112234484407474,0.011550201472445,0.0895960895214814,0.134872879293466,3.11310123198874e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0382416271617621,0.00394621162701136,0.0305070523728198,0.0459762019507044,3.90229431578274e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPXM1,Probable carboxypeptidase X1,42181,0.0717813615291273,0.007414584508483,0.0572487758925006,0.086313947165754,4.27593221966634e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0243564112193853,0.00251640982912439,0.0194242479543015,0.0292885744844691,4.35615106872832e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LBP,Lipopolysaccharide-binding protein,42217,-0.0610260069671315,0.00631755558459964,-0.0734084159129468,-0.0486435980213162,5.25830933163517e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LONP1,"Lon protease homolog, mitochondrial",39638,0.0914563085427492,0.009465470282187,0.0729039867896627,0.110008630295836,5.33790754046022e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,39919,0.04572930964277,0.00473339444672293,0.036451856527193,0.0550067627583469,5.36851788053329e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0555327909804208,0.0057505086966444,0.0442617939349978,0.0668037880258438,5.60673701990133e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSCAM,Down syndrome cell adhesion molecule,39934,0.0377629284025676,0.00391543666419179,0.0300886725407517,0.0454371842643835,6.28813691792361e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0462175816578229,0.00479931661667445,0.036810921089141,0.0556242422265049,7.27496003325527e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARD3,Partitioning defective 3 homolog,39757,0.0769603780854668,0.00799621152756114,0.0612878034914469,0.0926329526794866,7.65270772447595e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MIA,Melanoma-derived growth regulatory protein,42181,0.0383030088464389,0.00398582984372044,0.0304907823527469,0.046115235340131,8.52766738028609e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP170,Centrosomal protein of 170 kDa,39638,0.080013714434431,0.00833244143390456,0.0636821292239781,0.096345299644884,9.47314459395294e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG3,BAG family molecular chaperone regulator 3,41992,0.0419936944874919,0.00437485626794473,0.0334189762023202,0.0505684127726635,9.49568935971043e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL19,C-C motif chemokine 19,42249,0.116780159982732,0.0121722504335717,0.0929225491329315,0.140637770832533,9.92539072564178e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0767897527194556,0.00801079914448838,0.0610885863962584,0.0924909190426529,1.07910079391277e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.034998502500718,0.00365538452455059,0.0278339488325988,0.0421630561688371,1.19834795551979e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD40LG,CD40 ligand,42296,0.0817585904617701,0.00854242100237059,0.0650154452971237,0.0985017356264164,1.23855720796289e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF2,Fibroblast growth factor 2,42119,0.0713814473273321,0.00746118399522014,0.0567575266967006,0.0860053679579636,1.28785861079075e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL5,Insulin-like peptide INSL5,39930,0.105693779577503,0.0110447622612812,0.084046045545392,0.127341513609614,1.29545460893235e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPP1,Osteopontin,42286,-0.0453554770661758,0.00474397378626815,-0.0546536656872614,-0.0360572884450902,1.36672499725678e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL11,C-X-C motif chemokine 11,42249,0.0804446660229039,0.00841541169402355,0.0639504591026178,0.0969388729431901,1.38637234053228e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX9,Sorting nexin-9,42145,0.0698373002344825,0.00732616488342557,0.0554780170629684,0.0841965834059967,1.7914307297752e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0643357332196683,0.00675934011517291,0.0510874265939293,0.0775840398454072,2.13157949059056e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERI1,3'-5' exoribonuclease 1,39757,0.0351556248286027,0.00370239654012815,0.0278989276099516,0.0424123220472539,2.64071529367196e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0338333187819153,0.00356566424291158,0.0268446168658086,0.040822020698022,2.81239733935724e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD274,Programmed cell death 1 ligand 1,42016,0.034441043330639,0.00363867064429659,0.0273092488678177,0.0415728377934603,3.40906737159567e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SBSN,Suprabasin,39954,-0.0362564671027818,0.00383066930768109,-0.0437645789458368,-0.0287483552597269,3.52064023795336e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMIGO2,Amphoterin-induced protein 2,42070,0.0238812760618947,0.00252447853123336,0.0189332981406773,0.0288292539831121,3.58629239413203e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC16A1,Monocarboxylate transporter 1,41839,0.056282386768218,0.00595266186665941,0.0446151695095655,0.0679496040268704,3.76665007370019e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFP,Alpha-fetoprotein,41976,0.0663943469505657,0.00702803151976072,0.0526194051718347,0.0801692887292967,4.05430692587546e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0734308936419159,0.00778383502610644,0.0581745769907472,0.0886872102930845,4.60278021449907e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0379042839118622,0.00402634559087103,0.030012646553755,0.0457959212699694,5.71790605665389e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMOTL2,Angiomotin-like protein 2,39882,0.0496041309346628,0.00526977367262069,0.0392753745363262,0.0599328873329993,5.75767175138826e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0839251152718559,0.00893022128114796,0.0664218815608058,0.101428348982906,6.44830130211813e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0496508985526468,0.00528758278630941,0.0392872362914803,0.0600145608138132,7.13772043300343e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM1,Intercellular adhesion molecule 1,42126,0.0294504127005842,0.00313881307824394,0.0232983390672261,0.0356024863339424,7.4430884395964e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA2,Carbonic anhydrase 2,42103,0.0670858175861657,0.00715153095895923,0.0530688169066056,0.0811028182657257,7.58914485842155e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0319884424491905,0.00341266018803994,0.0252996284806323,0.0386772564177488,8.12046927188726e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTX3,Pentraxin-related protein PTX3,42119,-0.0503323627893823,0.00537021585251262,-0.060857985860307,-0.0398067397184576,8.19102604918786e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH7,Protocadherin-7,39930,0.0351661758462615,0.00376374304712674,0.0277892394738931,0.0425431122186299,1.1069500771478e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0359931682279311,0.00385229509920834,0.0284426698334828,0.0435436666223795,1.11127935430812e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0598459195320344,0.00640618858193673,0.0472897899114384,0.0724020491526303,1.12270064844649e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS27,Serine protease 27,42107,0.0404426921088989,0.00433226755977864,0.0319514476917327,0.048933936526065,1.16288428244779e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL24,C-C motif chemokine 24,42166,0.0827187303744431,0.00888197858794123,0.0653100523420783,0.100127408406808,1.42989054653961e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP25,Synaptosomal-associated protein 25,39586,0.0483115902153675,0.00519318465572482,0.0381329482901469,0.0584902321405882,1.6257707979682e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0312307998959755,0.00336042436671564,-0.0378172316547381,-0.0246443681372128,1.74743344029793e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB2B,Ras-related protein Rab-2B,39919,0.062479348362654,0.00672885446838076,0.0492907936046278,0.0756679031206803,1.90606208614111e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3C,Protein FAM3C,42129,0.0303484898202195,0.00327735177064166,0.0239248803497618,0.0367720992906771,2.34644665557183e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MET,Hepatocyte growth factor receptor,42158,-0.0191227257221594,0.00206836767402105,-0.0231767263632406,-0.0150687250810781,2.69044778806819e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA6,Carbonic anhydrase 6,42103,-0.0622995639457833,0.00675203374835033,-0.0755335500925499,-0.0490655777990166,3.19744005658249e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARFIP1,Arfaptin-1,39934,0.0689007405931237,0.00746695543619785,0.054265507938176,0.0835359732480715,3.26252368909721e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APLP1,Amyloid-like protein 1,42145,-0.0504662688528559,0.00548099041455395,-0.0612090100653816,-0.0397235276403301,3.82103799508583e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G15,Phospholipase A2 group XV,42181,0.0272416873869885,0.00296422822195215,0.0214318000719623,0.0330515747020147,4.48499838385624e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0644892744189064,0.00702438555453486,0.0507214787320181,0.0782570701057947,4.90363377510326e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0382538916100094,0.004166936434063,0.0300866961992459,0.0464210870207729,4.91217130954949e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM4,Intercellular adhesion molecule 4,42119,-0.0520732820658431,0.00567354463598324,-0.0631934295523702,-0.0409531345793159,5.0081239178379e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASAH1,Acid ceramidase,39876,0.0468133976211482,0.00509963737139613,0.0368181083732118,0.0568086868690846,5.07247561299742e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMSB10,Thymosin beta-10,42137,0.0751882094285645,0.00819535634720013,0.0591253109880522,0.0912511078690768,5.18460517476685e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP4,Dipeptidyl peptidase 4,41948,0.0276020530216851,0.00300988543267638,0.0217026775736394,0.0335014284697308,5.39067320714183e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0525329488067298,0.00573436157482576,0.0412936001200713,0.0637722974933883,5.87050595237328e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNA4,Ephrin-A4,41992,0.031928349906033,0.00348660134401236,0.0250946112717687,0.0387620885402972,6.07522255923197e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHI3L1,Chitinase-3-like protein 1,41907,0.0826776300103158,0.00903108936890034,0.0649766948472711,0.10037856517336,6.23127267309271e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOL1,Apolipoprotein L1,39990,0.0527161438693356,0.0057579380203184,0.0414305853495115,0.0640017023891596,6.33783638801948e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP6,Platelet glycoprotein VI,42115,0.0869417065795625,0.00950105603424724,0.0683196367524379,0.105563776406687,6.45385428133207e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTN,Pleiotrophin,41900,0.0490099411210994,0.00536648255140316,0.0384916353203492,0.0595282469218496,7.64105828590729e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0688933717323641,0.00757236326913051,0.0540515397248683,0.0837352037398598,1.07362855981295e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0321433899525616,0.00353425708819874,0.0252162460596921,0.0390705338454311,1.07855283355578e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL26,C-C motif chemokine 26,42119,0.0882072003908425,0.00969927402233933,0.0691966233070574,0.107217777474628,1.08399708578371e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL14,C-C motif chemokine 14,42152,0.0396008660598976,0.0043594633302894,0.0310563179325303,0.0481454141872648,1.19086934679822e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DENR,Density-regulated protein,39657,0.0562910789140269,0.00619791454777043,0.0441431664003968,0.0684389914276569,1.24392291983692e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3B,Protein FAM3B,42070,0.0344318818756256,0.00379320886176549,0.0269971925065653,0.041866571244686,1.26631880961289e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARB2,Lysosome membrane protein 2,41777,0.0322997795907016,0.00356080990026278,0.0253205921861865,0.0392789669952167,1.34550811413293e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100P,Protein S100-P,41900,0.0522450299699454,0.00576798291131982,0.0409397834637586,0.0635502764761323,1.51494840282858e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCF2,Neutrophil cytosol factor 2,42097,0.0812173464840159,0.00897919769591144,0.0636181190000295,0.0988165739680023,1.69757758802427e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA13,Carbonic anhydrase 13,41967,0.102490217202001,0.011354456561742,0.0802354823409872,0.124744952063016,2.01314724021299e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFRP1,Secreted frizzled-related protein 1,41968,0.0418668229017992,0.00463933393412468,0.0327737283909148,0.0509599174126835,2.05212249737047e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0528733819256548,0.00586017104907629,0.0413874466694653,0.0643593171818444,2.14066147468255e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0546150164399185,0.00605412833238158,0.0427489249084506,0.0664811079713864,2.16441277822788e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTNB,Dystrobrevin beta,39900,0.0442509098344796,0.00490756243620263,0.0346320874595225,0.0538697322094368,2.24638124117265e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0470715081504224,0.00522312497747279,0.0368341831945758,0.0573088331062691,2.34448270821462e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0944794815482777,0.0104873477383512,0.0739242799811094,0.115034683115446,2.35944203584942e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0671349033036092,0.00746390945347024,0.0525056407748076,0.0817641658324109,2.68378938896247e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRP2,Neuropilin-2,42137,-0.0272827741961006,0.00303353886228333,-0.033228510366176,-0.0213370380260253,2.70387000387239e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0390703900257347,0.00434416316424302,0.0305558302238183,0.047584949827651,2.76859828444211e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAL,Integrin alpha-L,39657,0.0423807160846451,0.00471226171824597,0.033144683116883,0.0516167490524072,2.77936766708027e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0661762520001242,0.00737230501997242,0.0517265341609783,0.0806259698392701,3.1725759956636e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP5,Platelet glycoprotein V,39736,0.0353953880099457,0.00394376463391903,0.0276656093274644,0.043125166692427,3.28654470754832e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0313614521103018,0.00349525358363528,0.0245107550863766,0.0382121491342269,3.35005447918034e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POMC,Pro-opiomelanocortin,39638,0.0710719044905457,0.00792224664240578,0.0555443010714304,0.086599507909661,3.40694567990234e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0450690119195984,0.00502918940380635,0.035211800688138,0.0549262231510589,3.62716684334114e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFB2,BPI fold-containing family B member 2,39927,0.0591573611855747,0.00661457508960365,0.0461927940099516,0.0721219283611979,4.35505072945178e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMD,Osteomodulin,42185,-0.0393791408111203,0.00442822317941836,-0.0480584582427803,-0.0306998233794603,6.70415313794117e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEK,Angiopoietin-1 receptor,42181,0.0212161453170738,0.00238780459159,0.0165360483175574,0.0258962423165902,7.17310947727638e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS22,Brain-specific serine protease 4,39657,0.0331815344968893,0.00373335536463826,0.0258641579821983,0.0404989110115803,7.19439017071084e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSR,"Glutathione reductase, mitochondrial",39949,0.0219768891472437,0.00247371423769278,0.0171284092413658,0.0268253690531215,7.4082818254596e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIGR,Polymeric immunoglobulin receptor,41987,0.0355290867717627,0.004000326944635,0.0276884459602781,0.0433697275832473,7.42454427181022e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAA4,Serum amyloid A-4 protein,39979,0.0315619223919002,0.00355373428377535,0.0245966031957005,0.0385272415880999,7.59487527585682e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.021897758609074,0.0024665393954936,0.0170633413939066,0.0267321758242415,7.65705932457079e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0401960829717209,0.00453300374629836,0.0313113956289761,0.0490807703144657,8.42885455398432e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPMT,Thiopurine S-methyltransferase,41843,0.0684833359602114,0.00772459478466087,0.0533431301822761,0.0836235417381467,8.57014669772992e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP3R1,Calcineurin subunit B type 1,42016,0.0385921184214108,0.00435425628586204,0.0300577761011212,0.0471264607417004,8.75338322532781e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABHD14B,Protein ABHD14B,41976,0.0533965432726826,0.00602884312201977,0.0415800107535239,0.0652130757918413,9.25685622742901e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0232565739005772,0.00262743266364189,0.0181068058798391,0.0284063419213153,9.70559464275315e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0541478372035639,0.00611843387162872,0.0421557068151716,0.0661399675919562,9.85517043876772e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSR1,Macrophage scavenger receptor types I and II,42249,0.045104827235958,0.00510046414978479,0.0351079175023798,0.0551017369695362,1.04218811397539e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN2,Dynactin subunit 2,42070,0.0904238999747817,0.0102313842657491,0.0703703868139134,0.11047741313565,1.09499598693538e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFA2,BPI fold-containing family A member 2,39281,-0.105454263878253,0.0119604446726321,-0.128896735436612,-0.0820117923198947,1.3592580332468e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UMOD,Uromodulin,42274,-0.0511506011403449,0.00580414592031511,-0.0625267271441625,-0.0397744751365273,1.36653342072967e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BST2,Bone marrow stromal antigen 2,42249,0.048466604964138,0.00549979014560746,0.0376870162787474,0.0592461936495286,1.37074254468725e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C7orf50,Uncharacterized protein C7orf50,39929,0.0216766723252824,0.00246008108161532,0.0168549134053164,0.0264984312452484,1.41615241663193e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PER3,Period circadian protein homolog 3,39657,0.116740769414773,0.0132492674990186,0.0907722051166971,0.14270933371285,1.42406798863581e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEL1L,Protein sel-1 homolog 1,39638,0.0298405063467329,0.00339097683941007,0.0231941917414891,0.0364868209519766,1.57203455257771e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NID2,Nidogen-2,42137,0.0691459587416695,0.00786469657520321,0.0537311534542712,0.0845607640290678,1.64541844843947e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPR,Nucleoprotein TPR,39575,0.046299849270192,0.00526799145786825,0.0359745860127702,0.0566251125276137,1.73513960038842e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPPB,Natriuretic peptides B,41900,-0.13254512657052,0.0151207250814517,-0.162181747730166,-0.102908505410875,2.07743813788638e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON1,Serum paraoxonase/arylesterase 1,39990,-0.0256223121741908,0.00292328408226328,-0.0313519489754268,-0.0198926753729547,2.13373479819851e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0540277518712323,0.00617169343784464,0.0419312327330568,0.0661242710094078,2.30268268659094e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP1,Interstitial collagenase,41693,0.0850422895614374,0.0097227578643088,0.0659856841473922,0.104098894975483,2.4620982025477e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0340975943853923,0.00390173352231806,0.0264501966816489,0.0417449920891357,2.68934624511964e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.040205293216381,0.00460712832631624,-0.0492352647359608,-0.0311753216968011,2.92563203645009e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.040972363978705,0.00469580522497997,0.0317685857377443,0.0501761422196658,2.96862155118798e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBS,Cystathionine beta-synthase,39638,0.0486579945890668,0.00558070421167574,0.0377198143341823,0.0595961748439513,3.20904775412755e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL1A1,Collagen alpha-1(I) chain,42310,-0.0220577152833693,0.00253262485780343,-0.027021660004664,-0.0170937705620745,3.39996165459262e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPO,Erythropoietin,42119,0.0685961269013493,0.00787896968015485,0.0531533463282458,0.0840389074744528,3.50195835318773e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROK1,Prokineticin-1,42119,0.0466953819841061,0.00537194228861357,0.0361663750984235,0.0572243888697887,3.95114017392103e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAGED1,Melanoma-associated antigen D1,41843,0.0452647248985254,0.00521107067521593,0.0350510263751022,0.0554784234219487,4.18066457847218e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0447922909610258,0.00515755507293251,0.0346834830180781,0.0549010989039736,4.31373443906446e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD2,Sushi domain-containing protein 2,42137,-0.0265543362348309,0.00305924451701247,-0.0325504554881754,-0.0205582169814865,4.40436283216126e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRG,Histidine-rich glycoprotein,39925,0.0291166804417118,0.00335619945264385,0.0225385295145299,0.0356948313688938,4.67896888989519e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSC,Dipeptidyl peptidase 1,42123,0.0415174131893229,0.0047874003729034,0.0321341084584323,0.0509007179202136,4.71583756968289e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LACRT,Extracellular glycoprotein lacritin,39895,0.0425202719468249,0.00491008151383217,0.0328965121797139,0.052144031713936,5.36755398606549e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FADD,FAS-associated death domain protein,42145,0.0711478079623694,0.00823048511399347,0.0550160571389422,0.0872795587857966,6.00892719340943e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAT,Catalase,39827,0.0488079088876282,0.00564459655971549,0.0377444996305859,0.0598713181446706,6.01299947315244e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMS,Spermine synthase,39586,0.0599565164868136,0.0069354115878411,0.046363109774645,0.0735499231989821,6.12778517069745e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGS10,Regulator of G-protein signaling 10,39934,0.0554680339935372,0.00642231859322409,0.0428802895508179,0.0680557784362564,6.5558715187497e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK7,Kallikrein-7,39475,0.0368490342454779,0.00426889774867838,0.0284819946580683,0.0452160738328876,6.87013812625906e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0327364427496032,0.00379387302045745,0.0253004516295066,0.0401724338696998,6.87814953923146e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0554441053038222,0.00642491254864714,0.0428512767084738,0.0680369338991706,6.97795900957434e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0613821741378267,0.00712304293592587,0.047421009983412,0.0753433382922414,7.59151089702894e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.02158370304592,0.00250403660420494,0.0166757913016783,0.0264916147901616,7.60920835879338e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPK1,Thiamin pyrophosphokinase 1,39958,0.0260337987962864,0.00302056821776091,0.020113485089475,0.0319541125030977,7.65769868723674e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0407037217048737,0.00472370899565038,0.031445252073399,0.0499621913363484,7.79022470141628e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0821900855390034,0.00953925370034488,0.0634931482863275,0.100887022791679,7.85206502039334e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD248,Endosialin,39966,-0.0375745436999914,0.00436938420494831,-0.0461385367416901,-0.0290105506582927,9.05382548308652e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MZT1,Mitotic-spindle organizing protein 1,41843,0.0487635182136291,0.00567539187871734,0.0376397501313431,0.0598872862959151,9.48756858255514e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FST,Follistatin,42166,0.0450948746027984,0.00525749237106148,0.0347901895555179,0.0553995596500789,1.07601657949063e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4M,C-type lectin domain family 4 member M,39945,-0.0458308882088578,0.00534854783485728,-0.0563140419651781,-0.0353477344525375,1.1802971989143e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BGN,Biglycan,41820,-0.109177592345405,0.0127482750748756,-0.134164211492161,-0.0841909731986493,1.2086622523883e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0683754244037728,0.00800376546567171,0.0526880440910562,0.0840628047164893,1.47880105000162e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1F,Protein phosphatase 1F,39958,0.0492020507646354,0.00576027896943407,0.0379119039845446,0.0604921975447261,1.49219023919996e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0606342926422047,0.00709927814308991,0.0467197074817485,0.0745488778026609,1.50157246883941e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM3,Myomesin-3,39736,-0.0893091611346626,0.0104590625303148,-0.10980892369408,-0.0688093985752456,1.5306497892701e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.047739279161353,0.00560189976983766,0.0367595556124712,0.0587190027102348,1.73109958445595e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLIF,Cobalamin binding intrinsic factor,42129,0.0700466478139082,0.00823455588454085,0.0539069182802082,0.0861863773476083,1.98054331973897e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0396446183841272,0.00466136716296412,0.0305083387447175,0.0487808980235369,2.05118655169593e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDK2,Protein sidekick-2,39736,0.0360853909991167,0.0042430074171948,0.0277690964614149,0.0444016855368185,2.05358564155215e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAM,Integrin alpha-M,42137,-0.0289082099624719,0.0034076180841293,-0.0355871414073654,-0.0222292785175785,2.41199982281596e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0513264509080286,0.00605399282617927,0.0394606249687172,0.0631922768473399,2.57530058941898e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO2,Gamma-enolase,42249,0.059482155910156,0.00702335219179243,0.0457163856142429,0.0732479262060692,2.72124828579746e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRN1,Secernin-1,42119,0.0506421837703711,0.00598164793644172,0.0389181538149453,0.0623662137257969,2.79294682085085e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0327291588958486,0.00387184542398912,-0.0403179759268672,-0.0251403418648299,3.18296254023906e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0809889465508519,0.00959079310037793,0.0621909920741112,0.0997869010275927,3.36906847155892e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0519353722074552,0.00615118356192099,0.03987905242609,0.0639916919888203,3.47079828986807e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0656669210820925,0.00778232392857255,0.0504135661820903,0.0809202759820947,3.55787455928417e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF22,Kinesin-like protein KIF22,39575,0.112789336854955,0.0134013087194388,0.0865227717648545,0.139055901945055,4.36816527417576e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0621229115386444,0.00738338280769694,0.0476514812355584,0.0765943418417304,4.4498845278292e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTC,Probetacellulin,41843,0.0666513806523143,0.00792385079984568,0.0511206330846167,0.0821821282200118,4.45994088058534e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSME2,Proteasome activator complex subunit 2,41955,0.0320060956409869,0.00380523883747759,0.0245478275195308,0.039464363762443,4.47252931766698e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DMD,Dystrophin,39638,0.0467113488466491,0.00555323920201597,0.0358270000106978,0.0575956976826004,4.54430281114052e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0295029633466119,0.00351065786125973,0.0226220739385428,0.036383852754681,4.74367520807911e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XRCC4,DNA repair protein XRCC4,41839,0.0334903463971452,0.00398704223102459,0.025675743624337,0.0413049491699534,4.92469760686106e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIMAP8,GTPase IMAP family member 8,39560,0.0454497820677603,0.00541044302497632,0.0348453137388067,0.0560542503967139,4.99914693774442e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSL,Cathepsin L1,42145,0.0221620986569933,0.00264027602938863,0.0169871576393916,0.0273370396745951,5.16757209335992e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0787593386144862,0.00939486378806017,0.0603454055898883,0.0971732716390841,5.76723045116473e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA4,Carbonic anhydrase 4,42310,-0.0219196564910885,0.00261727178870102,-0.0270495091969425,-0.0167898037852345,6.05408812040489e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO2,Roundabout homolog 2,42249,0.0204443023288103,0.00244194773983933,0.0156580847587252,0.0252305198988954,6.20531977639987e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANSC1,MANSC domain-containing protein 1,42181,-0.0250961867720095,0.00299860914556699,-0.0309734606973208,-0.0192189128466982,6.35957327975589e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0322875620861424,0.00385789447568011,0.0247260889138094,0.0398490352584755,6.37763942695855e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGBL1,Integrin beta-like protein 1,39966,0.0355618037867105,0.00425039257553613,0.0272310343386596,0.0438925732347613,6.61644414600856e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPT,Dermatopontin,42310,0.0229119680372496,0.00273926790613095,0.0175430029412329,0.0282809331332662,6.62842576219947e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIT,Vitrin,39958,0.0346467572961238,0.00415076242865487,0.0265112629359603,0.0427822516562874,7.80630076676877e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0365224365382756,0.00438419840862604,-0.0451154654191827,-0.0279294076573686,8.8248237239932e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSF,Cathepsin F,42181,0.0362073344001581,0.00434974510148946,0.0276818340012387,0.0447328347990774,9.3098740612206e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0776669032275608,0.00933538879018304,0.0593695411988021,0.0959642652563196,9.66558652394434e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDGF,Hepatoma-derived growth factor,42243,0.082002972260385,0.00985796856675945,0.0626813538695365,0.101324590651234,9.75137510047001e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA1,Carbonic anhydrase 1,41890,0.0505860300528773,0.0060824357317101,0.0386644560187255,0.0625076040870291,9.91558141587525e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0722491545602339,0.00868921929533945,0.0552182847413685,0.0892800243790992,1.00624539692202e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCAM1,Vascular cell adhesion protein 1,42199,-0.0248484948511498,0.00299108596965248,-0.0307110233516686,-0.0189859663506309,1.06906096355915e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDF1,Endothelial differentiation-related factor 1,39934,0.059477439505223,0.00716454115013775,0.045434938850953,0.073519940159493,1.14321050267451e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGMN,Legumain,42185,0.0324922714531962,0.00391934123683729,0.0248103626289951,0.0401741802773973,1.23559653022519e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFA,Protransforming growth factor alpha,42119,0.0405177130426072,0.00489049942558426,0.0309323341684621,0.0501030919167524,1.29164630766347e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRD1,Natural killer cells antigen CD94,42296,0.0421676053267525,0.00508975618676728,0.0321916832006887,0.0521435274528164,1.29216891800184e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0361400480310109,0.00436836747035423,0.0275780477891166,0.0447020482729052,1.42813587727865e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0191186153406288,0.00231249357539034,0.0145861279328637,0.0236511027483939,1.49479949542246e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACRBP,Acrosin-binding protein,39919,0.0356230168304512,0.00431218624887784,0.0271711317826506,0.0440749018782517,1.6050597060343e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR3,Toll-like receptor 3,42296,0.0544336080863005,0.00659585281488196,0.0415057365691319,0.0673614796034692,1.68903801084744e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD84,SLAM family member 5,42119,0.0283939768712241,0.00344389122864703,0.021643950063076,0.0351440036793723,1.80687830822339e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0300649089740952,0.00365106866260935,-0.0372210035528095,-0.0229088143953809,2.00538638453788e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0904831094740849,0.0110179338322877,0.068887959162801,0.112078259785369,2.36628933096128e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0620505683634426,0.00755478469519079,0.0472431903608686,0.0768579463660165,2.38731062463302e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0556144004102993,0.0067752120393901,0.0423349848130947,0.0688938160075039,2.48308221493994e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0788790667096233,0.00962551030153064,0.0600130665186232,0.0977450669006233,2.78487476661613e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAS2,Growth arrest-specific protein 2,39757,0.0460440317194574,0.00562486475307336,0.0350192968034337,0.0570687666354812,2.99896122770394e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CILP,Cartilage intermediate layer protein 1,39966,0.0488083815448543,0.00596413248371293,0.037118681876777,0.0604980812129317,3.04692254843888e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN8,Tetraspanin-8,39930,0.0842553514025073,0.0102982880149493,0.0640707068932067,0.104439995911808,3.10272645967209e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0476556140496987,0.0058314788263522,0.0362259155500484,0.059085312549349,3.29745009671661e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAST,Gastrin,39929,0.115442527647266,0.0141265324883849,0.0877545239700321,0.143130531324501,3.35438442498146e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGH,Gamma-glutamyl hydrolase,41933,0.02995503421659,0.00366713627144906,0.0227674471245498,0.0371426213086301,3.40156690020624e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CORO1A,Coronin-1A,41883,0.0781386683937367,0.00956797322720809,0.0593854408684089,0.0968918959190646,3.45407577196534e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREML2,Trem-like transcript 2 protein,42137,0.0303259244075626,0.00371969451409911,0.0230353231599283,0.0376165256551968,3.86660955801949e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD83,CD83 antigen,42119,0.0303611876642683,0.00373036087251969,0.0230496803541297,0.0376726949744069,4.33392257666882e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD93,Complement component C1q receptor,41654,-0.0276097294114564,0.00339331904311558,-0.0342606347359629,-0.0209588240869499,4.43493321834863e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDHB,Succinate dehydrogenase,39930,0.0576713948207665,0.00708694972080538,0.0437809733679879,0.071561816273545,4.44946697944764e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTA,Lymphotoxin-alpha,42119,0.0351681034411246,0.0043273306099927,0.0266865354455389,0.0436496714367103,4.78148066074542e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD101,Immunoglobulin superfamily member 2,39930,0.0377746585548221,0.0046674391411454,0.0286264778381771,0.046922839271467,6.40320228797864e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAPK2,Death-associated protein kinase 2,39657,0.0483133044466955,0.00597353933451689,0.0366051673510424,0.0600214415423487,6.7046971792119e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK4,Serine/threonine-protein kinase 4,42145,0.0762362938961828,0.00943073598579612,0.0577520513640224,0.0947205364283432,6.80664351758036e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSNK1D,Casein kinase I isoform delta,39657,0.0560936596000051,0.006940455461405,0.0424903668956513,0.0696969523043589,7.0270220121997e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIT,Citron Rho-interacting kinase,39649,0.0399992975694198,0.00494950816091566,0.0302982615740251,0.0497003335648145,7.06546200374653e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYM,Ketimine reductase mu-crystallin,39586,0.0658971060922902,0.0081686982167689,0.0498864575874231,0.0819077545971572,7.95209923229102e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDA,Cytidine deaminase,39946,0.0414985194160245,0.00514552402574629,0.0314132923255618,0.0515837465064872,8.06080793489465e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPP1,Tripeptidyl-peptidase 1,42057,0.0412036509617208,0.0051117011873979,0.0311847166344209,0.0512225852890207,8.22550112439419e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMBS,Porphobilinogen deaminase,42262,0.0349569209226328,0.00433880911815732,0.0264528550510445,0.0434609867942212,8.47732638899597e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL6A3,Collagen alpha-3(VI) chain,42310,0.0311521707413661,0.00386686213966969,0.0235731209476136,0.0387312205351187,8.51731548130609e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0577282956964758,0.00716838278575672,0.0436782654363926,0.0717783259565589,8.86889529539228e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANBP1,Ran-specific GTPase-activating protein,39638,0.0448312021479473,0.00556667325616493,0.033920522565864,0.0557418817300306,8.87273976160675e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0547356643030788,0.00680271972972158,0.0414023336328245,0.0680689949733331,9.39266672606574e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.0191423565487601,0.00238416620525062,-0.0238153223110514,-0.0144693907864689,1.0652442799274e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0326883909546598,0.00407940508910757,0.0246927569800089,0.0406840249293106,1.23181141247075e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0411793019270628,0.00514491307210491,0.0310952723057371,0.0512633315483884,1.32299075224909e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN5,CCN family member 5,42137,0.0327749120826232,0.00409716576369474,0.0247444671857815,0.0408053569794649,1.35120616227459e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPL,Periplakin,39657,0.027853865699168,0.00348268533698402,0.0210278024386793,0.0346799289596567,1.39272877241308e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN2,Nectin-2,42129,0.026683166760695,0.00333743905238309,0.0201417862180241,0.0332245473033658,1.39914010780657e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0339680799725235,0.00424787150155082,0.0256422518294839,0.0422939081155631,1.40757201869363e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD209,CD209 antigen,42171,-0.0335882740115034,0.00420721136240768,-0.0418344082818225,-0.0253421397411844,1.53614822927303e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0284473543943396,0.00356482359774165,0.021460300142766,0.0354344086459133,1.58082205815715e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.032770589559274,0.00410878143729941,0.0247173779421672,0.0408238011763809,1.63838808691192e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1F,V-type proton ATPase subunit F,41820,0.0574628238280695,0.00721109661800663,0.0433290744567765,0.0715965731993625,1.73474686550885e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSDE1,Cold shock domain-containing protein E1,39575,0.103445426572524,0.0130104458909309,0.0779449526262998,0.128945900518749,2.03232323052452e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRZB,Secreted frizzled-related protein 3,41973,0.0211790559690149,0.00266456729999818,0.0159565040610185,0.0264016078770113,2.03996056055687e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAM2,Neural cell adhesion molecule 2,42137,-0.0231117294977727,0.00290812781534853,-0.0288116600158558,-0.0174117989796896,2.05641308191002e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_E,,42119,0.0251594525600925,0.00317214592180638,0.0189420465533519,0.031376858566833,2.33688548537726e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTRK3,NT-3 growth factor receptor,42249,-0.0181362847913303,0.00228946904431803,-0.0226236441181936,-0.0136489254644669,2.52505210863063e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0355607670155338,0.00449022297956162,0.026759929975593,0.0443616040554746,2.57194172792094e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0370121257924483,0.00467555556505282,0.0278480368849448,0.0461762146999519,2.64062295019598e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0346694848012726,0.00437890442624439,0.0260868321258336,0.0432521374767117,2.65153780788038e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA2,Integrin alpha-2,39736,0.0295614829904169,0.00373435299486048,0.0222421511204903,0.0368808148603434,2.6833746142064e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VGF,Neurosecretory protein VGF,39934,0.0257707399772031,0.00325744675464561,0.0193861443380977,0.0321553356163085,2.78305655423595e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SF3B4,Splicing factor 3B subunit 4,42070,0.0617050938376143,0.0078139734108435,0.046389705952361,0.0770204817228675,3.08300698146891e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNM1,Dynamin-1,39930,0.0986790314900812,0.0124941202005811,0.0741905558969422,0.12316750708322,3.09475374637848e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADA,Adenosine deaminase,42296,0.0302514018892624,0.00383182500164715,0.022741024886034,0.0377617788924908,3.12845315140677e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX7,Syntaxin-7,39657,0.0417996185216989,0.00529414284289685,0.0314230985496211,0.0521761384937767,3.16624876180289e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2orf69,UPF0565 protein C2orf69,39649,0.050295276461472,0.0063721681655896,0.0378058268569163,0.0627847260660276,3.22980166850068e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDZD2,PDZ domain-containing protein 2,39575,0.0501539439387357,0.00635793534028519,0.0376923906717767,0.0626154972056946,3.35135458478795e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0280248828513835,0.00356180718169856,-0.0350060249275126,-0.0210437407752543,3.92474849843685e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0455159932398751,0.00578669934517776,0.0341740625233267,0.0568579239564235,3.95118293815502e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD46,Membrane cofactor protein,42107,0.02428649444861,0.00309219908728396,0.0182257842375335,0.0303472046596866,4.32861171491129e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGKZ,Diacylglycerol kinase zeta,41913,0.0306065656915092,0.00389999870920913,0.0229625682214593,0.0382505631615591,4.55455627452816e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APRT,Adenine phosphoribosyltransferase,42002,0.0398107733352203,0.0050779797525191,0.0298579330202829,0.0497636136501578,4.84884416148071e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELOB,Elongin-B,39575,0.033174685567638,0.00423257050874714,0.0248788473704937,0.0414705237647824,5.00289967728594e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL2A1,Collagen alpha-1(II) chain,39638,0.066610140882,0.00850798216442438,0.0499344958397282,0.0832857859242718,5.3617411386523e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA6,Integrin alpha-6,42119,0.0430497644381271,0.00550508753983858,0.0322597928600435,0.0538397360162107,5.67224026654078e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL4,ADAMTS-like protein 4,39638,0.0208461705260414,0.00266867458829703,0.0156155683329793,0.0260767727191036,6.16661264391956e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH5,Cadherin-5,42310,-0.0255907874788808,0.00327837937832618,-0.0320164110604002,-0.0191651638973615,6.3330108183944e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDK,Midkine,42129,0.0430240624686049,0.00552310371444592,0.0321987791882909,0.0538493457489189,7.19667197353194e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0485860297503269,0.00623851091317187,0.03635854836051,0.0608135111401437,7.30775624533016e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPME1,Protein phosphatase methylesterase 1,42070,0.0487491836954507,0.00627392088024713,0.0364522987701663,0.061046068620735,8.40627017379351e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0276181312744613,0.00355518612441544,-0.0345862960783156,-0.020649966470607,8.51769919677577e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0776228394729627,0.0100002500967386,0.058022349283355,0.0972233296625704,9.07182969607983e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0243506313796906,0.00313950518641944,-0.0305040615450727,-0.0181972012143084,9.37188668047998e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS7_LGALS7B,Galectin-7,42076,0.0366724309864444,0.00474733499902198,0.0273676543883613,0.0459772075845275,1.1987592491522e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPE,Ribulose-phosphate 3-epimerase,39757,0.0596833380009386,0.0077276881569631,0.044537069213291,0.0748296067885863,1.23043509736039e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.0282344901592894,0.00365843244738561,0.0210639625624136,0.0354050177561652,1.26849096564745e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL1,Angiopoietin-related protein 1,41920,0.0239270989567703,0.00310278912926472,0.0178456322634115,0.0300085656501292,1.33168595428855e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOLA1,BolA-like protein 1,39586,0.0454027014240169,0.0058881763731983,0.0338618757325483,0.0569435271154856,1.35802276077644e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0527234166797088,0.00684607439962803,0.0393051108564379,0.0661417225029798,1.44272792565055e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFCAB2,Dynein regulatory complex protein 8,39757,0.0292391113358448,0.00381287451679825,0.0217658772829202,0.0367123453887693,1.88448181478556e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0407883774463071,0.00532568276320124,0.0303500392304327,0.0512267156621816,2.00364887659738e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN1,Tetraspanin-1,41900,0.0600876235636998,0.00785778505007975,0.0446863648655435,0.0754888822618561,2.20002504787617e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSTB,Cystatin-B,41959,0.0357880658152975,0.00468245105274144,0.0266104617519243,0.0449656698786708,2.26625716461539e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINI2,Serpin I2,39930,0.0476979979917819,0.0062412509597029,0.0354651461107642,0.0599308498727996,2.30444955314718e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0607002812360135,0.00795410864667614,0.0451102282885283,0.0762903341834988,2.48240430644577e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0441733919663379,0.00579199494391588,0.0328210818762628,0.0555257020564131,2.60238166330386e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0555656520962263,0.00729551316866149,0.0412664462856498,0.0698648579068028,2.78072471738647e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH1,Cadherin-1,41697,0.0330369550608175,0.00433916200503058,0.0245321975309576,0.0415417125906774,2.84634997077806e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0364645874745944,0.00478995743341118,0.0270762709051085,0.0458529040440803,2.90244946519221e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0588433817700573,0.00773890060634854,0.0436751365816142,0.0740116269585005,3.10816212831481e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKD2,Serine/threonine-protein kinase D2,39575,0.0358333192937528,0.0047180188399507,0.0265860023674494,0.0450806362200561,3.3282381864119e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0328827326460676,0.00433609627865605,0.0243839839399018,0.0413814813522335,3.63555674824347e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENAH,Protein enabled homolog,41913,0.0394442732574459,0.00520445182738438,0.0292435476757726,0.0496449988391193,3.71359796891851e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD1C,T-cell surface glycoprotein CD1c,42181,0.0202365485006399,0.00267041480818208,0.015002535476603,0.0254705615246768,3.73447169678757e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FXN,"Frataxin, mitochondrial",42262,0.0594467799479179,0.00784538640667127,0.0440698225908422,0.0748237373049936,3.75500325761895e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AK1,Adenylate kinase isoenzyme 1,42145,0.0502821296375865,0.00663948063269525,0.0372687475975038,0.0632955116776692,3.87673015430227e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0980560219886225,0.0129611300175445,0.0726522071542353,0.12345983682301,4.16624573812375e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17D,Interleukin-17D,41913,0.027819294258232,0.0036820875056876,0.0206024027470843,0.0350361857693797,4.45113833312607e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAFA5,Chemokine-like protein TAFA-5,42070,0.0299440760178716,0.00396540774118158,0.0221718768451557,0.0377162751905875,4.58542158223083e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CENPF,Centromere protein F,39757,0.0438900228495826,0.00581873154540336,0.032485309020592,0.0552947366785732,4.95395750832496e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD302,CD302 antigen,42070,0.0253350920617493,0.00336071458465146,0.0187480914758325,0.0319220926476662,5.05349009256119e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSHB,Thyrotropin subunit beta,42145,0.0553980654662923,0.00735006944955561,0.0409919293451633,0.0698042015874213,5.11081008036442e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0296774575804781,0.0039449317985753,-0.0374095239056857,-0.0219453912552705,5.69643211431014e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0199915153723441,0.00265691488455657,0.0147839621986132,0.0251990685460749,5.70005984174512e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNC,Tenascin,42217,-0.0391947575201134,0.00521162895538517,-0.0494095502726683,-0.0289799647675584,5.79180094605642e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMA4,Laminin subunit alpha-4,42185,0.0277565334612399,0.00369353427236042,0.0205172062874135,0.0349958606350663,6.05127429451476e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0357376953831588,0.00476533234384164,0.0263976439892292,0.0450777467770884,6.89965569165389e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0369508219947868,0.00493046568274234,0.0272871092566119,0.0466145347329618,7.15808975040035e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRCAM,Neuronal cell adhesion molecule,42145,0.0231818475206229,0.00310126411687319,0.0171033698515514,0.0292603251896944,8.19579571340448e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,39575,0.04904392225893,0.0065659303667437,0.0361746987401123,0.0619131457777476,8.66418454917882e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0459066707118649,0.00615379017289505,-0.0579680994507392,-0.0338452419729906,9.18631902126123e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0547589847378648,0.00734324421649361,0.0403662260735373,0.0691517434021922,9.3870316784035e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0418823640892057,0.00562745643155731,-0.052912178695058,-0.0308525494833533,1.04750283807387e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0378580577542623,0.00508973711793246,0.0278821730031147,0.0478339425054099,1.09701279158044e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0250012003103798,0.00337636815457829,0.0183835187274063,0.0316188818933532,1.39150321557001e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGES2,Prostaglandin E synthase 2,39579,0.0445346944179293,0.00601474736188469,0.0327457895886353,0.0563235992472233,1.41553451632899e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0324600154069634,0.00438934694042262,0.023856895403735,0.0410631354101917,1.49588522552217e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0431391341413276,0.00583334744186813,0.0317057731552661,0.0545724951273892,1.51347669857351e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0323177382757858,0.00437290308836662,0.0237468482225873,0.0408886283289844,1.56887326335187e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C5,Complement C5,39979,0.0119864035943241,0.0016223733588608,0.00880655181095693,0.0151662553776913,1.59254052049594e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY75,Lymphocyte antigen 75,42119,0.0308563698264784,0.0041835475034953,0.0226566167196276,0.0390561229333291,1.73067714539896e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL20,C-C motif chemokine 20,42296,0.0688719045305595,0.00934036106619602,0.0505647968408153,0.0871790122203037,1.75634110967746e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F3,Tissue factor,42174,-0.0207389934199124,0.00282179785694457,-0.0262697172195238,-0.0152082696203011,2.10211295096012e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C4BPB,C4b-binding protein beta chain,42181,0.0302863490509726,0.00412390826272779,0.0222034888560261,0.038369209245919,2.18960571796662e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.037273034907041,0.00508290480498816,0.0273105414892642,0.0472355283248178,2.38093689495632e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLC,Galectin-10,42119,-0.0531470640033289,0.00724876945591726,-0.0673546521369268,-0.0389394758697311,2.39852446444204e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RCOR1,REST corepressor 1,41900,0.0352918267603556,0.00481630595115314,0.0258518670960954,0.0447317864246157,2.47869949296801e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.0198890224533824,0.00271445357762708,-0.0252093514655315,-0.0145686934412333,2.48358793391664e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0397222258056387,0.0054220410236918,0.0290950253992028,0.0503494262120747,2.53104267494826e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASET2,Ribonuclease T2,42258,0.0211673074763475,0.00289461091054349,0.0154938700916823,0.0268407448610128,2.76475232372955e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP9,Caspase-9,39657,0.0502468265162998,0.00689116628340818,0.0367401406008198,0.0637535124317799,3.27503203882733e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL8,Interleukin-8,42035,0.0533793519814545,0.00732397183052223,0.0390243671936309,0.0677343367692781,3.31397994139709e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPCAL1,Hippocalcin-like protein 1,42296,0.057891822478824,0.00794695972452964,0.0423157814187459,0.0734678635389021,3.39807306590814e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB8,Serpin B8,42296,0.0459484516272823,0.00631004954879119,0.0335807545116516,0.0583161487429131,3.4738810720112e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0440456131528056,0.0060566734383965,0.0321745332135484,0.0559166930920627,3.77642433166672e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMM2,Phosphomannomutase 2,39575,0.0470827835856158,0.00647785189472614,0.0343861938719525,0.059779373299279,3.88862497738998e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRSF1,G-rich sequence factor 1,39486,0.0651808047516571,0.00898608675824846,0.0475680747054901,0.0827935347978241,4.33662265348226e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX6,Syntaxin-6,41843,0.0513611793245454,0.00709045207282649,0.0374638932618055,0.0652584653872854,4.60704750563015e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.0185067892839325,0.00255800886184579,0.0134930919147147,0.0235204866531502,4.90926114955381e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0271659179239753,0.00375802680211079,0.0198001853918382,0.0345316504561125,5.13489897041137e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK4,Dickkopf-related protein 4,41992,0.035982980530185,0.00497980212928086,0.0262225683567945,0.0457433927035755,5.25168356875885e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0894489487352219,0.0123858210549026,0.0651727394676127,0.113725158002831,5.45584733345084e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0486131386317402,0.00674718823830419,0.035388649684664,0.0618376275788164,6.18485981191969e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0291093101938876,0.00404299528619235,0.0211850394329506,0.0370335809548246,6.4057659802215e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A12,Protein S100-A12,41910,0.056858380401244,0.0079300086183487,0.0413155635092806,0.0724011972932075,7.89395460044406e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WAS,Wiskott-Aldrich syndrome protein,41913,0.0508046742608857,0.00708932893972511,0.0369095895390245,0.0646997589827469,8.10738359550077e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0373592956272984,0.00523101121766481,0.0271065136406754,0.0476120776139214,9.68726952616082e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0304314818126481,0.00426869777134434,0.0220648341808132,0.038798129444483,1.07359378856069e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPA1,Inositol monophosphatase 1,42016,0.0470414645698872,0.00660055052133969,0.0341043855480614,0.059978543591713,1.078990759179e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BSG,Basigin,42284,0.0160516309909584,0.00225502356275505,0.0116317848079585,0.0204714771739583,1.14822032370468e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD80,T-lymphocyte activation antigen CD80,39958,0.0263381775395406,0.00370127877074977,0.0190836711488711,0.0335926839302102,1.17823181156634e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0233552203318633,0.00328532158152389,-0.0297944506316501,-0.0169159900320765,1.22792974468486e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0431200496646356,0.00606837160978716,0.0312260413094527,0.0550140580198184,1.25808259172929e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGT,Angiotensinogen,39990,0.0166824317741459,0.00235084521618261,0.012074775150428,0.0212900883978638,1.35696556550197e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0270755005614708,0.00382944631762664,0.0195697857789226,0.034581215344019,1.62163197890512e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX5,Sorting nexin-5,39638,0.0227159166626944,0.00321816204186891,0.0164083190606313,0.0290235142647574,1.78204572111754e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBS4,Thrombospondin-4,42189,0.0346066087560179,0.00490602762368331,0.0249907946135986,0.0442224228984371,1.82393844138648e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL1,Fc receptor-like protein 1,42145,0.0348916777020854,0.00494677814426428,0.0251959925393274,0.0445873628648434,1.83051873586603e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRR3,Small proline-rich protein 3,39929,0.0478875392933513,0.00680546922192125,0.0345488196183856,0.0612262589683169,2.08316956908915e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0283006193390462,0.00402338102033365,0.0204147925391923,0.0361864461389002,2.10493374637865e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0287741123582792,0.00409297056053888,0.020751890059623,0.0367963346569354,2.16243409669878e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300LF,CMRF35-like molecule 1,42262,0.045413275039217,0.00648420315657917,0.0327042368523218,0.0581223132261122,2.60986139794597e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR2,Folate receptor beta,42249,-0.0219591491165185,0.00313693392539481,-0.0281075396102923,-0.0158107586227446,2.67546379927595e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH1,Protocadherin-1,42264,0.0155409965229812,0.00222455774198538,0.0111808633486898,0.0199011296972725,2.95701150153185e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAA10,N-alpha-acetyltransferase 10,39575,0.0382480672664283,0.00547417885778752,0.0275186767051648,0.0489774578276919,2.97106012937862e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0357793952817851,0.0051286050895475,0.025727329306272,0.0458314612572982,3.17145590254377e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMPD3,AMP deaminase 3,39929,0.0519003546648596,0.00744183355246721,0.0373143609020238,0.0664863484276953,3.24891549535432e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB6,Integrin beta-6,41913,0.0231166497996278,0.00331973038323511,0.016609978248487,0.0296233213507686,3.47710651238349e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL15A1,Collagen alpha-1(XV) chain,39966,0.0203055616493867,0.00291792860260422,0.0145864215882824,0.026024701710491,3.61812382252618e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHGA,Chromogranin-A,39966,-0.0637491402179771,0.00918553639243593,-0.0817527915471515,-0.0457454888888027,4.12950356423151e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0333895728591478,0.00481688383387347,-0.0428306651735398,-0.0239484805447558,4.34361787694245e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0278907192456608,0.00403711423283151,0.0199779753493111,0.0358034631420106,5.1643474290487e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA4,Annexin A4,42088,0.0540251365016196,0.00782634489147954,0.0386855005143197,0.0693647724889195,5.31976811266834e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRDL1,Chordin-like protein 1,42166,0.0243217632664354,0.00353320127369645,0.0173966887699903,0.0312468377628804,6.08485678963333e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.030981027313751,0.0045036607756368,0.0221538521935028,0.0398082024339991,6.34156303565238e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRDT,Bromodomain testis-specific protein,39575,0.0271719336442008,0.00394985250054442,0.0194302227431338,0.0349136445452679,6.34535083814421e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD6,Programmed cell death protein 6,42145,-0.0524070404061345,0.00762084103343618,-0.0673438888316695,-0.0374701919805996,6.3893199271303e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COLEC12,Collectin-12,42123,0.0203057522781278,0.00295780786722415,0.0145084488583684,0.0261030556978871,6.93255049561842e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.015394036791299,0.00224387854585381,0.0109960348414255,0.0197920387411725,7.16373345922974e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSC2,Desmocollin-2,41984,-0.0259733431963262,0.00379904839738263,-0.0334194780551962,-0.0185272083374562,8.44912959981618e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0304547423352876,0.00445704539926829,0.0217189333527217,0.0391905513178534,8.67513556605051e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0387213046374507,0.00567132809294722,0.0276055015752742,0.0498371076996273,9.0908443131727e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLYR1,Putative oxidoreductase GLYR1,39919,0.0427476536301935,0.00626593038082468,0.0304664300837771,0.0550288771766099,9.42063295491767e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0393086089639457,0.00576566338303516,0.0280079087331968,0.0506093091946946,9.64446976347293e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBP1,Z-DNA-binding protein 1,39657,0.0303991807086759,0.00446352411812745,0.0216506734371461,0.0391476879802058,1.02250696171208e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0253428671308135,0.00373355298927985,-0.032660630989802,-0.018025103271825,1.18627432851386e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPM3,Tropomyosin alpha-3 chain,39575,-0.0339244282635616,0.00499865566992231,-0.0437217933766093,-0.0241270631505138,1.20632914445703e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST5,Cystatin-D,41846,0.0411700799571126,0.00607568381705345,0.0292617396756879,0.0530784202385374,1.28590254808852e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHCHD6,MICOS complex subunit MIC25,39919,0.0212366250498312,0.00313819775625002,0.0150857574475812,0.0273874926520812,1.37837931388599e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTN2,Alpha-actinin-2,39575,-0.0471977104107444,0.00697543921925578,-0.0608695712804857,-0.0335258495410031,1.38874214981149e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0201630034399882,0.00298348391559625,0.0143153749654196,0.0260106319145569,1.45405989682031e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIMAP7,GTPase IMAP family member 7,39736,-0.0234202153835144,0.00347444340291011,-0.0302301244532182,-0.0166103063138106,1.65404128408778e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL3,Insulin-like 3,39929,0.0655784030512235,0.00973041201966826,0.0465067954926738,0.0846500106097733,1.66610964067516e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CX3CL1,Fractalkine,42016,-0.0242970277755089,0.00360885662707159,-0.0313703867645692,-0.0172236687864486,1.73423831923126e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK6,Kallikrein-6,42158,0.0224535989331996,0.00333637630667993,0.015914301372107,0.0289928964942923,1.76557796686957e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECE1,Endothelin-converting enzyme 1,41839,0.0256777125984725,0.00382072672590585,0.018189088215697,0.033166336981248,1.88340592122987e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0246284114975166,0.00368519872321886,0.0174054220000076,0.0318514009950255,2.43174447427383e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RALY,RNA-binding protein Raly,39919,0.0346837445712311,0.00520093133940011,0.0244899191460069,0.0448775699964553,2.69992024477453e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.036528748700985,0.00549564962962624,0.0257572754269175,0.0473002219750524,3.11111371565013e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXN,Thioredoxin,39854,0.0308702909659146,0.00464388839486257,0.0217682697119839,0.0399723122198452,3.11878982355547e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1RL,Complement C1r subcomponent-like protein,39958,0.014115945000722,0.00213033671331262,0.00994048504262925,0.0182914049588147,3.60121252315626e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACHE,Acetylcholinesterase,39736,0.0244913654504413,0.00369805619762129,0.0172431753031036,0.031739555597779,3.68770488089917e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGR2,Anterior gradient protein 2 homolog,41740,0.0717722931887868,0.010846803656778,0.0505125580215019,0.0930320283560718,3.81012671942621e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0451523729943899,0.00683355402389101,-0.0585461388812163,-0.0317586071075635,4.0543020976299e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1A,Protein phosphatase 1A,41843,0.0223940956082547,0.00339052568583234,0.0157486652640234,0.0290395259524861,4.12966015760101e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0357520170689044,0.00541622932837448,0.0251362075852905,0.0463678265525184,4.24222440159142e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0409954428012077,0.00621030975770361,0.0288232356761087,0.0531676499263068,4.26577383140713e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSM,Oncostatin-M,42051,0.0492427947631494,0.00747139252140996,0.0345988654211858,0.0638867241051129,4.5362765073935e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA7A,Semaphorin-7A,42272,0.0203200081804525,0.00308408761237527,0.0142751964601969,0.026364819900708,4.60058144224799e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0285986223699143,0.0043424238040363,0.0200874717140031,0.0371097730258254,4.72251583926759e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGCR6,Protein DGCR6,39586,0.0297185793947878,0.00452533156669258,0.0208489295240703,0.0385882292655052,5.35989193295211e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0313240937050209,0.00477194357088057,0.021971084306095,0.0406771031039468,5.46512643464357e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEO1,RNA polymerase-associated protein LEO1,39934,0.0205933165667588,0.00314519590530425,0.0144287325923625,0.0267579005411552,6.10175621556984e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0185397067347911,0.00283179542052202,-0.0240900257590143,-0.012989387710568,6.12946519846727e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0265831560162712,0.00406137116997463,0.0186228685231209,0.0345434435094215,6.19970573195584e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.0395284995988178,0.00604223614154587,0.0276857167613878,0.0513712824362477,6.3389611240724e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CR2,Complement receptor type 2,42217,0.0328683907708955,0.00503770576651467,0.0229944874685267,0.0427422940732642,7.06523056673383e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO1,Roundabout homolog 1,42144,0.0168783778695744,0.00258798200946134,0.0118059331310302,0.0219508226081187,7.19199530690783e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0517705713676345,0.00794819663032541,0.0361921059721967,0.0673490367630723,7.60124819017485e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0595416886681949,0.0091421515610431,0.0416230716085505,0.0774603057278394,7.68462663005905e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP8,Caspase-8,42224,0.0429459663371227,0.00659864334160784,0.0300126253875714,0.0558793072866741,7.86642348364017e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0364888051069462,0.00561169959062357,0.025489873909324,0.0474877363045684,8.19538090829991e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0172028446194815,0.00264691930168549,-0.0223908064507851,-0.0120148827881779,8.35428858988923e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300A,CMRF35-like molecule 8,39736,0.0214353667054558,0.0033017644185259,0.0149639084451451,0.0279068249657666,8.82512134230565e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN4B,Sodium channel subunit beta-4,39638,0.0304508704811923,0.00470258575627223,0.0212338023988987,0.0396679385634858,9.86126124426122e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0407788399044549,0.00632639922332052,0.0283790974267467,0.0531785823821631,1.19762829290434e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0284351199206298,0.00441403930837685,0.0197836028762111,0.0370866369650484,1.22015413218891e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0340404058118165,0.00528643211437082,0.0236789988676497,0.0444018127559833,1.25091676548626e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AZU1,Azurocidin,41751,0.0523595379530535,0.00813756226791406,0.0364099159079419,0.068309159998165,1.28340464796406e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0181301142526397,0.00282740864401911,0.0125883933103623,0.0236718351949172,1.4906921890557e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYAR,Cell growth-regulating nucleolar protein,41843,0.0368893351338932,0.0057675769325533,0.0255848843460887,0.0481937859216976,1.64876468673942e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB37,Ras-related protein Rab-37,41913,0.0558404583062637,0.00877733876087318,0.0386368743349523,0.0730440422775752,2.05808720367902e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALB2,Calretinin,41839,0.0202197723481595,0.00318160575106309,0.0139838250760759,0.0264557196202432,2.14963916669992e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0306902825099603,0.00483356839399767,-0.0401640765621958,-0.0212164884577249,2.23050507709135e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0228891254024318,0.00362122681048649,0.0157915208538783,0.0299867299509853,2.68261511781481e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0190923774265227,0.00302082227554901,0.0131715657664466,0.0250131890865988,2.69216807839822e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0257007381582664,0.0040704317087909,0.0177226920090362,0.0336787843074966,2.80535449038539e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0365367885931249,0.00579135108491106,0.0251857404666993,0.0478878367195506,2.89777851189387e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0305466502441642,0.00484140078494691,0.0210575047056682,0.0400357957826601,2.90455862722041e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARF2,Scavenger receptor class F member 2,42249,-0.0193736149162699,0.00307210898475963,-0.0253949485263988,-0.013352281306141,2.9460820205978e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL25,C-C motif chemokine 25,42296,0.0334187598389489,0.00530478490051465,0.0230213814339402,0.0438161382439576,3.07266101561582e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0256715882252237,0.00408616525969648,0.0176627043162186,0.0336804721342288,3.45252273439458e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C7,Complement component C7,39722,-0.022641480062093,0.00360543552861904,-0.0297081336981863,-0.0155748264259997,3.51614353085151e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.0158639766018181,0.00253088172354043,-0.0208245047799574,-0.0109034484236789,3.76382011460096e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EBI3_IL27,Interleukin-27,42247,-0.020728686610433,0.00330828394638241,-0.0272129231453425,-0.0142444500755235,3.82326086178034e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGER,Advanced glycosylation end product-specific receptor,42093,0.0277923274410538,0.00443667703248949,0.0190964404573744,0.0364882144247332,3.8606952540018e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN8,Septin-8,39906,0.0220697205649058,0.00352479718483564,0.0151611180826279,0.0289783230471837,3.9569111603278e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0188599513040309,0.003012956528468,0.0129545565082336,0.0247653460998282,3.97529950048586e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN3,Calsyntenin-3,39929,0.0204680036303069,0.0032695661837436,0.0140596539101694,0.0268763533504443,3.98492261998338e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.0268402829862459,0.00429036596803857,0.0184311656888903,0.0352494002836015,4.06877544123803e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SATB1,DNA-binding protein SATB1,39934,0.019749979229104,0.00316222987537342,0.0135520086733721,0.0259479497848359,4.37333624964932e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0290367441792497,0.00465224193923471,0.0199183499783496,0.0381551383801497,4.46680409730508e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSB,Cathepsin B,42153,-0.0341986685764435,0.00548458456395191,-0.0449484543217893,-0.0234488828310978,4.63951290983916e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.025591872638458,0.00410483682896496,-0.0336373528232293,-0.0175463924536867,4.69145177999797e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCT,Secretin,39649,0.0323893266841245,0.00520815551275129,0.022181341879132,0.0425973114891171,5.18533250727283e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0242891390709263,0.00390710046350607,0.0166312221624544,0.0319470559793982,5.26275991140217e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0471974058034297,0.00761065603619729,0.032280519972483,0.0621142916343764,5.79099539235434e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRELP,Prolargin,42123,0.0156312474454368,0.00253027591326191,0.0106719066554434,0.0205905882354301,6.69134507854599e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.02565751446483,0.00416545796586714,0.0174932168517304,0.0338218120779296,7.54875663474215e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB2A2,Mammaglobin-A,39575,-0.0206940692181821,0.00336326137319964,-0.0272860615096534,-0.0141020769267109,7.86936573694712e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNU13,NHP2-like protein 1,39575,0.0417891287364022,0.00681412711830724,0.02843343958452,0.0551448178882844,8.93629596087322e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.033615624683814,0.00548703440480362,0.0228610372503989,0.0443702121172291,9.23752622829858e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0175575114016157,0.00286643088683413,0.0119393068634208,0.0231757159398106,9.30447264354345e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0609319393881182,0.00995015781469127,0.0414296300713233,0.0804342487049131,9.452799150375e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D17,TBC1 domain family member 17,41839,0.0283833466197978,0.00465938777652082,0.019250946577817,0.0375157466617786,1.14852097497465e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA1,Alpha-1-antitrypsin,39795,-0.00536414064506103,0.000883469527111032,-0.00709574091819866,-0.00363254037192341,1.30686367000446e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF1C,Kinesin-like protein KIF1C,39575,0.0228404806915334,0.00376653252529714,0.015458076941951,0.0302228844411158,1.3709641680047e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRN,Progranulin,42077,0.0164471441994172,0.00271500734997695,0.0111257297934624,0.0217685586053721,1.41614581492292e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGMB,RGM domain family member B,42249,0.0183068169228739,0.00302856331385512,0.0123708328277178,0.0242428010180299,1.53571048792311e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CABP2,Calcium-binding protein 2,39649,0.042776323374034,0.00707849792322234,0.0289024674445182,0.0566501793035498,1.56022019228043e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM2,Myomesin-2,39575,-0.0363736005270235,0.0060205079509887,-0.0481737961109613,-0.0245734049430856,1.5752714084271e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0178812552532698,0.00296125069517062,0.0120772038907354,0.0236853066158042,1.59697700758119e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFAP1,Actin filament-associated protein 1,39736,0.0544894966564619,0.0090289111977138,0.0367928307089429,0.072186162603981,1.64019714564223e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.019718383199868,0.00326776960248578,0.0133135547789959,0.0261232116207401,1.64867921052388e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA3,Protein disulfide-isomerase A3,39736,0.0160142146981076,0.00265488564170776,0.0108106388403604,0.0212177905558548,1.67108041675477e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0376652014206069,0.00625381438824677,0.0254077252196432,0.0499226776215706,1.75916615166652e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0205103200288936,0.00341947057860058,0.0138081576948365,0.0272124823629508,2.05899083700297e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX2,Sorting nexin-2,39919,0.0552750267632985,0.00923858153972068,0.0371674069454459,0.073382646581151,2.25602989882046e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLVRB,Flavin reductase,42137,0.0411758700348793,0.00688380341510266,0.0276836153412781,0.0546681247284805,2.2658656969534e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYZL2,Lysozyme-like protein 2,39560,0.0234856096880034,0.00393039175683973,0.0157820418445976,0.0311891775314093,2.36683841493836e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0253720375159719,0.00424970772475487,0.0170426103754523,0.0337014646564914,2.44095096043462e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDM1,Nuclear protein MDM1,39649,0.0203115090538953,0.00340317941222211,0.01364127740594,0.0269817407018507,2.46959368843154e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0411527382783973,0.00690374647268232,0.0276213951919399,0.0546840813648546,2.58479017942369e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LXN,Latexin,41960,-0.0441832619787799,0.00741325699854886,-0.0587132456959357,-0.0296532782616242,2.58539537177043e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MARCO,Macrophage receptor MARCO,42145,0.0165832893913711,0.00279151151873704,0.0111119268146465,0.0220546519680957,2.90923704894253e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN3,CCN family member 3,42299,0.0217717397282736,0.00366954325700339,0.0145794349445469,0.0289640445120002,3.04454601605064e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK3,Dickkopf-related protein 3,42310,-0.0188900231687455,0.00318465953519481,-0.0251319558577273,-0.0126480904797637,3.07283256012724e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL34,Interleukin-34,41814,0.0234322946605811,0.00395366345093067,0.015683114296757,0.0311814750244052,3.16727825329446e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0332390908180003,0.00560877141219291,0.0222458988501022,0.0442322827858984,3.17596895119436e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR15L,Protein GPR15L,39930,0.039774446508736,0.00674157691849642,0.026560955748483,0.052987937268989,3.7418511055293e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0255983308544888,0.00434348389382756,0.0170851024225868,0.0341115592863908,3.87290913055094e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0620490741299656,0.0105511608565171,0.0413687988511921,0.0827293494087392,4.20239842113016e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.0180186936646146,0.00306588449954912,-0.0240278272837309,-0.0120095600454984,4.27059472899754e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4D,C-type lectin domain family 4 member D,42119,0.0393524071040068,0.0066971963695453,0.026225902219698,0.0524789119883156,4.30316046784088e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0102299140736664,0.00174292955191505,0.00681377215191287,0.0136460559954199,4.47538424712542e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTB,Lymphotoxin-beta,39919,0.0218100250974122,0.00372064507273748,0.0145175607548467,0.0291024894399776,4.70388808087717e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKD1,Polycystin-1,39958,0.0171933730042501,0.00294162731643565,0.0114277834640362,0.0229589625444639,5.20961128092022e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIM,Vimentin,41900,0.0723588699781121,0.0124009662002967,0.0480529762255305,0.0966647637306936,5.50633454403031e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPQ,Carboxypeptidase Q,39960,0.0236057506836017,0.00404679410690895,0.0156740342340602,0.0315374671331433,5.58579131990292e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIL1,Nucleotide exchange factor SIL1,39638,0.0206259900931111,0.00354586005176836,0.0136761043916451,0.027575875794577,6.16057276059258e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0271982442283317,0.00468763225726742,0.0180104850040875,0.0363860034525758,6.69679417829248e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD276,CD276 antigen,42123,-0.0225270953855535,0.00388276375652567,-0.0301373123483438,-0.0149168784227632,6.70676613093555e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSAP,Prosaposin,39886,0.017896906359753,0.00308466417404872,0.0118509645786175,0.0239428481408885,6.73307763267322e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0337965475193319,0.00583214384157874,0.0223655455898376,0.0452275494488263,7.01953509493731e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COPB2,Coatomer subunit beta',39575,0.0269354718214735,0.00464879479088393,0.017823834031341,0.036047109611606,7.05874572155817e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR2,Complement factor H-related protein 2,39904,0.035707794159319,0.00616368894449481,0.0236269638281092,0.0477886244905288,7.08786569828131e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0255111008639122,0.00441448491887531,-0.0341634913049078,-0.0168587104229166,7.71417258984493e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFB,Vascular endothelial growth factor B,39657,0.0184296265309288,0.00318976460326772,0.0121776879085241,0.0246815651533336,7.77548839043828e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0280608193962403,0.00485744252532002,0.0185402320466131,0.0375814067458676,7.77843256647673e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.041983763129325,0.00726847823929039,0.0277375457803158,0.0562299804783341,7.85121500398372e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR5,Complement factor H-related protein 5,39864,0.0258983533968832,0.00450565963770445,0.0170672605069825,0.0347294462867839,9.26710211090509e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STC2,Stanniocalcin-2,42113,0.0149035292877012,0.00259351796165474,0.00982023408285796,0.0199868244925445,9.31012252071338e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPING1,Plasma protease C1 inhibitor,39959,0.0114518207259002,0.00200072044525632,0.00753040865319783,0.0153732327986026,1.06773986423048e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX3,Syntaxin-3,39929,0.0235653925149939,0.00412187799702153,0.0154865116408317,0.0316442733891561,1.11062942847635e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF21,Immunoglobulin superfamily member 21,39638,0.0248128309468084,0.00434753408947357,0.0162916641314402,0.0333339977621766,1.17716053191124e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TK1,"Thymidine kinase, cytosolic",39757,0.0290618008105758,0.00509738321510167,0.0190709297089765,0.039052671912175,1.21902500786398e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300C,CMRF35-like molecule 6,42249,0.0216707549154017,0.00380669006929236,0.0142096423795887,0.0291318674512148,1.27539749024432e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK14,Kallikrein-14,42262,-0.0284786969766603,0.00500486511065353,-0.0382882325935412,-0.0186691613597794,1.29493737967245e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0315754213911119,0.00555002003921216,0.0206973821142561,0.0424534606679677,1.30304182519311e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KEL,Kell blood group glycoprotein,41839,0.0222725651268098,0.0039166469194038,0.0145959371647784,0.0299491930888413,1.32301371862865e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JAM2,Junctional adhesion molecule B,42249,0.0167817682306778,0.00295170760839016,0.0109964213182331,0.0225671151431226,1.33145722249418e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0157090125245074,0.00278263769284667,0.0102550426465279,0.0211629824024868,1.68176091821082e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0397725476466908,0.00705378313206201,0.0259471327078493,0.0535979625855324,1.75676244714348e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0285367657992249,0.00508405987196095,0.0185720084501814,0.0385015231482684,2.0286298038115e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LUZP2,Leucine zipper protein 2,39919,0.02726309828159,0.00486124035382555,0.0177350671880919,0.0367911293750881,2.09163700478228e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASGR2,Asialoglycoprotein receptor 2,39990,0.0160074952039325,0.00285606930433352,0.0104095993674388,0.0216053910404262,2.13429144249664e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE3,Eosinophil cationic protein,42081,0.0658393668962701,0.011767838297794,0.0427744038325939,0.0889043299599463,2.2510441015282e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A13,Protein S100-A13,39657,0.0215198641046565,0.00384649215877294,0.0139807394734615,0.0290589887358514,2.26295623502033e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0189763387702455,0.00339510755929182,-0.0256307495864575,-0.0123219279540336,2.3244501072067e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPE,Carboxypeptidase E,42134,-0.0235551403079967,0.00422250251614358,-0.0318312452396382,-0.0152790353763553,2.47284007973464e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GC,Vitamin D-binding protein,39979,0.0155506257433061,0.00279129944367075,0.0100796788337114,0.0210215726529007,2.5887913052198e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWC2,Brorin,41973,0.0245900028614672,0.00442383414340438,0.0159192879403946,0.0332607177825398,2.77267330095232e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA7,Carbonic anhydrase 7,39757,-0.0201133524206388,0.0036254607740345,-0.0272192555377464,-0.0130074493035312,2.95873335678742e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0360186295188067,0.00650287905503071,0.0232729865709465,0.0487642724666669,3.10032831851629e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0404645210651366,0.00730756640506884,0.0261416909112017,0.0547873512190715,3.12763139693131e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPHS1,Nephrin,39657,0.0199150904077474,0.00359693349220565,0.0128651007630243,0.0269650800524704,3.15286587312077e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG4,Regenerating islet-derived protein 4,42144,0.0305079350735052,0.00551167190688721,0.0197050581360062,0.0413108120110041,3.16740299066459e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH3,Cadherin-3,42249,0.0220238981177968,0.00397977225456822,0.0142235444988431,0.0298242517367505,3.18850481083149e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFIC,Nuclear factor 1 C-type,39934,0.0273180678878932,0.00494337746121942,0.0176290480639031,0.0370070877118833,3.34483619982934e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0143653199827914,0.00260247385694932,0.00926447122317071,0.0194661687424121,3.45489375240873e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UROS,Uroporphyrinogen-III synthase,39649,0.0394688371175439,0.00715293485141014,0.02544908480878,0.0534885894263078,3.5090453011482e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,41963,0.069881129999835,0.0127013398293214,0.0449865039343652,0.0947757560653049,3.82697049574854e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPH1,Neurexophilin-1,41839,0.0231061342640145,0.00420143548725475,0.0148713207089952,0.0313409478190338,3.8775469751202e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0208824867116281,0.00380473791674812,0.0134252003948017,0.0283397730284544,4.12456719450994e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0303082453556845,0.00552826987455671,-0.0411436543098157,-0.0194728364015534,4.27062785583454e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0649818993713137,0.0118623220095902,0.041731748232517,0.0882320505101105,4.37795383271518e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,39906,0.022685188745379,0.00414409564054545,0.0145627612899099,0.030807616200848,4.49132932447416e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0148951366885114,0.00272441628344118,0.00955528077296664,0.0202349926040561,4.65096529816839e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNG,Interferon gamma,41913,0.0674893113667572,0.0123473635234899,0.043288478860717,0.0916901438727975,4.68885795714776e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0183757200333668,0.00336170265581022,0.0117867828279788,0.0249646572387549,4.69783989137205e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST1,Cystatin-SN,38503,0.0628773149051185,0.0115101583589555,0.0403174045215657,0.0854372252886712,4.80117929447632e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.0113347262176284,0.00207794741368134,-0.0154075031484439,-0.00726194928681301,4.98913955376522e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPTLC1,Serine palmitoyltransferase 1,39929,0.0227729476915831,0.004180762187907,0.0145786538032854,0.0309672415798809,5.22734203173638e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTG,Protogenin,42262,0.0144514552809311,0.00265483578424085,0.009247977143819,0.0196549334180431,5.31615472284068e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAP,Cartilage-associated protein,39649,0.0290563305341915,0.00533780092643956,0.01859424071837,0.0395184203500131,5.33599791958437e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0183182225645136,0.00337149940833309,-0.0249263614048465,-0.0117100837241808,5.65185213999869e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0177919552653094,0.00328055343397401,0.0113620705347203,0.0242218399958984,5.94531260896447e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOB,Apolipoprotein B-100,39990,0.0133642005820029,0.00246412366457347,0.00853451819943886,0.0181938829645669,5.96340737741801e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTP1,Glutathione S-transferase P,41759,-0.0410133329860149,0.00756576836950492,-0.0558422389902445,-0.0261844269817853,6.03428854640945e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENSA,Alpha-endosulfine,39919,0.030992577308318,0.00573370515915618,0.0197545151963719,0.0422306394202641,6.60016324361077e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMOX1,Heme oxygenase 1,42007,-0.0287524229358232,0.00532696075813427,-0.0391932660217663,-0.01831157984988,6.87149123305855e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PADI4,Protein-arginine deiminase type-4,41814,0.0426197103155531,0.00790852204842197,0.027119007100646,0.0581204135304602,7.20320806485127e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP13,Collagenase 3,41839,-0.0188028075262073,0.00349248812606713,-0.0256480842532989,-0.0119575307991158,7.41799443674201e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLIC5,Chloride intracellular channel protein 5,39649,-0.0183380461256474,0.00340906756385582,-0.0250198185508048,-0.01165627370049,7.63456255037923e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX2,Peroxiredoxin-2,39819,0.0349287320709012,0.00652979417251674,0.0221303354927684,0.047727128649034,9.01144750251346e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A11,Protein S100-A11,42027,0.0267447013241078,0.00500206654200538,0.0169406509017773,0.0365487517464384,9.10238837811457e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREML1,Trem-like transcript 1 protein,39990,0.0304476698468838,0.00572785030171949,0.0192210832555136,0.041674256438254,1.08241464865686e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0135092061506674,0.00254275018230681,0.00852541579334607,0.0184929965079888,1.09646119302228e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WIF1,Wnt inhibitory factor 1,42262,-0.0193157036426341,0.0036367075472643,-0.0264436504352721,-0.0121877568499961,1.10543004623441e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR2,TGF-beta receptor type-2,42181,0.0196498423757192,0.00370219472163653,0.0123935407213117,0.0269061440301268,1.1281330688773e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0159394167838398,0.0030066362753519,0.01004640968415,0.0218324238835295,1.16757026595372e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0449236910111975,0.00849836211982381,0.0282669012563428,0.0615804807660522,1.268956183667e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0162576975992287,0.00307976727730163,-0.0222940414627399,-0.0102213537357175,1.31988958949511e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1B,Interleukin-1 beta,41825,0.0321413830171002,0.00609916983065809,0.0201870101490103,0.04409575588519,1.38721434248809e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPCAM,Epithelial cell adhesion molecule,42125,-0.053099570032004,0.0101134873104356,-0.0729220051604579,-0.0332771349035502,1.54091230715942e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0156844444327449,0.00299432453269842,0.00981556834865599,0.0215533205168338,1.65263438490063e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLU,Clusterin,39979,0.0170379484058443,0.00325363797856229,0.0106608179678622,0.0234150788438264,1.66493718879973e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAMP5,Vesicle-associated membrane protein 5,41900,0.0293026721138869,0.00559846943676008,0.0183296720178372,0.0402756722099367,1.68358530449581e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0187963351300341,0.00359276192213994,0.0117545217626398,0.0258381484974284,1.70420331455599e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPARCL1,SPARC-like protein 1,42169,-0.015343230932702,0.00295419997129425,-0.0211334628764387,-0.00955299898896523,2.0913751512601e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0367081757821323,0.00707008126412075,0.0228508165044556,0.0505655350598089,2.11719241125766e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QA,Complement C1q subcomponent subunit A,42230,-0.0125051599623855,0.00241846711016408,-0.0172453554983071,-0.00776496442646387,2.36525026071636e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0355834258256937,0.00690127489713345,0.0220569270273122,0.0491099246240753,2.56446532741841e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XG,Glycoprotein Xg,42261,0.0192404996715869,0.00374148184453251,0.0119071952563032,0.0265738040868706,2.74883345953632e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSH,Pro-cathepsin H,41865,0.0414460643240171,0.00806458386404926,0.0256394799504805,0.0572526486975536,2.79728879397812e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A14,Protein S100-A14,39934,0.0286212022824786,0.00559799702228788,0.0176491281187944,0.0395932764461629,3.22669550443578e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPG,Macrophage-capping protein,42015,0.0325095493270264,0.00636367259311165,0.0200367510445276,0.0449823476095253,3.28984878853434e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0202955042566773,0.0039785430828098,0.0124975598143701,0.0280934486989845,3.41946000546236e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPO,Myeloperoxidase,42137,0.0247229954950094,0.0048616697188488,0.0151941228460657,0.034251868143953,3.71971974814173e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA9,Carbonic anhydrase 9,42262,-0.0256599713498533,0.00504618676519792,-0.0355504974096412,-0.0157694452900654,3.72449192440869e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.020874166066838,0.00411199519590998,0.0128146554828544,0.0289336766508215,3.90894390130792e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD14,Monocyte differentiation antigen CD14,41932,0.0225991982858304,0.00445542002413974,0.0138665750385165,0.0313318215331443,3.98330374047642e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL3,Myosin light chain 3,39638,-0.0430929292696726,0.00849648438934364,-0.0597460386727861,-0.026439819866559,4.00356629126e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS3,Galectin-3,42196,0.0162266570568233,0.00320129095083878,0.00995212679317926,0.0225011873204673,4.05622211357813e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPOCK1,Testican-1,42016,0.0143042509958987,0.00282262975419633,0.00877189667767385,0.0198366053141235,4.08000641602633e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMS1,PMS1 protein homolog 1,39649,0.0270927092251812,0.0053495840779832,0.0166075244323342,0.0375778940180283,4.16185495841299e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.028935207825914,0.0057284522575069,-0.0401629742506275,-0.0177074414012005,4.44901934682633e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGFAC,Hepatocyte growth factor activator,39897,0.014758276862686,0.00292405642694802,0.00902712626586788,0.0204894274595041,4.55328737513859e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP6,Gastrotropin,41881,0.0309503555259941,0.00613776466233093,0.0189203367878255,0.0429803742641627,4.65278156167809e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0273935896011672,0.00545743308536637,0.0166970207538491,0.0380901584484853,5.25931149471458e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0181738579008075,0.00362147039688078,0.0110757759229212,0.0252719398786938,5.27687005595124e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0167853397523193,0.00334940020170658,0.0102205153569744,0.0233501641476642,5.48361495442526e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR1,Cadherin-related family member 1,41839,0.0224265241790634,0.00447729845335345,0.0136510192104907,0.0312020291476362,5.54356111539269e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDC1,Syndecan-1,42145,0.0218252317781568,0.00437496953261977,0.0132502914942221,0.0304001720620916,6.15535764042097e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK4,Kallikrein-4,42262,-0.0337353002477635,0.00676535737536006,-0.0469954007034692,-0.0204751997920578,6.22446430533975e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC16,Mucin-16,42070,0.102781173220996,0.020628741463999,0.0623488399515581,0.143213506490434,6.35711135760712e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIPF,Gastric triacylglycerol lipase,39638,0.0338544824432693,0.00679736452416439,0.0205316479759071,0.0471773169106315,6.43698233172372e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL3,Fc receptor-like protein 3,41913,0.0288369876955816,0.00579114003929443,0.0174863532185645,0.0401876221725987,6.4546872871657e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0257258732145464,0.00517559798933356,0.0155817011554526,0.0358700452736402,6.77510873072973e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL9,C-X-C motif chemokine 9,42185,0.034849904327546,0.00702467012753652,0.0210815508775744,0.0486182577775176,7.09528083507223e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFD,Vascular endothelial growth factor D,42275,-0.0205787559224739,0.00417157636090044,-0.0287550455898388,-0.0124024662551091,8.18910532603012e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.025427243971713,0.00515485898011425,-0.0355307675727369,-0.015323720370689,8.20646244281401e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSTL3,Follistatin-related protein 3,42084,0.0174457172583597,0.00353879112368603,0.0105096866559351,0.0243817478607844,8.32706750776683e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.0178553671277284,0.00362202384437819,0.0107562003927471,0.0249545338627096,8.35374127545402e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.0184126180680432,0.00374134328796007,0.0110795852236415,0.025745650912445,8.69433808853428e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRUNE2,Protein prune homolog 2,39757,0.0153466697802496,0.00312105218892825,0.00922940748995027,0.021463932070549,8.90660404234564e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBD,Thrombomodulin,42145,0.015701643810705,0.00319450805159657,0.00944040802957568,0.0219628795918342,8.97303284902845e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAFB2,Scaffold attachment factor B2,39934,0.0144710597095807,0.00294558057745,0.00869772177777871,0.0202443976413827,9.10377726284959e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL15,Interleukin-15,42119,0.0174904538082894,0.00356561357205704,0.0105018512070576,0.0244790564095212,9.43634937971789e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PVALB,Parvalbumin alpha,42208,0.0592188215610695,0.0120743253849231,0.0355531438066202,0.0828844993155188,9.47360443376121e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD99,CD99 antigen,42137,-0.0105574138345074,0.00215439073556992,-0.0147800196762245,-0.00633480799279037,9.67403433962807e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFR,Epidermal growth factor receptor,42310,0.00843022864053332,0.00172532984486153,0.00504858214460472,0.0118118751364619,1.03986443227438e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRISP3,Cysteine-rich secretory protein 3,39889,-0.014399312096464,0.00294723362591304,-0.0201758900032535,-0.00862273418967443,1.04475117041399e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0401320727022651,0.00822650782967094,0.02400811735611,0.0562560280484201,1.08462448042196e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF7,SLAM family member 7,42119,-0.0314669311956968,0.00646172819288174,-0.0441319184537451,-0.0188019439376486,1.13009867617109e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE1,Ribonuclease pancreatic,39990,0.0129844821294192,0.00267184677968159,0.00774766244124323,0.0182213018175951,1.19106848375252e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDI2,Protein DDI1 homolog 2,39736,0.0393336566599243,0.00809476164516296,0.0234679238354049,0.0551993894844437,1.1949824787812e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN4,Contactin-4,42137,-0.0123217390572666,0.00254054288851774,-0.0173012031187614,-0.00734227499577181,1.24808435836542e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOC,Brother of CDO,41900,-0.012178958672562,0.00251157547145921,-0.017101646596622,-0.00725627074850195,1.2540639013017e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.01649673031897,0.00340308376357529,0.00982668614236244,0.0231667744955776,1.26678001909957e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBS2,Thrombospondin-2,42137,0.0202155513020062,0.0041754813052648,0.0120316079436872,0.0283994946603253,1.30292743896297e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0181202503574616,0.00374708882855634,0.0107759562534912,0.025464544461432,1.34342713249804e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOBR,Apolipoprotein B receptor,39638,-0.02242149218581,0.00464415719891678,-0.0315240402956869,-0.0133189440759331,1.39836514627135e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.0142037795218114,0.00294337649696868,0.00843476158775276,0.01997279745587,1.41046239348616e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFHD1,EF-hand domain-containing protein D1,39934,0.0187097078433024,0.00389155850641397,0.011082253170731,0.0263371625158738,1.54586988047562e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROCR,Endothelial protein C receptor,39575,-0.0179705482827635,0.00374353526863232,-0.0253078774092829,-0.0106332191562442,1.60421408228927e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ULBP2,UL16-binding protein 2,42016,0.0203738842121791,0.00425466021905849,0.0120347501828245,0.0287130182415337,1.69739596954991e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0139191195389166,0.00291708221428071,0.0082016383989264,0.0196366006789068,1.84681708582133e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHCY,Adenosylhomocysteinase,42145,0.0345948565546045,0.00726901023332692,0.0203475964972837,0.0488421166119253,1.96345689349765e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0280831975983758,0.0059138849266338,0.0164919831421736,0.0396744120545781,2.07313788504191e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYGD,Gamma-crystallin D,39929,0.0503131027600996,0.010602005245294,0.0295331724793233,0.0710930330408759,2.10409111893526e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL21,C-C motif chemokine 21,42185,0.0196283763859355,0.00413833620845593,0.0115172374173619,0.0277395153545092,2.12654620651855e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2,Apoptosis regulator Bcl-2,39930,0.0273476085366578,0.00577264436909879,0.0160332255732241,0.0386619915000914,2.19054010585585e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRG3,Proteoglycan 3,39966,-0.0254868161984015,0.00538129044353101,-0.0360341454677223,-0.0149394869290808,2.20406999647169e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPEP1,Dipeptidase 1,41997,-0.0233963354490805,0.00496445702255539,-0.0331266712132891,-0.013665999684872,2.4683246000733e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0211106393795854,0.00448605170007505,-0.0299033007117325,-0.0123179780474383,2.55303113947381e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0120101029147454,0.00255347256793605,-0.0170149091479,-0.00700529668159072,2.58917625713155e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.015453151163777,0.00330406013909002,0.00897719329116057,0.0219291090363934,2.93868544549714e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0135404188038242,0.00290495800769667,0.00784670110873872,0.0192341364989097,3.17476261404067e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42070,0.0402872771786206,0.00868244242226036,0.0232696900309903,0.057304864326251,3.51546578088392e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP12,Macrophage metalloelastase,42146,0.0274144755580684,0.00590924077811783,0.0158323636329574,0.0389965874831793,3.5294149244088e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0315496969070586,0.00681556746659453,0.0181911846725334,0.0449082091415839,3.71466653432948e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCN2,Transcobalamin-2,42286,-0.0151244877525771,0.00327085635936303,-0.0215353662169286,-0.00871360928822554,3.79827641270984e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0310400254921189,0.00671263147208819,0.0178832678068261,0.0441967831774117,3.80354763014072e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH12,Protocadherin-12,39934,0.0127179558472565,0.00275667918652485,0.00731486464166778,0.0181210470528452,4.00273113347343e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB44,Ras-related protein Rab-44,39919,0.0223924899702081,0.00485581433320804,0.0128750938771203,0.0319098860632958,4.04193555326027e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0424169775892079,0.00920505978087301,0.0243750604186968,0.060458894759719,4.10342979423367e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.017515097966333,0.00380539649497482,0.0100565208361823,0.0249736750964836,4.2158561225327e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.0073488274935438,0.00160802593894188,-0.0105005583338699,-0.00419709665321771,4.92653982245606e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOSB,Protein fosB,41839,0.0189893055337772,0.00416457928431371,0.0108267301365224,0.0271518809310321,5.16816722549251e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.016912347541672,0.00370937126100576,0.00964197987010076,0.0241827152132433,5.18468349091954e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0348911621832444,0.00766499497631228,0.0198677720296724,0.0499145523368165,5.36968288464782e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0261570366279415,0.00575233702590885,0.0148824560571601,0.0374316171987228,5.48355063972756e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0212000176323338,0.00466879975143709,0.0120491701195171,0.0303508651451505,5.65257751671632e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0248777831025062,0.00549481296386252,0.0141079496933357,0.0356476165116768,6.0313256456286e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0207950512936185,0.00460940001169443,0.0117606272706974,0.0298294753165396,6.49387282035009e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG3,Desmoglein-3,42196,0.0171235877933044,0.0037975533668763,0.00968038319422682,0.0245667923923819,6.56444018414787e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0217549279412974,0.00482990731218179,0.0122883096094211,0.0312215462731737,6.73022707371138e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM3,Intercellular adhesion molecule 3,42310,-0.0131801434508459,0.00292652159056681,-0.0189161257683569,-0.00744416113333498,6.73351595286638e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0253880908639695,0.00564522030622272,0.014323459063773,0.0364527226641661,6.94159950989605e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF16,Fibroblast growth factor 16,39657,0.0225895440672427,0.00502515033580238,0.01274024940907,0.0324388387254153,7.01793846260853e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0156079826792096,0.00347260221744016,-0.0224142830253923,-0.00880168233302686,7.02767237300328e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG1A,Lithostathine-1-alpha,42105,-0.0242075947877826,0.00539013662439673,-0.0347722625716002,-0.013642927003965,7.14466969181288e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL2,Fc receptor-like protein 2,42229,0.0243051379915675,0.00541188567812309,0.0136978420624462,0.0349124339206887,7.14496160155924e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ODAM,Odontogenic ameloblast-associated protein,41814,0.0261379476740293,0.0058288605705397,0.0147133809557715,0.0375625143922871,7.37943932801377e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CR1,Complement receptor type 1,39970,0.0170996797736013,0.00383617156158471,0.00958078351289525,0.0246185760343073,8.37204549193645e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC2,Mucin-2,39966,0.0447181607581696,0.0100337739334382,0.0250519638486307,0.0643843576677085,8.40025218044131e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPNMB,Transmembrane glycoprotein NMB,41802,0.0140298190579134,0.00314849361087024,0.00785877158060773,0.0202008665352191,8.41739015364778e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNLY,Granulysin,42137,0.0259703908240888,0.00583283743387277,0.0145380294536982,0.0374027521944794,8.55770833040908e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAM,Signal transducing adapter molecule 1,39919,0.0174139222877983,0.00391396046479213,0.00974255977680573,0.0250852847987909,8.70209834476467e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP4,Guanylate-binding protein 4,41839,0.0235823278311634,0.00530954187216512,0.0131756257617197,0.033989029900607,9.00581958137999e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH17,Protocadherin-17,42145,0.0179833330482163,0.00404976698972501,0.0100457897483553,0.0259208763480773,9.04249233068113e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0141462686292811,0.00320289976910064,0.00786858508184383,0.0204239521767183,1.01177028659466e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OLFM4,Olfactomedin-4,39347,0.0591735556446727,0.013398436769513,0.0329126195764271,0.0854344917129182,1.01315051941943e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",39586,0.0399110686541371,0.00907719788009757,0.0221197608091459,0.0577023764991283,1.1086633185945e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0206123223192712,0.0046899456142928,0.0114200289152573,0.0298046157232851,1.11776427779976e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLASP1,CLIP-associating protein 1,39560,0.0357064192978418,0.00812639454471114,0.019778685990208,0.0516341526054757,1.12390862150348e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0249747272469249,0.00568484626178603,0.0138324285738243,0.0361170259200256,1.12701162644958e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0911972049208383,0.0207625808591835,0.0505025464368385,0.131891863404838,1.1296988222574e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0176388040013192,0.00401781214815949,-0.0255137158117118,-0.00976389219092662,1.14331551183954e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,39929,0.114486710947818,0.0260944585154961,0.0633415722574454,0.16563184963819,1.15753250932688e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCC,Netrin receptor DCC,39649,0.0105847039252774,0.00242019960947263,0.00584111269071108,0.0153282951598438,1.23399267580838e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THY1,Thy-1 membrane glycoprotein,42249,0.0138039870238145,0.00315958842203449,0.00761119371662689,0.0199967803310021,1.25784351184391e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0411712388199518,0.00943705740313199,0.0226746063098131,0.0596678713300905,1.29628695985666e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0166086001773616,0.00381101986982769,-0.0240781991222239,-0.00913900123249936,1.32189807046379e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB6A,Ras-related protein Rab-6A,42119,0.0208946238354006,0.00480521909501299,0.0114763944091751,0.0303128532616261,1.3818905342941e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0244133194686037,0.00562701528351878,0.0133843695129069,0.0354422694243005,1.44642175573391e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSV,Cathepsin L2,42200,0.0187584518884055,0.00432829333624841,0.0102749969493586,0.0272419068274524,1.4753334712975e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRTN,Neurturin,41913,0.0232242754233329,0.00536020927411944,0.0127182652460588,0.033730285600607,1.48359195003296e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA12,Carbonic anhydrase 12,42070,-0.0152812956093553,0.00353776959245998,-0.0222153240105768,-0.00834726720813371,1.57522965743154e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEO1,Neogenin,39934,0.0105287513551963,0.00244262915785895,0.00574119820579277,0.0153163045045999,1.64322764584161e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6L2,Seizure 6-like protein 2,42070,-0.0112684132934989,0.00261486380750903,-0.0163935463562166,-0.0061432802307812,1.64882671213477e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0160493574694409,0.00373326896031748,0.00873215030721864,0.0233665646316631,1.72778395118143e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA1,Annexin A1,39699,0.0206387682893675,0.00480344312152084,0.0112240197711867,0.0300535168075484,1.74867037199412e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDN1,Endothelin-1,39638,0.0136525834431979,0.00317823480119827,0.00742324323284934,0.0198819236535466,1.75673310759001e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNPEP,Aspartyl aminopeptidase,39929,0.0263136189715896,0.00615726765152521,0.0142453743746002,0.038381863568579,1.93925906766683e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0144253902284453,0.00338606585294307,-0.0210620793002137,-0.00778870115667692,2.05927798154207e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMNB2,Lamin-B2,39929,0.0131889604094074,0.00310214523587391,0.00710875574709456,0.0192691650717203,2.13987216483921e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,42145,0.00806516882172177,0.00189735766133152,0.00434634780551199,0.0117839898379316,2.14494887524974e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMB,Granzyme B,42119,0.0310852617902096,0.00734501551596349,0.0166890313789212,0.0454814922014981,2.32987580406522e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERC2,ERC protein 2,39649,0.0337658529727441,0.00798206756722921,0.0181210005409748,0.0494107054045133,2.3535184143385e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICOSLG,ICOS ligand,42070,0.00874186345406749,0.00206670390597616,0.00469112379835421,0.0127926031097808,2.35384540173149e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAX,Apoptosis regulator BAX,41814,0.0420212106598979,0.00993566008718333,0.0225473168890186,0.0614951044307773,2.35963972983213e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE6,Ribonuclease K6,39937,0.014741288880667,0.00348983180575918,0.00790121854137898,0.021581359219955,2.41805975261926e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN1,Nectin-1,39657,0.0150503477370271,0.00356662936314763,0.00805975418525774,0.0220409412887964,2.46506120287416e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS53,Serine protease 53,39929,0.0174283953083249,0.00413111533023839,0.00933140926105768,0.0255253813555922,2.47505393663966e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0180989962939479,0.00430267712836723,0.00966574912234812,0.0265322434655477,2.6108529903768e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPB6,Heat shock protein beta-6,42262,0.0184600556672922,0.00439730422630026,0.00984133938374372,0.0270787719508407,2.70940423911972e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0470528832815132,0.0112525871873057,0.024997812394394,0.0691079541686323,2.91749261161618e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD3,Extracellular superoxide dismutase,39990,-0.0274414371600259,0.00656633714736245,-0.0403114579688563,-0.0145714163511955,2.94838973352188e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTF4,Neurotrophin-4,41843,0.0170640883799447,0.00409903522360124,0.00902997934168627,0.0250981974182031,3.16146222455847e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.0129518784297705,0.00311129755228812,0.00685373522728583,0.0190500216322552,3.16612700319578e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAM,Basal cell adhesion molecule,42137,-0.0110430484907897,0.0026541907207791,-0.0162452623035167,-0.00584083467806264,3.19360663216448e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHISA5,Protein shisa-5,39966,0.0116754371063233,0.00280786806316971,0.00617201570251069,0.017178858510136,3.23240581518676e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0470903892531868,0.0113636119500867,0.0248177098310168,0.0693630686753569,3.43449240765578e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA7,Thyroxine-binding globulin,39979,0.00822499233599385,0.00198522408061194,0.00433395313799444,0.0121160315339933,3.45112473632492e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C9orf40,Uncharacterized protein C9orf40,39930,0.0347851356282676,0.00841167910772198,0.0182982445771325,0.0512720266794027,3.56988685378257e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP3,Dual specificity protein phosphatase 3,41839,0.0383817250214858,0.00929939065058481,0.0201549193463396,0.0566085306966321,3.69234807011967e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0174761109077286,0.00423615638549537,0.0091732443921577,0.0257789774232996,3.72631021765187e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0134711261670159,0.00327006862373533,0.00706179166449471,0.0198804606695372,3.81964195259461e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0251383478051554,0.00611548853642551,0.0131519902737615,0.0371247053365494,3.96965284939072e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARG1,Arginase-1,42015,0.0224129313234399,0.00546262479709311,0.0117061867211374,0.0331196759257424,4.10307883340576e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100G,Protein S100-G,39934,-0.0217033386272134,0.00528965644998035,-0.0320710652691748,-0.0113356119852519,4.10721514156577e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QSOX1,Sulfhydryl oxidase 1,39767,0.0176403935648907,0.0043110055226908,0.0091908227404167,0.0260899643893646,4.30778632634209e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0195145469109959,0.00478974306187657,0.0101266505097179,0.028902443312274,4.64878865068428e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM,Paralemmin-1,39859,0.0134557366361087,0.00331211423725406,0.0069639927310907,0.0199474805411266,4.88620356256065e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0202099160512033,0.00499147299226048,0.0104266289863728,0.0299932031160339,5.18150803375929e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN2,Ataxin-2,39586,0.0462520177958382,0.0114701706058593,0.023770483408354,0.0687335521833225,5.55893544586454e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00799831343217365,0.00198473151701038,0.00410823965883329,0.011888387205514,5.61584930374997e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0308664566760765,0.00769401458949335,-0.0459467252714835,-0.0157861880806696,6.06578322415326e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NELL2,Protein kinase C-binding protein NELL2,42185,0.0125587132964189,0.00313173756299646,0.00642050767294582,0.018696918919892,6.10067479274424e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18BP,Interleukin-18-binding protein,42217,0.0135905225729297,0.00339201715438254,0.00694216895033996,0.0202388761955195,6.19215220817279e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUCA2A,Guanylin,42083,-0.0152258691421257,0.00380668199431866,-0.0226869658509903,-0.00776477243326111,6.37412666902165e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD55,Complement decay-accelerating factor,41714,0.011403438087253,0.00285186311168859,0.00581378638834337,0.0169930897861626,6.40695699172817e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIF,Leukemia inhibitory factor,41839,0.0216393286297389,0.00542127699501725,0.0110136257195051,0.0322650315399727,6.5995300101652e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.0183716739079014,0.00461083912748424,0.00933442921803232,0.0274089185977705,6.79899309441483e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBPMS,RNA-binding protein with multiple splicing,39657,0.0277576502825739,0.00697030646094563,0.0140958496191205,0.0414194509460274,6.86969094723395e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUCA1,Tissue alpha-L-fucosidase,42212,0.0358921625940765,0.00904565692892097,0.0181626750133913,0.0536216501747616,7.28839430556347e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.030948696080424,0.00782095635140343,-0.0462777705291748,-0.0156196216316733,7.63120578653445e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.0127451585845684,0.00322324999890126,0.0064275885867219,0.0190627285824148,7.72123424766012e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AOC3,Membrane primary amine oxidase,42217,-0.0126625263996837,0.00320561183673009,-0.0189455255996747,-0.00637952719969273,7.85082474633685e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX18,Sorting nexin-18,39930,0.0186542882860545,0.00473227978557669,0.00937901990632414,0.0279295566657848,8.13164518807841e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B2M,Beta-2-microglobulin,39979,0.012960224367495,0.00329180087108911,0.00650829466016034,0.0194121540748297,8.29557442614918e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALPI,Intestinal-type alkaline phosphatase,39657,0.0531783510932227,0.0135500339400172,0.026620284570789,0.0797364176156563,8.74032990927804e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0164184887413967,0.00419375396268834,0.00819873097452758,0.0246382465082659,9.09530171765107e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA5,Protein disulfide-isomerase A5,39560,0.0259742069703463,0.00666711180348427,0.0129066678355171,0.0390417461051755,9.84281572342789e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC12A2,Solute carrier family 12 member 2,39575,-0.0111195471437408,0.00285581230902966,-0.0167169392694389,-0.00552215501804265,9.93301040312477e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRAL,GDNF family receptor alpha-like,39574,-0.0265989825508263,0.00683664028910193,-0.039998797517466,-0.0131991675841865,0.00010056612584053
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA11,Serpin A11,42310,-0.0175580359290355,0.00451540614145037,-0.0264082319662782,-0.00870783989179273,0.000101352553289284
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRH,Corticoliberin,41830,0.0360493674300435,0.00928284355199312,0.0178549940681369,0.05424374079195,0.000103489803563188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0157248474170697,0.00405671486472336,0.00777368628221193,0.0236760085519275,0.000106693520536418
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECM1,Extracellular matrix protein 1,39720,0.0153022048502797,0.00394784331787436,0.007564431947246,0.0230399777533135,0.000106757511089956
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0344392074102752,0.00889187355756908,0.0170111352374398,0.0518672795831106,0.000108074887325188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0254547978775045,0.00658620969011114,0.0125458268848866,0.0383637688701223,0.000111679696626797
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YAP1,Transcriptional coactivator YAP1,39929,0.0115181529651167,0.00298514969269094,0.0056672595674425,0.017369046362791,0.000114725046188102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PODXL,Podocalyxin,42070,0.00630883973142642,0.00163600244251688,0.00310227494409334,0.0095154045187595,0.000115673808968426
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWF,von Willebrand factor,42310,-0.0307364984980939,0.00800458112637511,-0.0464254775057891,-0.0150475194903987,0.000123656394453981
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALPP,"Alkaline phosphatase, placental type",42070,0.0432519342710646,0.0112652166076561,0.0211721097200588,0.0653317588220705,0.000123887965604101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.0108201367323398,0.00282091506105601,-0.0163491302520096,-0.00529114321267005,0.000125917500621312
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK8,Kallikrein-8,41668,0.0151949428031069,0.0039650110558434,0.00742352113365386,0.02296636447256,0.000127567475915075
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0235791820734054,0.00615881528179462,0.011507904121088,0.0356504600257229,0.000129506793175936
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAV,Integrin alpha-V,42262,-0.00687279304725254,0.00179700262809981,-0.0103949181983282,-0.00335066789617691,0.000131573792552026
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.023599195907589,0.00619488564826448,0.0114572200369906,0.0357411717781874,0.000140015360808151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.0199904848156191,0.00525408556284049,0.00969247711245175,0.0302884925187865,0.000142582848716967
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0427279111296195,0.0112322332264462,0.0207127340057851,0.064743088253454,0.000143119849649002
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0231809936849869,0.00609971884437992,0.0112255447500023,0.0351364426199715,0.000145255313505813
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF5,Fibroblast growth factor 5,41913,-0.0140094352897496,0.00368840096111988,-0.0212387011735445,-0.00678016940595459,0.000146374428698703
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0151208001651585,0.00398814488150705,0.00730403619740466,0.0229375641329123,0.000150439409714913
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB1A1,Uteroglobin,42165,0.0219522252186388,0.00579503641809257,0.0105939538391773,0.0333104965981002,0.000152454275310848
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CENPJ,Centromere protein J,39757,0.028749240019177,0.00759748115289356,0.0138581769595056,0.0436403030788484,0.000155104654977201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0146488218184895,0.00387627118192567,-0.0222463133350638,-0.0070513303019152,0.000158066409805131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMH,Granzyme H,41900,0.0320833736659915,0.00850422451802933,0.0154150936106541,0.048751653721329,0.000162230185509857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0166550748632483,0.00442781295815054,0.0079765614652732,0.0253335882612233,0.000169634688815981
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL9A2,Collagen alpha-2(IX) chain,39757,0.0181413772423461,0.00482359895513667,0.0086871232902782,0.0275956311944139,0.000170125696371193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0145348915563494,0.00388100288430403,-0.0221416572095853,-0.00692812590311352,0.000181210608473136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L15,Bcl-2-like protein 15,39657,0.0228914306977475,0.00612023871254849,0.0108957628211524,0.0348870985743425,0.000184741122130747
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDRG1,Protein NDRG1,41839,0.0266668023174976,0.00714970803263534,0.0126533745735323,0.0406802300614629,0.000192450749867968
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPESP1,Sperm equatorial segment protein 1,39958,0.0135386054614158,0.00363038018504174,0.00642306029873403,0.0206541506240976,0.000192982462384382
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.0126654441408938,0.00339701079783262,0.00600730297714184,0.0193235853046457,0.000193631176524938
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDK1,Cyclin-dependent kinase 1,39560,0.0147017241581983,0.00394679727498179,0.00696600149923394,0.0224374468171626,0.000196314342573221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFLAM,Pikachurin,39930,0.0124371464109417,0.00334455857338912,0.005881811607099,0.0189924812147844,0.000201279401292596
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSR,Insulin receptor,39657,0.00688537818722044,0.00185248658749627,0.00325450447572775,0.0105162518987131,0.00020273324343497
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLMP,CXADR-like membrane protein,42262,0.00887580668135973,0.00239304099901936,0.00418544632328179,0.0135661670394377,0.000208897426503422
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.025750208982581,0.00695800373724582,0.0121125216575792,0.0393878963075828,0.000215932199244856
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0299348996422209,0.00810155362921205,0.0140558545289653,0.0458139447554765,0.000220956304800981
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0284809247016025,0.00772239753560738,0.013345025531812,0.043616823871393,0.000227025130781666
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0103673314274622,0.00281157585541607,0.0048566427508467,0.0158780201040777,0.000227469407830017
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPON1,Spondin-1,42144,0.0129971781366738,0.00352778091143178,0.00608272755026747,0.01991162872308,0.000230283052151219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHB6,Ephrin type-B receptor 6,41997,0.0130527279318715,0.00354376393451448,0.00610695062022317,0.0199985052435199,0.000231144352341968
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0169994730997918,0.0046157471161874,-0.0260463374475191,-0.00795260875206446,0.000231675866601593
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM26,Tripartite motif-containing protein 26,39560,0.0228365263745842,0.00621129776794888,0.0106623827494044,0.035010669999764,0.000237482253258963
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.0118928949177574,0.00324635474857647,-0.0182557502249673,-0.00553003961054753,0.000249767296285983
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.0199021915128587,0.00544660334753872,0.00922684895168282,0.0305775340740346,0.000259127779140773
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHB4,Ephrin type-B receptor 4,42310,-0.010001436042447,0.00274209917901781,-0.0153759504333219,-0.00462692165157211,0.0002659254257899
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0223887505183387,0.0061455476835748,0.0103434770585321,0.0344340239781454,0.000270633817950697
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0149811332274764,0.00412666636359003,0.00689286715484,0.0230693993001129,0.000284109870148889
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FMR1,Synaptic functional regulator FMR1,41843,0.0141707952058274,0.00391154009867882,0.00650417661241694,0.0218374137992379,0.000292501672358972
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN10,Ataxin-10,41839,0.0287561493467911,0.00794367924851098,0.0131865380197096,0.0443257606738726,0.000295697730804983
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP1,Methionine aminopeptidase 1,41839,0.0113659612098865,0.00314456681583763,0.00520261025084471,0.0175293121689282,0.00030207210362181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0351084530824089,0.00971729520568955,0.0160625544792574,0.0541543516855604,0.000303784897663429
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G1B,Phospholipase A2,42299,-0.0173927666573098,0.00481720839767309,-0.026834495116749,-0.00795103819787052,0.0003066405090479
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD200,OX-2 membrane glycoprotein,42119,-0.0106325641431403,0.0029450448711419,-0.0164048520905784,-0.00486027619570218,0.000306921681923069
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.0115136310715796,0.00319395605272215,0.00525347720824418,0.017773784934915,0.000313745329496297
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP3,"Fatty acid-binding protein, heart",39958,0.0211959160387646,0.00588577368473384,0.00965979961668627,0.0327320324608429,0.000318088767791516
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALB1,Calbindin,42070,0.0175938699308306,0.00489181965186381,0.00800590341317751,0.0271818364484836,0.000323569793115687
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP9,Fatty acid-binding protein 9,42119,0.0219215347793962,0.00610459261402632,0.00995653325590465,0.0338865363028878,0.000330591266738471
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HCG22,Protein PBMUCL2,39575,-0.0225112065982288,0.00628052297410328,-0.0348210316274713,-0.0102013815689864,0.000339464249778063
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD1,Bromodomain-containing protein 1,39757,-0.0117772902295909,0.00328996491591413,-0.0182256214647826,-0.0053289589943992,0.000345368080587251
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN3,Neuronal-specific septin-3,39934,-0.0302992387543692,0.0084699971784441,-0.0469004332241196,-0.0136980442846187,0.000348684832580663
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST7,Cystatin-F,42148,0.0364858020852137,0.0102124261826906,0.01646944676714,0.0565021574032874,0.000354563182001238
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP1,Caspase-1,41839,0.0264876613822795,0.00746161081575143,0.0118629041834067,0.0411124185811523,0.000386774871748079
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.0132423789136875,0.00374083163030854,0.00591034891828278,0.0205744089090923,0.000401543472372091
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17RA,Interleukin-17 receptor A,42137,0.0169523032209687,0.00479825063600502,0.0075477319743989,0.0263568744675386,0.000412213872071674
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM5,Intercellular adhesion molecule 5,42145,0.0175578019259625,0.00497764482228096,0.00780161807429184,0.0273139857776332,0.000421160343844696
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL3A1,Collagen alpha-1(III) chain,39966,0.00899779551773318,0.00255162873816463,0.0039966031909305,0.0139989878445359,0.000423077697727515
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300E,CMRF35-like molecule 2,42232,0.0159243941920158,0.00451786615622865,0.00706937652580763,0.0247794118582239,0.000425256360255746
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.0103375542870365,0.00293441380756125,0.00458610322421642,0.0160890053498565,0.000428583524616478
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0278568953438385,0.00790881474789276,0.0123556184379687,0.0433581722497083,0.000429296496127374
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITM2A,Integral membrane protein 2A,42119,-0.0236274328676692,0.00672144113231745,-0.0368014574870114,-0.010453408248327,0.000440806124196192
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF5,Eukaryotic translation initiation factor 5,39575,0.0161757568619782,0.00460203497881354,0.00715576830350366,0.0251957454204527,0.000441669938332852
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00735748144056852,0.00209470548689492,-0.0114631041948826,-0.00325185868625448,0.000445770795007607
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.0117572364368276,0.00335312829391381,0.00518510498075652,0.0183293678928987,0.000455770959837303
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRPB1,Signal-regulatory protein beta-1,42100,0.0180059756260766,0.00516747120344473,0.00787773206732495,0.0281342191848283,0.000494649234759795
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PI3,Elafin,41966,0.0211781008480891,0.00607995822752458,0.00926138272214089,0.0330948189740373,0.000496924142878294
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA4,Apolipoprotein A-IV,39979,0.0129607074046667,0.00372142665902738,0.00566671115297308,0.0202547036563604,0.000498201704817427
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0136956121149541,0.00393600736526553,0.00598103767903361,0.0214101865508745,0.000504111826305743
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD59,CD59 glycoprotein,41638,0.00887849104155428,0.00255306882529358,0.00387447614397887,0.0138825059391297,0.000507619039742093
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA4,Carboxypeptidase A4,39518,0.0165272334409148,0.00475586081394098,0.00720574624559047,0.0258487206362391,0.000512589414450336
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.018307101051102,0.00527846912758756,-0.0286529005411736,-0.00796130156103035,0.00052546457051852
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RCC1,Regulator of chromosome condensation,39919,0.0195661961839126,0.0056430686797014,0.00850578157169782,0.0306266107961273,0.000527673177489359
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMNB1,Lamin-B1,39908,0.0229040956697188,0.00661213622380815,0.00994430867105485,0.0358638826683828,0.000534281679993558
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMOD1,Leiomodin-1,39934,-0.0129710390095505,0.00375231049680282,-0.0203255675832841,-0.00561651043581702,0.000548607223740665
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.020802573835926,0.00602133512117748,0.00900075699841812,0.0326043906734338,0.000552695512724294
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTPN,Myotrophin,41900,0.0121154025077892,0.00351162084240123,0.00523262565668275,0.0189981793588956,0.000562141702793195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.0135327033158966,0.00392406775949433,0.00584153050728773,0.0212238761245055,0.000565513862509247
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0172226558210084,0.00499560137299413,0.00743127712993986,0.0270140345120769,0.000567723244012819
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0285173483904478,0.00828282380206813,0.0122830137383943,0.0447516830425013,0.00057754073150682
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOH,Beta-2-glycoprotein 1,42137,-0.0136190446254642,0.00395740950685741,-0.0213755672589048,-0.0058625219920237,0.000580451552589623
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD1,Programmed cell death protein 1,42232,0.0155760822666794,0.00453454226071141,0.00668837943568507,0.0244637850976738,0.000594352525213212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.0214237889212155,0.00624218652503607,0.00918910333214478,0.0336584745102862,0.000600723053160561
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN2,Prefoldin subunit 2,41839,0.0204985259269506,0.00597612639743559,0.00878531818797683,0.0322117336659243,0.000605268351761579
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AREG,Amphiregulin,42070,0.0144830313477713,0.00423337644979411,0.00618561350617486,0.0227804491893678,0.000625412215486233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.0110610796498628,0.00323806957750173,-0.0174076960217662,-0.00471446327795945,0.000637462093038784
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0171622919136895,0.00503559340361314,-0.0270320549847712,-0.00729252884260772,0.000656287752805889
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUK1,Guanylate kinase,39575,-0.0147968998073061,0.00435257829156791,-0.0233279532587792,-0.00626584635583303,0.000677318625693383
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0153596543021174,0.00452230140126912,-0.0242233650486048,-0.00649594355562988,0.000685111382951801
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPTC,Opticin,42070,-0.016661809917251,0.00490645994253552,-0.0262784714046206,-0.00704514842988135,0.000686028182227067
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0134643016629848,0.00397564341544371,0.00567204056871514,0.0212565627572545,0.000709840328397577
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO4,Roundabout homolog 4,39638,-0.00667377894085317,0.0019738063096038,-0.0105424393076766,-0.00280511857402972,0.000724276705784873
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.014908066161262,0.00441346941968769,0.00625766609867417,0.0235584662238499,0.000732978745748576
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFR4,Fibroblast growth factor receptor 4,39736,0.0191231737007927,0.00567064455465977,0.00800871037365951,0.0302376370279258,0.000747941808064206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP8,Neutrophil collagenase,42224,0.0260466394542719,0.00774036979722772,0.0108755146517056,0.0412177642568382,0.000767443364337817
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.0105314682987361,0.00313389107067684,0.00438904180020949,0.0166738947972627,0.000780563046257031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGN,Mimecan,42137,0.0156591691214291,0.00467691238394323,0.00649242084890035,0.0248259173939578,0.000815644141112854
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0241990358917719,0.00723999642015013,0.0100086429082777,0.0383894288752662,0.00083284395420386
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0201961808198757,0.00605540254790952,0.008327591825973,0.0320647698137783,0.000855015969346799
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP112,Centrosomal protein of 112 kDa,39575,0.0159786170705771,0.00480144201465553,0.00656779072185231,0.025389443419302,0.000877977336745546
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0186707837147227,0.0056141588769918,0.00766703231581874,0.0296745351136266,0.000884992344587531
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.0105758510360053,0.00318485541688386,0.00433353441891297,0.0168181676530977,0.000900396615940119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.0127812657167148,0.00385458432301648,0.00522628044360248,0.0203362509898271,0.000916058653125128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD3,Bromodomain-containing protein 3,39575,0.0170311862468421,0.00513630634825194,0.00696402580426828,0.0270983466894159,0.000916635700527047
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSN,Gelsolin,39943,-0.0067809210609397,0.00204862359197799,-0.0107962233012165,-0.00276561882066285,0.000935907235826792
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEPD,Xaa-Pro dipeptidase,39990,0.00943631607134346,0.00285217795925325,0.0038460472712071,0.0150265848714798,0.000941015494721263
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANPEP,Aminopeptidase N,42187,0.00973184116800327,0.00294868112184591,0.00395242616918528,0.0155112561668213,0.000967941515739447
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRPX,Sushi repeat-containing protein SRPX,39958,-0.013690835551383,0.00417227575130302,-0.0218684960239369,-0.00551317507882904,0.00103610885734618
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.0100835878966092,0.00307727524404129,0.00405212841828828,0.0161150473749301,0.00105308888010286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS4,Galectin-4,42123,0.0199574672189663,0.00610288729245734,0.0079958081257499,0.0319191263121827,0.00107752436024734
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.0112029080867005,0.00343387377636599,0.00447251548502314,0.0179333006883778,0.00110783245638184
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPS10,40S ribosomal protein S10,39575,-0.0147286725099553,0.0045154508044586,-0.0235789560866942,-0.00587838893321646,0.00111030074793692
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.0119259166112128,0.00365672617689817,0.00475873330449236,0.0190930999179332,0.00111152855863738
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPA2,Replication protein A 32 kDa subunit,39657,0.0108922970533396,0.00334721171983987,0.00433176208245344,0.0174528320242257,0.00114077744810926
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0184739765860974,0.00567856282665566,0.00734399344585232,0.0296039597263425,0.00114418827796944
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00780191104121561,0.00240048102932843,0.00309696822373188,0.0125068538586993,0.00115628205090956
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.021766293414263,0.00670808921949137,-0.0349141482844661,-0.00861843854405992,0.00117891846310904
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0227103368242169,0.00701333943057687,0.00896419154028629,0.0364564821081476,0.00120657199919589
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,41839,0.0134191711474388,0.00414544200259958,0.00529410482234364,0.021544237472534,0.00121052222721603
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00726686340440529,0.00225157692401405,-0.0116799541754728,-0.00285377263333776,0.0012526336313532
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_DRA,,42060,-0.012699002318945,0.00393962504887003,-0.0204206674147303,-0.00497733722315973,0.00126978669432705
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP7,Retinoid-binding protein 7,39930,0.0217801299586975,0.00675807068665442,0.00853431141285482,0.0350259485045401,0.00127288841589379
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTF3,Neurotrophin-3,42119,0.0120066188333447,0.00372830665057316,0.00469913779822134,0.0193140998684681,0.00128316863419468
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL5,ADAMTS-like protein 5,39958,-0.013973967779024,0.00434330239955039,-0.0224868404821428,-0.00546109507590527,0.00129738941228537
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.0240302656106729,0.00747548106582323,0.00937832272165938,0.0386822084996864,0.00131017878963291
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.00945083822854448,0.00294467103752453,-0.0152223934620925,-0.00367928299499641,0.00133348467023318
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCP2,Non-specific lipid-transfer protein,41843,0.0257922845891604,0.0080366017093485,0.0100405452388373,0.0415440239394835,0.00133351486201829
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHNAK2,Protein AHNAK2,39638,0.0107447061808634,0.00337048418244605,0.00413855718326914,0.0173508551784576,0.00143718747534768
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MST1,Hepatocyte growth factor-like protein,39854,0.0231466211942052,0.00729289486506035,0.00885254725868695,0.0374406951297235,0.00150831581136167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP1,DNA topoisomerase 1,39930,0.0414242679020113,0.0130535157333512,0.0158393770646428,0.0670091587393797,0.00151057814687101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0153969877681184,0.00485455201882738,-0.0249119097250201,-0.00588206581121677,0.00151905924536706
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.0131278922648437,0.00414610078535571,0.00500153472554655,0.021254249804141,0.00154718262972989
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRLB,Fc receptor-like B,41843,0.0210906763652046,0.00667459852615582,0.00800846325393917,0.03417288947647,0.00158209964389066
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCP1,Plastin-2,39966,0.0162516737441262,0.00518309421641496,0.00609280907995292,0.0264105384082996,0.00171989420283076
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNL1,Thioredoxin-like protein 1,39570,0.0345217386812677,0.0110098880999187,0.0129423580054271,0.0561011193571083,0.00172001983775873
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.0112685109432587,0.0035991709954682,-0.0183228860943764,-0.004214135792141,0.00174750593294886
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RYR1,Ryanodine receptor 1,39575,-0.0114273261394916,0.00365124854612369,-0.0185837732898941,-0.00427087898908922,0.00175441425013533
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0126801346828143,0.0040536321220243,-0.0206252536419819,-0.00473501572364663,0.00176404947149309
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM25,Transmembrane protein 25,39934,-0.0158094279583566,0.00506924678357345,-0.0257451516541606,-0.00587370426255265,0.00182109892687142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD7,T-cell antigen CD7,39636,0.0150397190890741,0.00484002782529722,0.00555326455149152,0.0245261736266566,0.00189244358841284
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.00922845201659434,0.00297151708711905,0.003404278525841,0.0150526255073477,0.00190257206078983
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MILR1,Allergin-1,41913,-0.0171879433106106,0.00553459229384931,-0.0280357442065552,-0.00634014241466592,0.00190325537464821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAU,Urokinase-type plasminogen activator,42137,-0.00958792810580073,0.00308860323186583,-0.0156415904402578,-0.00353426577134371,0.00191127984413673
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0135997785530767,0.00438400456269929,-0.0221924274959673,-0.0050071296101861,0.00192617214445856
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.00896963408991154,0.0028927047156337,-0.0146393353325536,-0.00329993284726948,0.00193411569365417
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.028911522205671,0.00934198974681924,0.0106012223019053,0.0472218221094367,0.00197442258439826
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCUN1D2,DCN1-like protein 2,39560,-0.0267224867307928,0.00863493270011346,-0.0436469548230152,-0.00979801863857042,0.00197511355995031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NLGN2,Neuroligin-2,39586,-0.0156490465278322,0.00506032426473702,-0.0255672820867168,-0.00573081096894763,0.00198976526559021
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0168513531892205,0.00546988477742096,0.00613037902547544,0.0275723273529656,0.00206986646442304
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0119007958928035,0.00386924558014944,0.00431707455571063,0.0194845172298964,0.00210399039373823
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC6A,C-type lectin domain family 6 member A,41843,0.0157475914677779,0.00513150285990548,0.00568984586236312,0.0258053370731926,0.00215349824696927
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TERF1,Telomeric repeat-binding factor 1,39657,-0.00963123843423739,0.00314362828524095,-0.0157927498733097,-0.00346972699516512,0.00219119762117012
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN1,Contactin-1,42310,-0.00883290740321481,0.0028876757419525,-0.0144927518574417,-0.00317306294898792,0.00222632320550831
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,0.0131131369805259,0.00429158343535396,0.00470163344723209,0.0215246405138196,0.0022508767585225
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.0121959694475123,0.003995454846171,0.00436487794901714,0.0200270609460075,0.00227497546352783
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLH1,Glutamate carboxypeptidase 2,39657,0.034520145620227,0.0113133462036431,0.0123459870610866,0.0566943041793674,0.00228410966586335
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0127942740289354,0.00420435064830459,0.00455374675825844,0.0210348012996124,0.00234610852794096
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP152,Centrosomal protein of 152 kDa,39560,0.013795337538672,0.00454984104541869,0.00487764908965131,0.0227130259876926,0.0024346804548614
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC11A,C-type lectin domain family 11 member A,42118,-0.0158754641135051,0.00524750734956811,-0.0261605785186586,-0.00559034970835159,0.00248825159518861
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINI1,Neuroserpin,39713,0.00947109018182312,0.00313085176880967,0.00333462071495616,0.0156075596486901,0.00249132026768553
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRK1,NKG2-D type II integral membrane protein,39929,0.015344757544289,0.00509812761735592,0.0053524274142714,0.0253370876743066,0.00261925281446596
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SULT1A1,Sulfotransferase 1A1,42249,-0.0417867659033048,0.0138982021508657,-0.0690272421190015,-0.014546289687608,0.00264640819453121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.011792528501282,0.00392719164835936,0.0040952328704977,0.0194898241320664,0.00268115823832723
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JCHAIN,Immunoglobulin J chain,41913,-0.0198966942450345,0.00663204601038854,-0.0328955044253961,-0.00689788406467298,0.0027040478153228
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0109631691327228,0.00368351617685746,-0.0181828608393634,-0.0037434774260822,0.00292294997521714
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0176050150472294,0.0059959969901055,0.00585286094662265,0.0293571691478362,0.00333015597927129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA4,Ephrin type-A receptor 4,39736,0.00926823335969648,0.00315915589365858,0.00307628780812567,0.0154601789112673,0.00335556402532587
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.0099829082411608,0.00340371506131042,0.00331162672099237,0.0166541897613292,0.00336336367635008
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.0156222074837045,0.00532984822203012,0.00517570496852545,0.0260687099988835,0.00338461228407026
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX5,Syntaxin-5,39657,0.0126036849520208,0.00430051253988138,0.0041746803738533,0.0210326895301883,0.00338847457416264
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00949637066171257,0.00326276078276161,0.00310135952749983,0.0158913817959253,0.00361534204003446
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGA,Glycoprotein hormones alpha chain,42137,-0.0194574796898943,0.00669096337380877,-0.0325717679025595,-0.00634319147722916,0.00364311775438916
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNPY2,Protein canopy homolog 2,41900,0.0190344090001283,0.00658179348300659,0.00613409377343536,0.0319347242268212,0.00383443918285613
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0159895934273047,0.00554682348168761,-0.0268613674514124,-0.005117819403197,0.00394961913651205
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0315454088601087,0.0109453772442139,-0.052998348258768,-0.0100924694614494,0.00395830878907965
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,41960,0.00948140708907866,0.00329002369526947,0.0030329606463505,0.0159298535318068,0.00395957745090744
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP7,Dipeptidyl peptidase 2,42054,0.0195218714348088,0.00679912064885694,0.00619559496304922,0.0328481479065684,0.00409509985281672
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL36G,Interleukin-36 gamma,39624,0.0208483270162268,0.0072622910373658,0.0066142365829898,0.0350824174494637,0.00410260170361193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKLR,Pyruvate kinase PKLR,42143,0.0192978144525464,0.00674017026445948,0.00608708073420585,0.032508548170887,0.00420155526835809
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP164,Centrosomal protein of 164 kDa,41913,0.019272597208583,0.00673513690660406,0.006071728871639,0.0324734655455269,0.00422297903257214
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGA4,Pepsin A-4,39990,0.0231132421483852,0.00810803377548241,0.00722149594843965,0.0390049883483307,0.00437070630586625
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNMA2,Paraneoplastic antigen Ma2,39586,0.0136717617472409,0.00481618415450069,0.00423204080441951,0.0231114826900622,0.00453790538891125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD27,CD27 antigen,42181,-0.0130910570265994,0.00461887249768082,-0.0221440471220538,-0.00403806693114496,0.00460006021625769
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0124225948480293,0.00440613556668327,-0.0210586205587285,-0.00378656913733011,0.00481860679079823
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.0116209983370817,0.00412914753340125,0.00352786917161527,0.0197141275025482,0.00489444507256636
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0121527111046659,0.00432020947417606,-0.020620321674051,-0.00368510053528086,0.00491697139379549
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLL4,Delta-like protein 4,39638,0.0267926029887539,0.00954266491880994,0.00808897974788644,0.0454962262296214,0.00499897227655624
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH6,Cadherin-6,42145,-0.011797883727447,0.00420960801911809,-0.0200487154449185,-0.00354705200997556,0.00507631499680622
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.0134549119590682,0.00483437484671665,0.00397953725950354,0.0229302866586328,0.00539202733635392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PREB,Prolactin regulatory element-binding protein,41913,0.00853072436181079,0.00306862093195046,0.00251622733518788,0.0145452213884337,0.00544374825384123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB5,Serpin B5,41900,0.014599593573907,0.00526298819782323,0.00428413670617345,0.0249150504416405,0.00554467911440432
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0129569410356693,0.00467840159677171,-0.0221266081653419,-0.00378727390599675,0.00562150151906987
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0346831469432432,0.0125333430446919,0.010117794575647,0.0592484993108393,0.00566059225710351
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.00926490869932648,0.0033613728007834,0.00267661800979101,0.0158531993888619,0.00585389072670351
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN1,Calsyntenin-1,41839,0.0150964042182154,0.00548948938622574,0.00433700502121298,0.0258558034152179,0.00596659342906546
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRR4,Proline-rich protein 4,39652,-0.0211118354986089,0.00768357753991647,-0.0361716474768451,-0.00605202352037259,0.00601200715357343
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0240420229533128,0.00876889722228907,0.00685498439762625,0.0412290615089994,0.0061213314406554
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0174064746308446,0.00636611028861955,0.00492889846515026,0.0298840507965389,0.00626058097913307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.00707779895435568,0.00258940696388006,0.00200256130515076,0.0121530366035606,0.00627726403692337
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP290,Centrosomal protein of 290 kDa,39757,0.0156667414139481,0.00573598837512881,0.00442420419869563,0.0269092786292006,0.00631829568585372
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLIN3,Perilipin-3,42145,0.0126453157399067,0.00463274012911527,0.00356514508684073,0.0217254863929726,0.00635019168756569
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPHA2,Glycoprotein hormone alpha-2,39930,-0.0128821996898187,0.00472341202076781,-0.0221400872505236,-0.00362431212911379,0.00639517045551618
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.0182908228336078,0.0067072746583572,-0.0314370811639879,-0.00514456450322765,0.00640107176586197
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,39090,0.016701945981095,0.0061255022867878,0.00469596149899088,0.0287079304631991,0.00640920757920301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A16,Protein S100-A16,41814,-0.0179649533930127,0.00659445847033435,-0.030890091994868,-0.00503981479115736,0.00645324366857491
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF1,Macrophage colony-stimulating factor 1,42185,0.00793606100031283,0.00292063610962027,0.00221161422545711,0.0136605077751686,0.0065912825202987
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MB,Myoglobin,42310,-0.0164508907671947,0.00606590576970092,-0.0283400660758085,-0.0045617154585809,0.0066956842413107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.00991620297494527,0.00365870049373672,0.0027451500072213,0.0170872559426692,0.00673245755809248
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPLX2,Complexin-2,39560,-0.00898157113355674,0.00331714635592878,-0.0154831779911772,-0.00247996427593634,0.0067872699670815
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB39B,Ras-related protein Rab-39B,39575,0.0270269715591895,0.00998640536726091,0.00745361703935814,0.0466003260790209,0.00681270713165089
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.0156759233024024,0.00579258427772504,0.0043224581180613,0.0270293884867435,0.0068143861427395
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00799472660134398,0.00295789553536045,-0.0137922018506505,-0.00219725135203749,0.00688533245967477
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAL,Galanin peptides,42185,-0.0194403515797707,0.00720375023367769,-0.0335597020377789,-0.00532100112176241,0.00697088455953733
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0156903238686696,0.0058191102222954,-0.0270957799043686,-0.00428486783297061,0.00702124991751283
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXDC2,Plexin domain-containing protein 2,39929,0.00796910101099715,0.00296558775107387,0.00215654901889238,0.0137816530031019,0.0072160919378028
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKAP4,Cytoskeleton-associated protein 4,42247,0.00823838704514531,0.00306777891909905,0.00222554036371118,0.0142512337265794,0.00725183697023707
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0121663399356533,0.00453607591481436,-0.0210570487286895,-0.00327563114261716,0.00732613276243801
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0100698298782428,0.00375744444127828,0.00270523877333732,0.0174344209831482,0.00737172309255464
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.011241688186139,0.00422888488373336,0.00295307381402167,0.0195303025582564,0.00786279162420205
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP1,"Fatty acid-binding protein, liver",42123,0.0273450024553896,0.0102886492327829,0.00717924995913503,0.0475107549516441,0.00787488865859145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,42119,0.010558718748447,0.00397379314349756,0.00277008418719175,0.0183473533097022,0.00789114470103952
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASN,Vasorin,41975,-0.00787843868833257,0.00296523968897818,-0.0136903084787298,-0.00206656889793533,0.00789491096629901
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0246080041118071,0.00927906302771432,0.00642104057748702,0.0427949676461271,0.00801326268273563
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.0171573464843764,0.00649032872999691,-0.0298783907951704,-0.0044363021735825,0.00821435358659613
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTX1,Neuronal pentraxin-1,42137,0.0119270777078518,0.00451672760057648,0.00307429161072192,0.0207798638049817,0.00828431616293289
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMOD4,Tropomodulin-4,39560,-0.0114351673704671,0.0043332243352519,-0.0199282870675608,-0.00294204767337337,0.00832805978909411
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALCAM,CD166 antigen,42310,0.00560941933239147,0.0021283326943499,0.00143788725146567,0.00978095141331728,0.00840848779725498
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR101,Probable G-protein coupled receptor 101,39586,-0.0165287231133239,0.00629032006786596,-0.0288577504463412,-0.00419969578030659,0.00860978747857916
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0134358315445617,0.00514183931410444,-0.0235138366002064,-0.00335782648891703,0.00898400853206328
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKCQ,Protein kinase C theta type,41913,0.0119688408051453,0.00462858438864122,0.00289681540340853,0.0210408662068821,0.00972434380535141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0195635408855768,0.00757831461966814,0.00471004423102728,0.0344170375401264,0.00984702545898847
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK15,Kallikrein-15,39900,0.0146912511622847,0.00569357139221911,0.00353185123353528,0.0258506510910342,0.00988330505955072
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ID4,DNA-binding protein inhibitor ID-4,39757,-0.0117004499675358,0.00454027390046431,-0.0205993868124458,-0.00280151312262575,0.00997787684118051
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.0101680617383752,0.00394733815482061,0.00243127895492682,0.0179048445218236,0.0100096769411455
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17A,Interleukin-17A,41877,-0.0119273608475201,0.00464311238835335,-0.0210278611286926,-0.0028268605663475,0.0102151105141969
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.0146873056425855,0.0057184433497267,-0.0258954546080499,-0.00347915667712121,0.0102295438365235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0187134933887511,0.0072898103699955,0.00442546506355995,0.0330015217139423,0.0102687434469279
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA2,GDNF family receptor alpha-2,42070,0.00579068584814669,0.00225739896128447,0.00136618388402914,0.0102151878122642,0.0103222835627602
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSAP,Gamma-secretase-activating protein,41843,0.0232508960213006,0.00912314545754245,0.00536953092451742,0.0411322611180838,0.0108280109583876
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00911113521667086,0.00357794440451313,0.00209836418382513,0.0161239062495166,0.0108929661676286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.012410590296703,0.00488099498189282,0.00284384013219303,0.0219773404612129,0.0110153921867992
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC4A1,Band 3 anion transport protein,39966,0.0130803024081072,0.0051542169460166,0.00297803719391466,0.0231825676222997,0.0111688411426274
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.00862211447894276,0.00340107684003133,0.00195600387248136,0.0152882250854042,0.0112524505958269
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRAS,GTPase Hras,39750,0.0271538716422241,0.0107187723971727,0.00614507774376571,0.0481626655406826,0.0113129894670198
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0152981644320245,0.00604780056407435,0.00344447532643877,0.0271518535376102,0.0114350206627227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,42223,0.0112189898730543,0.00443937284877007,0.002517819089465,0.0199201606566437,0.0115102442938806
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,L1CAM,Neural cell adhesion molecule L1,42181,0.00808958636030926,0.00321076041804393,0.00179649594094315,0.0143826767796754,0.0117627572531592
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYO6,Unconventional myosin-VI,39934,0.0101898778704278,0.00404827578165282,0.00225525733838827,0.0181244984024673,0.0118465137528042
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0152351904542507,0.00606493846078226,0.00334791107111751,0.027122469837384,0.012016276669852
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EXTL1,Exostosin-like 1,39575,0.0129296441315541,0.00514827053546999,0.00283903388203289,0.0230202543810752,0.0120377426489406
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTA4H,Leukotriene A-4 hydrolase,42262,-0.0161328986535442,0.00644190851649172,-0.028759039345868,-0.00350675796122047,0.0122786532951226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP4,Bone morphogenetic protein 4,41992,-0.0127865085775062,0.00512038665512947,-0.02282246642156,-0.00275055073345243,0.0125305784709082
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0208047414093185,0.00834566825442597,-0.0371622511879934,-0.0044472316306436,0.012685330141881
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0400832606015338,0.0161126718388664,0.00850242379735563,0.0716640974057119,0.0128699466688805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17C,Interleukin-17C,41913,-0.0190613311247714,0.00767157070570249,-0.0340976097079482,-0.00402505254159449,0.0129793054210251
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK11,Kallikrein-11,42062,0.00866815573071575,0.00348923337750554,0.00182925831080489,0.0155070531506266,0.0129942382824837
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOC,Myocilin,42137,-0.011986160163323,0.0048374993772856,-0.0214676589428027,-0.0025046613838432,0.0132331283028155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.00579335318707718,0.00233958989151054,-0.0103789493744378,-0.00120775699971652,0.0132928312882448
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARTN,Artemin,41913,0.0121068165148946,0.00489201847613388,0.00251846030167221,0.021695172728117,0.0133430655891144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA4C,Semaphorin-4C,42070,-0.00744827027300842,0.00301117528271952,-0.0133501738271387,-0.00154636671887816,0.0133903236538731
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.0799742058189233,0.0324037147985711,0.016462924813724,0.143485486824123,0.0135971609704879
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC13A1,Solute carrier family 13 member 1,39919,0.0160446716515193,0.00650214824767242,0.00330046108608137,0.0287888822169573,0.0136170764440143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL14,C-X-C motif chemokine 14,41913,0.0152251521301009,0.0061865416629542,0.00309953047071067,0.0273507737894911,0.0138671758179105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLL1,Delta-like protein 1,42181,-0.00815649347603858,0.00331981350884404,-0.0146633279533729,-0.00164965899870427,0.0140260715844912
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD109,CD109 antigen,42137,-0.00903571094542521,0.00369066053683932,-0.0162694055976303,-0.00180201629322015,0.0143672492880743
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTR,Methionine synthase,39575,0.0172980326817169,0.00706629044727557,0.00344810340505679,0.031147961958377,0.0143821057690293
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.0104959025725805,0.00429719139219636,0.00207340744387565,0.0189183977012854,0.0146009991138589
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0181506731830321,0.0074365834715098,0.00357496957887285,0.0327263767871913,0.014670729335086
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RSPO1,R-spondin-1,42016,0.00896531219109927,0.00368611868372856,0.0017405195709913,0.0161901048112072,0.0150211461709089
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0226647778658833,0.00934956936542443,0.00433962190965144,0.0409899338221152,0.0153602795908076
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN2,Calsyntenin-2,42296,-0.0104440696587244,0.00432978451004763,-0.0189304472984177,-0.00195769201903103,0.0158720180033573
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.00864486510117986,0.00359174530636746,0.00160504430069964,0.0156846859016601,0.0161031443263673
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCAN,Versican core protein,42249,-0.00782052337746294,0.00325374810272028,-0.0141978696587947,-0.0014431770961312,0.0162503102207967
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPH3,Neurexophilin-3,39657,0.00779113021009108,0.00324475994055908,0.00143140072659528,0.0141508596935869,0.0163603900183113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB2,Integrin beta-2,42079,-0.00745855387677397,0.00310996632293098,-0.0135540878697187,-0.00136301988382925,0.0164860109616876
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0181955650299281,0.00758748784165288,0.00332408886028841,0.0330670411995677,0.0164936472039771
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,42119,0.012647454398293,0.00527702324677547,0.00230448883461306,0.0229904199619729,0.0165568490115038
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,39934,0.0103093330387312,0.00430294184336866,0.00187556702572867,0.0187430990517338,0.0165966249242517
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QL2,Complement C1q-like protein 2,39657,0.0111534765473756,0.00465644977866534,0.0020268349811915,0.0202801181135596,0.0166244470042451
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA6C,Semaphorin-6C,39657,0.00668374294854893,0.00279046607935313,0.00121442943301679,0.0121530564640811,0.0166275326284639
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS5,Transmembrane protease serine 5,41946,-0.00998032948192243,0.00416981412571579,-0.0181531651683254,-0.00180749379551947,0.0167035244667675
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGN,Secretagogin,41913,-0.0114920258969797,0.00480739932677972,-0.0209145285774679,-0.00206952321649141,0.0168398549258759
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.00993281238163832,0.00415661390181477,0.00178584913408138,0.0180797756291953,0.0168811275366226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.0099141589031953,0.00415583030121022,0.00176873151282326,0.0180595862935673,0.0170648833931988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0148171762567685,0.00622006252002696,-0.0270084987960213,-0.00262585371751562,0.0172283916721286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY6D,Lymphocyte antigen 6D,42041,0.0101729801744444,0.00430176817030266,0.0017415145606512,0.0186044457882376,0.0180521363398159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH4,Myosin-4,39575,-0.0116486848309008,0.00495651129681967,-0.0213634469726673,-0.00193392268913423,0.0187820338419411
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM3,Paralemmin-3,39575,0.0192646763376905,0.00820352896120535,0.00318575957372804,0.035343593101653,0.018874939983287
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.0133349790281887,0.00568391658966461,0.00219450251244603,0.0244754555439313,0.0189862025507449
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGA,Fibrinogen alpha chain,39735,0.00788943919443442,0.00336765517005869,0.0012888350611194,0.0144900433277494,0.0191617727276234
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPA33,Cell surface A33 antigen,42070,0.033728954069461,0.0144617125855679,0.00538399740174779,0.0620739107371741,0.0196999273988565
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.00601984061175816,0.00259345403960328,0.000936670694135727,0.0111030105293806,0.0202925126287318
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MATN3,Matrilin-3,41992,-0.00826841498308347,0.00356979725854304,-0.0152652176098278,-0.00127161235633911,0.0205615987034967
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPN1,Epsin-1,39757,0.0108326711786243,0.00467927874262711,0.00166128484307513,0.0200040575141734,0.0206293390658951
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEG1,Protein LEG1 homolog,39398,-0.0176760067802169,0.00764006621541194,-0.0326505365624243,-0.00270147699800953,0.0207087220126592
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0140372502172672,0.00608555940511644,-0.0259649466512955,-0.00210955378323902,0.0210927967006117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00733367663613149,0.00318447167807541,-0.0135752411251593,-0.00109211214710369,0.0213002905716293
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0193168428719066,0.00838815542520656,0.00287605823850171,0.0357576275053114,0.0213045691831292
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3D,Protein FAM3D,39930,0.0216248106364629,0.00947205557781045,0.00305958170395445,0.0401900395689714,0.0224481335872564
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVI2B,Protein EVI2B,39560,-0.00983647766070447,0.0043241927667068,-0.0183118954834498,-0.00136105983795915,0.0229398835270713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.0144034545773452,0.00634185232090643,0.00197342402836856,0.0268334851263217,0.0231521757028989
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0132106596878495,0.00582854191434877,0.00178671753572594,0.0246346018399731,0.0234339354189254
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF3,Granulocyte colony-stimulating factor,41913,0.0117575665897946,0.00519454590706582,0.0015762566119456,0.0219388765676436,0.0236243286147448
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST6,Cystatin-M,41864,0.0121789071245119,0.00538156717283771,0.00163103546574996,0.0227267787832738,0.0236469664138079
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0232824618366506,0.0102995710867493,0.00309530250662192,0.0434696211666792,0.0238080749657211
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.00597570017505162,0.00265069906167119,0.000780330014176087,0.0111710703359272,0.0241908012953824
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPC1,Glypican-1,42262,0.00719390872616865,0.0031963025204783,0.000929155786031186,0.0134586616663061,0.0244205650096293
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0168456655255545,0.00748731019998067,0.00217053753359235,0.0315207935175166,0.0244751762809513
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD5,Sushi domain-containing protein 5,39695,-0.00838026288374312,0.00372544600345118,-0.0156821370505074,-0.00107838871697881,0.0245024089697791
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMIGO1,Amphoterin-induced protein 1,39649,0.0122810402897944,0.00549495695879116,0.00151092465056378,0.0230511559290251,0.0254395079628193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOX9,Transcription factor SOX-9,39649,0.00667659178710909,0.00299359906470882,0.000809137620279813,0.0125440459539384,0.0257482507215562
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NME1,Nucleoside diphosphate kinase A,39657,-0.00528677986918005,0.00237243475839907,-0.00993675199564222,-0.000636807742717884,0.0258725821498054
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RALB,Ras-related protein Ral-B,39657,0.00714040139119874,0.00320665211569862,0.000855363244429448,0.013425439537968,0.0259842829874102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD82,CD82 antigen,39757,-0.00996964436070925,0.0044823001868089,-0.0187549527268547,-0.0011843359945638,0.0261532407261266
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMG4,Proteasome assembly chaperone 4,39657,0.0134428074005704,0.00605006709662024,0.00158467589119468,0.025300938909946,0.0263084017933203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF2,Trefoil factor 2,42166,0.0140032761496607,0.00632082056841272,0.00161446783557176,0.0263920844637496,0.026747750146421
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSAB1,Tryptase alpha/beta-1,42281,0.0124625663384533,0.00563543538886377,0.00141711297628028,0.0235080197006263,0.0270201436126241
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00933296432852948,0.00422685276702423,-0.017617595751897,-0.00104833290516198,0.0272636915222241
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0169065373944308,0.00765878297763296,-0.0319177520305914,-0.00189532275827025,0.0273017982385323
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLPS,Colipase,42115,0.017604281077317,0.00797824074529941,0.00196692921653018,0.0332416329381039,0.0273631966616763
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP2,Guanylate-binding protein 2,41913,0.014446871731269,0.00656372218511345,0.00158197624844665,0.0273117672140913,0.0277518400497633
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR4,Complement factor H-related protein 4,39945,0.0174040869040734,0.0079108629408204,0.00189879554006539,0.0329093782680814,0.0278252936466671
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.0102059275336139,0.00464077697441372,0.00111000466376299,0.0193018504034648,0.0278817654118929
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00720282324836145,0.00328119138211228,-0.0136339583573015,-0.000771688139421383,0.0281711493337118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL4,Myosin light chain 4,39638,0.0122412568896674,0.00557975844970496,0.00130493032824569,0.0231775834510891,0.0282656301412471
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEBP1,Heme-binding protein 1,41900,-0.0123114598873562,0.0056228675261474,-0.0233322802386051,-0.00129063953610731,0.0285753600567225
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN2B,Sodium channel subunit beta-2,39649,-0.00665313156173012,0.00305582662065956,-0.0126425517382229,-0.000663711385237374,0.0294870850442729
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00742455091591445,0.00341312324111274,-0.0141142724684954,-0.000734829363333477,0.0296292459576896
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUCL3,Mucin-like protein 3,39560,-0.0100303259678842,0.00461164268158508,-0.0190691456237909,-0.000991506311977404,0.0296513726659045
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.00676571419373207,0.0031218349746602,-0.0128845107440661,-0.00064691764339808,0.0302353500028591
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MKI67,Proliferation marker protein Ki-67,39657,0.00948060618658849,0.00440114840837364,0.000854355306176153,0.0181068570670008,0.0312522237836409
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00857526812686527,0.00400637524614127,0.000722772644428374,0.0164277636093022,0.0323401152092643
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3GL3,Endophilin-A3,39690,0.0196847548487028,0.00921724066874076,0.00161896313797095,0.0377505465594347,0.0327301928538721
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACRV1,Acrosomal protein SP-10,39657,0.0245400599819499,0.0114940003344981,0.00201181932633364,0.0470683006375662,0.0327803034904294
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUP50,Nuclear pore complex protein Nup50,39575,-0.00724928105866704,0.00343119209924886,-0.0139744175731948,-0.000524144544139273,0.0346439431187312
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00825034589003487,0.00391666658207595,0.000573679389166001,0.0159270123909037,0.0351859427884723
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMBN,Ameloblastin,41913,-0.00623654021502664,0.00296081768391941,-0.0120397428755087,-0.000433337554544585,0.0351919864115781
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,39930,0.0109744055843621,0.0052135629415557,0.000755822218912985,0.0211929889498113,0.0353156795146168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0190432764872314,0.00906230354699346,0.00128116153512422,0.0368053914393386,0.035631041516927
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.0119142335697247,0.00567052399308379,0.000800006543280461,0.0230284605961689,0.0356558592516112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEX101,Testis-expressed protein 101,39649,0.0140152571104322,0.0066723931066054,0.000937366621485589,0.0270931475993788,0.0357088633749359
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF3,Trefoil factor 3,42143,-0.00816904806281292,0.00390090709915141,-0.0158148259771497,-0.000523270148476153,0.0362659952663975
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM171B,Protein FAM171B,39919,0.00593796920474729,0.00287509927367188,0.000302774628350399,0.0115731637811442,0.0389164595345059
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00892550881522897,0.0043276801829309,0.000443255656684394,0.0174077619737735,0.0391907664701512
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPHS2,Podocin,39657,-0.022694384344208,0.0110185159057754,-0.0442906755195277,-0.00109809316888834,0.0394545170086019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYTL1,Cytokine-like protein 1,39966,0.00567812725409072,0.00276290959754745,0.000262824442897713,0.0110934300652837,0.0398896413586648
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MBL2,Mannose-binding protein C,39826,-0.0244715215298345,0.0119276811180364,-0.0478497765211859,-0.00109326653848319,0.0402260667991285
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0184955290656651,0.00906331056349365,-0.0362596177701126,-0.000731440361217538,0.0413041911616303
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL28,C-C motif chemokine 28,42075,0.0129897755396545,0.00638309154415374,0.000478916113113183,0.0255006349661958,0.0418675001699794
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTPP1,dCTP pyrophosphatase 1,42145,0.00694755260196824,0.00342587944537707,0.000232828889029178,0.0136622763149073,0.0425836815606175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA6,Corticosteroid-binding globulin,39979,0.00338060860091931,0.00166799609754329,0.000111336249734467,0.00664988095210416,0.042711411549722
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBLN2,Fibulin-2,39966,-0.00704810882957243,0.00347774214838277,-0.0138644834404027,-0.000231734218742207,0.0427232065495285
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSBP1,Heat shock factor-binding protein 1,39638,0.0210880770768377,0.0104181019057203,0.000668597341625908,0.0415075568120494,0.0429760315392601
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RSPO3,R-spondin-3,42262,0.00613846986669593,0.00303924748747828,0.000181544791238497,0.0120953949421534,0.0434305251986252
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNL1,Interferon lambda-1,41839,0.0099012030937496,0.00492497313315803,0.000248255752759868,0.0195541504347393,0.0444083157037289
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG4,Desmoglein-4,42018,0.0103977932342503,0.00518068596939341,0.000243648734239207,0.0205519377342614,0.0447664667716095
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.006907339429164,0.00344409459543628,-0.0136577648362191,-0.000156914022108899,0.0449234857515529
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDS,Iduronate 2-sulfatase,42296,0.00198858309033717,0.00099485378454965,3.86696726198546e-05,0.00393849650805448,0.0456421801719866
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0141625606047215,0.00712089039830778,-0.0281195057854047,-0.000205615424038207,0.0467350659349115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL12,Stromal cell-derived factor 1,41913,0.00849925860261725,0.00427382666608677,0.00012255833708719,0.0168759588681473,0.0467573604894295
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0116359525608726,0.00586325564569258,0.000143971495315115,0.02312793362643,0.047214620670586
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0175574069215064,0.00885728177794175,-0.0349176792062722,-0.000197134636740582,0.0474750014176522
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP9,Matrix metalloproteinase-9,42125,0.012823683511758,0.00647132483338716,0.000139886838319113,0.0255074801851968,0.0475424023964373
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTKN2,Rhotekin-2,39575,-0.0109141934802665,0.00550871013952193,-0.0217112653537295,-0.000117121606803503,0.0475869093230958
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS1,"Nitric oxide synthase, brain",41839,-0.012590935977354,0.0063662782399797,-0.0250688413277142,-0.000113030626993806,0.047977103035851
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OBP2B,Odorant-binding protein 2b,41979,-0.0122297886023044,0.00619629991986491,-0.0243745364452397,-8.50407593692305e-05,0.0484336264709126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.0103578666229304,0.00525126513311984,6.53869620154714e-05,0.0206503462838452,0.0485831074223704
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",39575,0.011765918426578,0.00597201634708172,6.07663862978811e-05,0.0234710704668582,0.0488433966353212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAD2,Glutamate decarboxylase 2,39657,-0.00962641067895777,0.00489920572212036,-0.0192288538943137,-2.39674636018615e-05,0.0494517260219109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOC2B,Double C2-like domain-containing protein beta,39649,0.00773167983305649,0.00397593719980448,-6.11570785602833e-05,0.0155245167446733,0.051846288310996
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.0082024741619101,0.00422391762402728,-7.64043811833683e-05,0.0164813527050036,0.0521732316394965
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A3,Protein S100-A3,39919,0.00895085317090074,0.00462243283294559,-0.000109115181672606,0.0180108215234741,0.0528442726186035
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDNRB,Endothelin receptor type B,39657,0.00917553168672133,0.00473902854820721,-0.00011296426776481,0.0184640276412075,0.052873195255706
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB118,Beta-defensin 118,39586,0.0119445136568204,0.00616996765190407,-0.000148622940911563,0.0240376502545524,0.052904116864024
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0121869377550943,0.00630565458939474,-0.000172145240119357,0.024546020750308,0.0532943871601917
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0176227783476042,0.00912146039673098,-0.0355008407251969,0.000255284029988548,0.0533794604956233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA1549,UPF0606 protein KIAA1549,39757,0.0142690342592998,0.00740302659628158,-0.000240897869412069,0.0287789663880117,0.0539477422833321
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00627472515225456,0.00326418256311639,-0.000123072671453563,0.0126725229759627,0.0545896716650619
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0169335933712844,0.00883198186763607,-0.034244277831851,0.000377091089282341,0.0552252995408419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0157065546420923,0.00819681973908148,-0.000359212046507369,0.031772321330692,0.0553641236473706
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0256383982965252,0.0134049878017621,-0.000635377794928598,0.051912174387979,0.0558206491623507
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSHB,Follitropin subunit beta,39638,-0.00847970076508861,0.00443993643282489,-0.0171819761734254,0.000222574643248171,0.0561758639190321
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.0122957929117983,0.00643946822754748,-0.000325564814194726,0.0249171506377914,0.0562311432694957
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.0175752180981252,0.0092227274085976,-0.000501327622726141,0.0356517638189764,0.0567178398947583
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0126843493463869,0.00669650287198679,-0.000440796282707222,0.025809494975481,0.0582280062004929
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGM2,Phosphoglucomutase-2,39649,0.012432484942169,0.00657568321492459,-0.000455854159083249,0.0253208240434212,0.0586937790933237
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR1,Folate receptor alpha,42110,0.00602946380098111,0.00319094675971114,-0.000224791848052728,0.012283719450015,0.058839126977422
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPS,Calcyphosin,39929,0.0193898560426995,0.0102803650041195,-0.000759659365374636,0.0395393714507737,0.0593062556438931
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTN,Titin,39575,-0.0141102544105454,0.00749156398346114,-0.0287937198181293,0.00057321099703842,0.0596609791814412
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.00889163996992998,0.00472688738409412,-0.000373059302894501,0.0181563392427545,0.0599827899668586
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MERTK,Tyrosine-protein kinase Mer,42296,0.00501349378924702,0.0026687880917856,-0.000217330870652748,0.0102443184491468,0.0603250403554965
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0141685926013147,0.00757281361261077,-0.000674122079402437,0.0290113072820318,0.0613734196180657
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANK2,Ankyrin-2,39575,-0.014146424409748,0.00756144170892277,-0.0289668501592366,0.000674001339740646,0.0613906089657629
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEB,Nebulin,39575,-0.00805534815958972,0.00430583139711482,-0.0164947776979348,0.00038408137875532,0.0613994370357993
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIP1,Huntingtin-interacting protein 1,39575,0.00666319034205578,0.0035640629913602,-0.000322373121010199,0.0136487538051218,0.061573082372186
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTOA,Otoancorin,39586,-0.0106171796984963,0.0056890951280144,-0.0217678061494045,0.00053344675241193,0.0620353337377481
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNNI3,"Troponin I, cardiac muscle",41900,0.0169208606040596,0.00907707814261014,-0.000870212555456312,0.0347119337635755,0.062325358441499
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,0.00704845790577952,0.00379725711117443,-0.000394166032122354,0.0144910818436814,0.0634471024724727
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0253270325605269,0.0136765736010259,-0.00147905169748379,0.0521331168185376,0.0640688748937635
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD48,CD48 antigen,42166,0.00611042772558783,0.00332599432679746,-0.00040852115493518,0.0126293766061109,0.066206187674689
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL5,Interleukin-5,41913,0.0273179926495468,0.0149517066200759,-0.001987352325802,0.0566233376248956,0.0677098316174806
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.006360477456627,0.00348663397792777,-0.0131942800533654,0.00047332514011142,0.0681369378481604
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1B,Protein phosphatase 1B,39657,0.012167622051088,0.00667107444429839,-0.000907683859736885,0.0252429279619128,0.068188518510996
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.00771547758270625,0.00424089037239042,-0.0160276227125915,0.00059666754717897,0.068887483492657
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FZD8,Frizzled-8,39586,0.00847966559721778,0.0046626246364832,-0.000659078690289285,0.0176184098847249,0.068992606084052
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REN,Renin,42145,-0.0158694662459106,0.00877895299371511,-0.0330762141135922,0.001337281621771,0.0706797616932508
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELAVL4,ELAV-like protein 4,39586,0.0160274058120445,0.00887549407579412,-0.00136856257651198,0.033423374200601,0.0709762658336968
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNG,Uracil-DNA glycosylase,39919,0.00687817749300825,0.0038140003241353,-0.000597263142296941,0.0143536181283134,0.0713516154600266
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.0091246451790547,0.00506803627401221,-0.0190579962761186,0.000808705918009226,0.0718202317800023
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH7B,Myosin-7B,39560,-0.00835360161451221,0.00464189210894754,-0.0174517101480494,0.000744506919024973,0.0719495243411776
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMMD9,COMM domain-containing protein 9,39919,0.00775410298137273,0.00431650796640152,-0.000706252632774252,0.0162144585955197,0.0724602268804731
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,41430,0.00816999781167035,0.00454906877262402,-0.000746176982672734,0.0170861726060134,0.0725225710002785
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.0047621153951804,0.00265535475030202,-0.000442379915411552,0.00996661070577235,0.0729361738526256
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1A,Interleukin-1 alpha,41913,0.0112315517083365,0.00626332805426903,-0.00104457127803076,0.0235076746947038,0.0729597652474071
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIRREL1,Kin of IRRE-like protein 1,39586,-0.0107945798946179,0.00604328068872516,-0.0226394100445193,0.00105025025528337,0.0740925241069712
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00606820258794715,0.00339912272349694,-0.0127304831260012,0.000594077950106854,0.0742520731195028
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.0088326270889854,0.00496091057833085,-0.0185560118225139,0.000890757644543062,0.0750306579658673
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENOPH1,Enolase-phosphatase E1,39919,0.0101959077719844,0.00577302168012376,-0.00111921472105816,0.021511030265027,0.0774009640553079
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMCH,Pro-MCH,39575,-0.0157592701707211,0.00892722671346794,-0.0332566345291182,0.00173809418767611,0.0775404701368474
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00931883399170474,0.00529082408583376,-0.0196888491999389,0.00105118121652944,0.0782121456053344
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA8,Carbonic anhydrase-related protein,39657,0.00506005436823845,0.00288091890444169,-0.000586546684467268,0.0107066554209442,0.07904731510014
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC44A4,Choline transporter-like protein 4,39649,-0.0130898080519508,0.00745456992108976,-0.0277007650972867,0.00152114899338511,0.0791256585578042
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF20B,Kinesin-like protein KIF20B,39586,0.0142106865037612,0.0080941005053607,-0.0016537504867458,0.0300751234942681,0.0791701665321857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00522944123231488,0.0029810951046673,-0.000613505172833026,0.0110723876374628,0.0794190302773346
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCN,Decorin,41900,-0.00435401238724118,0.00248693054296949,-0.00922839625146139,0.000520371476979032,0.0800107379700352
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHODH,Dihydroorotate dehydrogenase,39575,0.00879085194225612,0.00502589475095495,-0.00105990176961558,0.0186416056541278,0.0802996437421857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCND2,G1/S-specific cyclin-D2,39757,0.00702311757146323,0.00401655648652215,-0.000849333142120185,0.0148955682850466,0.0803977267761415
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD58,Lymphocyte function-associated antigen 3,42100,-0.00329518990311609,0.00188513181013826,-0.00699004825098709,0.000399668444754904,0.0804886427074115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSC1,Hamartin,39657,0.0139675326685784,0.00800235368681151,-0.00171708055757213,0.029652145894729,0.0809381617882338
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR158,Probable G-protein coupled receptor 158,39934,0.006543615819941,0.00375166455258755,-0.000809646703130598,0.0138968783430126,0.0811530717646595
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00847714122948113,0.00486143908237773,-0.00105127937197922,0.0180055618309415,0.0812256582969532
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00554903611054885,0.0031831953407063,-0.000690026757235504,0.0117880989783332,0.0813215447160239
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL5,Fc receptor-like protein 5,42137,-0.0111485967432862,0.00639692758636204,-0.0236865748125558,0.00138938132598338,0.0813904065403
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GKN1,Gastrokine-1,41538,0.00535056185997377,0.0030710108660514,-0.000668619437486977,0.0113697431574345,0.0814831631051912
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0102602460175166,0.0058943225267413,-0.00129262613489639,0.0218131181699295,0.0817633609900085
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FH,"Fumarate hydratase, mitochondrial",39586,0.0154882001102735,0.00890968303881002,-0.00197477864579415,0.0329511788663411,0.0821761381574985
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC12A,C-type lectin domain family 12 member A,39657,0.00382597051970813,0.00220685658660735,-0.000499468390042272,0.00815140942945854,0.0830037664340597
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00427998283754592,0.00247118393198811,-0.000563537669150782,0.00912350334424262,0.0833038170991829
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0116318833086216,0.00673698263749291,-0.00157260266086446,0.0248363692781077,0.0842725506812715
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBX2,Chromobox protein homolog 2,39575,-0.00736811980041127,0.00427022713187627,-0.0157377649788888,0.00100152537806623,0.0844721781264793
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00477629856840084,0.00276884265019132,-0.0102032301627758,0.000650633025974155,0.0845517351921181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR1,Toll-like receptor 1,39657,0.00498609848915876,0.00289428746460513,-0.000686704941467295,0.0106589019197848,0.0849639084064196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B4,Protein ATP1B4,39560,-0.007745151999854,0.00453274932532138,-0.0166293406774839,0.00113903667777592,0.0875330796986919
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEDD9,Enhancer of filamentation 1,39657,0.00624226908652772,0.00366169747626873,-0.000934657966958989,0.0134191961400144,0.0882696461149807
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00950436437515746,0.00557743955043092,-0.00142741714368714,0.0204361458940021,0.0883952875023175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRMD7,FERM domain-containing protein 7,39649,0.00626906068102023,0.00368215588721121,-0.00094796485791375,0.0134860862199542,0.0886801274160351
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYMP,Thymidine phosphorylase,42070,0.0122494111874726,0.0071981377245109,-0.00185893875256877,0.026357761127514,0.0888258326039422
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL6,Fc receptor-like protein 6,42119,0.0126355515518033,0.00743558422481994,-0.00193819352884379,0.0272092966324504,0.0892790109407256
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYT1,Synaptotagmin-1,39929,0.00736638408116534,0.00433535539091548,-0.00113091248502899,0.0158636806473597,0.0893199014168137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.0107788916399485,0.00636096199139169,-0.00168859386317917,0.0232463771430762,0.0901914445851684
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPN3,Calpain-3,39919,-0.00712702057956339,0.00422460836839708,-0.0154072529816217,0.00115321182249489,0.0916260700947704
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF7,Fibroblast growth factor 7,39560,-0.0141383844863202,0.00841169713969457,-0.0306253108801216,0.00234854190748115,0.092830172520981
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00627461914798699,0.00373759089334911,-0.0136002972989513,0.00105105900297727,0.0932219945751771
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2RB,Cytokine receptor common subunit beta,39657,-0.00771154703343629,0.00460002622755884,-0.0167275984394516,0.00130450437257904,0.0936854553172086
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM25,RNA-binding protein 25,39560,-0.00845833101658067,0.00506756799991354,-0.0183907642964112,0.00147410226324988,0.0951240410908733
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAP1A,Ras-related protein Rap-1A,39657,-0.0124610338503007,0.00747899679664406,-0.0271198675717231,0.00219779987112165,0.095714441179331
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBH,Dopamine beta-hydroxylase,39978,0.020463532139748,0.0123319663968687,-0.00370712199811457,0.0446341862776106,0.0970649461138165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NINJ1,Ninjurin-1,41843,0.00976351544741461,0.0058840801252149,-0.00176928159800659,0.0212963124928358,0.0970769359937345
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00902701884432789,0.00545721261550263,-0.019723155570713,0.00166911788205727,0.0981263194903276
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.0089517672158368,0.0054121399672964,-0.0195595615517378,0.00165602712006414,0.0981527887488722
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00958282977688064,0.00579722442371972,-0.0209453896473713,0.00177973009361002,0.0983584094629543
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBA,Lysosomal acid glucosylceramidase,39649,0.00992328963912193,0.00600732130835422,-0.00185106012525234,0.0216976394034962,0.098590292490413
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGMA,Repulsive guidance molecule A,42249,-0.00573809923722306,0.00347884377929332,-0.012556633044638,0.00108043457019185,0.0990831765943395
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TG,Thyroglobulin,39919,-0.0186694986150272,0.0113434010825507,-0.0409025647368266,0.00356356750677209,0.0998231000884146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNA1,Ephrin-A1,42113,0.00521488267516309,0.00318441729212628,-0.00102657521740443,0.0114563405677306,0.101523142695256
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00835362213779665,0.005103934869844,-0.00165009020709758,0.0183573344826909,0.101720480457636
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAG,S-arrestin,39586,-0.00926550418107967,0.00566125036755514,-0.0203615549014877,0.0018305465393284,0.101731572042489
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.015575832762223,0.00952348296062022,-0.0342418593650386,0.00309019384059263,0.101968908067852
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN4,Nectin-4,42181,-0.00588978379124317,0.00363644519450523,-0.0130172163724734,0.00123764878998707,0.105329794598477
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00689561468700493,0.00426127285717032,-0.0152477094870588,0.00145648011304889,0.105647078481941
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00631995852881166,0.00392185647388201,-0.0140067972176204,0.00136688015999708,0.107105634946554
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00568814111211605,0.00353085100348216,-0.00123232685470899,0.0126086090789411,0.107212173907769
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPK13,Mitogen-activated protein kinase 13,39560,0.00759661131755385,0.00472235474573533,-0.00165920398408739,0.0168524266191951,0.107721911914516
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACE,Angiotensin-converting enzyme,39990,-0.00469604118411324,0.00292311640385896,-0.0104253493356768,0.00103326696745031,0.108187708189329
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00994817722730754,0.00620218341539147,-0.0221044567214748,0.00220810226685974,0.108747268521879
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,41913,0.0103414308864836,0.00645790010785577,-0.00231605332491372,0.0229989150978809,0.109320659804081
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.00639416199217478,0.00399456227814446,-0.0142235040573379,0.00143518007298836,0.109463046155647
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,39929,0.00527342104893738,0.00330381198353907,-0.00120205043879919,0.011748892536674,0.110480392354688
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB6B,Ras-related protein Rab-6B,41839,0.00818910675012698,0.00513131463494414,-0.00186826993436352,0.0182464834346175,0.110533174210794
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEX33,Testis-expressed protein 33,39757,-0.0066482211277356,0.00417229144736328,-0.0148259123645676,0.00152947010909643,0.111093872912803
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.0106082363146297,0.00665840119092481,-0.0236587026488423,0.00244223001958295,0.111141719056943
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00757541338682493,0.00477247985379785,-0.0169294739002687,0.00177864712661885,0.112469985509265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGS8,Regulator of G-protein signaling 8,41913,-0.0109725894278331,0.00691633756459782,-0.0245286110544448,0.00258343219877866,0.112655584679757
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.007815856639976,0.00493779040797528,-0.0174939258396076,0.00186221255965554,0.113475279891151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,39575,0.0170358614270118,0.0107958614431971,-0.00412402700165462,0.0381957498556782,0.114594598803331
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00436961973094866,0.00277246284897251,-0.00980364691493479,0.00106440745303747,0.115036317697836
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.00590046548030293,0.00374390276929882,-0.00143758394752276,0.0132385149081286,0.115044381609182
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD177,CD177 antigen,42123,-0.021908728804665,0.0139316810260667,-0.0492148236157557,0.00539736600642563,0.11583873352863
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.011750360206958,0.00748472862287285,-0.00291970789387274,0.0264204283077888,0.116464100965203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG1B,Lithostathine-1-beta,42310,-0.00965820151963982,0.00617007721709864,-0.0217515528651532,0.00243514982587352,0.117528838977747
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00657169301093857,0.00420492132541961,-0.014813338808761,0.00166995278688386,0.118114938129636
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,-0.0082330146136638,0.00531279217926185,-0.018646087285017,0.00218005805768943,0.121251931912245
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSP90B1,Endoplasmin,41774,0.0106245610508283,0.00688728735557594,-0.00287452216610056,0.0241236442677571,0.122943713852772
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.0110000445750983,0.00713713367334224,-0.0249888265748491,0.00298873742465247,0.123286920402426
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TUBB3,Tubulin beta-3 chain,39586,-0.00477490509215048,0.00309922369587039,-0.0108493835360565,0.00129957335175549,0.123424027826758
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELENOP,Selenoprotein P,39979,0.00375355580601188,0.00244704412197286,-0.00104265067305493,0.00854976228507868,0.125078555483475
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00828637218543697,0.00546332896749455,-0.00242175259085236,0.0189944969617263,0.129364527305028
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRXN3,Neurexin-3,39649,0.00589672095116776,0.00389617504081459,-0.00173978212882884,0.0135332240311644,0.130190422398209
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.0113250814586846,0.00750520293771808,-0.026035279216612,0.00338511629924287,0.13133672599369
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRR5,Proline-rich protein 5,39657,0.00769877308530939,0.00510288078912484,-0.0023028732613753,0.0177004194319941,0.131401189785579
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRL,Prolactin,42249,0.0119912910469525,0.00795952779168667,-0.00360938342475341,0.0275919655186583,0.131953552131411
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTXR,Neuronal pentraxin receptor,42145,0.00556146424410435,0.00369306922290693,-0.00167695143279324,0.0127998799210019,0.132111208447242
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARB1,Scavenger receptor class B member 1,41839,0.00904414154107546,0.00601930726401339,-0.00275370069639078,0.0208419837785417,0.132986203724192
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFD,Complement factor D,39979,0.00327960721781595,0.00219089105550633,-0.00101453925097646,0.00757375368660836,0.13443960434956
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.0050058735157629,0.00334530022411966,-0.00155091492351163,0.0115626619550374,0.134575781557479
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00550522877248553,0.0036806269498993,-0.0127192575942882,0.00170880004931709,0.13475245497013
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NELL1,Protein kinase C-binding protein NELL1,42181,0.00678763103538473,0.00455779142858509,-0.00214564016464205,0.0157209022354115,0.136448225970435
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCG3,Secretogranin-3,42144,-0.00536208685897871,0.00360122043817541,-0.0124204789178025,0.00169630519984509,0.136520185511019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.0044845779114075,0.00302275550548351,-0.0104091787021552,0.00144002287934018,0.137936592695347
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH17,Cadherin-17,42145,0.0108953545418116,0.00737953235403432,-0.00356852887209565,0.0253592379557189,0.139852046800265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00616478346599374,0.00419417055350366,-0.00205579081887344,0.0143853577508609,0.141632219386985
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00827961097908889,0.00565748076609787,-0.0193682732806407,0.00280905132246293,0.143364642360189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAC1,Cartilage acidic protein 1,42310,-0.00489081172594522,0.00334878463143341,-0.0114544296035547,0.00167280615166426,0.144182858047083
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.0114302612291314,0.00783490481925609,-0.0267866746748733,0.00392615221661057,0.144624082822063
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INHBB,Inhibin beta B chain,39736,0.00823098269490795,0.0056493689224017,-0.00284178039299937,0.0193037457828153,0.145151798875545
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM1,Myomesin-1,39586,0.00771055124987675,0.0053023551333963,-0.00268206481157999,0.0181031673113335,0.145926415225683
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLGN,Calmegin,39649,0.00717999451652805,0.00494898901124049,-0.00252002394550332,0.0168800129785594,0.146863876926426
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VNN2,Vascular non-inflammatory molecule 2,42070,0.00740702605421868,0.00511449594267598,-0.00261738599342623,0.0174314381018636,0.147572754917502
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASPN,Asporin,39958,0.0043249791987387,0.003013732464666,-0.00158193643200666,0.0102318948294841,0.151288810459215
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0142714982660201,0.00995305178075818,-0.00523648322426589,0.0337794797563062,0.151634500965173
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL4,Interleukin-4,41913,0.0146416365875963,0.0102160398867587,-0.00538180159045067,0.0346650747656433,0.151823942415996
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIRREL2,Kin of IRRE-like protein 2,41839,0.00618605793637848,0.00431924280155701,-0.00227965795467327,0.0146517738274302,0.152107657553367
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EP300,Histone acetyltransferase p300,39657,0.0047658017228564,0.00332991112152219,-0.00176082407532709,0.0112924275210399,0.152398332845874
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSPN,Claspin,41820,0.00550632871453773,0.00385061444875293,-0.002040875605018,0.0130535330340935,0.152744374188469
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EXOSC10,Exosome component 10,39575,-0.00897495269966928,0.00630660800073418,-0.0213359043811083,0.00338599898176971,0.154734726081916
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,H2AP,Huntingtin-interacting protein M,39560,-0.00773617270836033,0.00545273777428422,-0.0184235387459574,0.00295119332923673,0.155994948380029
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPE4,NXPE family member 4,39575,-0.00490960089309639,0.00346144992969763,-0.0116940427553037,0.00187484096911097,0.156112499152532
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REST,RE1-silencing transcription factor,39560,-0.00525074485152266,0.00370499004037318,-0.0125125253306541,0.00201103562760878,0.156450286412695
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMA1,Proteasome subunit alpha type-1,41843,0.00707853064808836,0.00501449209058671,-0.00274987384946159,0.0169069351456383,0.158086941663475
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00555024038477801,0.00394265031788219,-0.0132778350078271,0.00217735423827108,0.15923535635582
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMA1,Laminin subunit alpha-1,39575,-0.00786895083974534,0.00559170762767563,-0.0188286977899896,0.0030907961104989,0.159380513836135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBQLN3,Ubiquilin-3,39575,0.00855372019860863,0.00608369307224412,-0.00337031822298984,0.0204777586202071,0.159750104828746
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00821582425169651,0.00586326828884291,-0.0032761815944356,0.0197078300978286,0.161171742898202
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.0052547528375927,0.00375877528774426,-0.00211244672638605,0.0126219524015714,0.1621371600419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX1B,Syntaxin-1B,39649,0.00607133317192332,0.00435032489099875,-0.00245530361443423,0.0145979699582809,0.162861659250159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFL4,Insulin growth factor-like family member 4,39657,0.0107784045216129,0.00773058584901568,-0.00437354374245784,0.0259303527856836,0.163268763829169
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GM2A,Ganglioside GM2 activator,39733,0.00576269731427966,0.00416948912982977,-0.00240950138018668,0.013934896008746,0.166965311473853
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00533594947904348,0.00386865426428577,-0.0129185118370436,0.00224661287895663,0.167837180164798
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD70,CD70 antigen,42119,-0.00657728688837105,0.00478909092499138,-0.0159639051013541,0.00280933132461205,0.169654087186596
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNGR1,Interferon gamma receptor 1,42185,0.00320657588318985,0.00234056963667885,-0.00138094060470069,0.0077940923710804,0.17071014525699
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD5L,CD5 antigen-like,39925,0.00711118694097739,0.00519414738421174,-0.00306934193207763,0.0172917158140324,0.171002404904145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FDX1,"Adrenodoxin, mitochondrial",39575,0.00932396096082571,0.00681447718386849,-0.00403241431955653,0.022680336241208,0.171259432294579
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00582696021161138,0.00427225291521866,-0.0142005759254399,0.0025466555022172,0.172624472781517
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIF1L,Allograft inflammatory factor 1-like,39638,0.00836852290503338,0.00614169951098503,-0.00366920813649727,0.020406253946564,0.173044461291021
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00904308794288123,0.00664173162920991,-0.0220608819361326,0.00397470605037018,0.17336561921626
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP29,Dual specificity phosphatase 29,39649,-0.00992869046024821,0.00729645488901229,-0.0242297420427123,0.00437236112221588,0.173618752735141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DRAXIN,Draxin,42016,0.00623809706845717,0.00460036930217243,-0.00277862676380078,0.0152548209007151,0.175122246490199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSB,Lupus La protein,41839,0.00863791986218065,0.00637871952189433,-0.00386437040073223,0.0211402101250935,0.175702798209513
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBN2,Fibrillin-2,39649,0.00879972829605957,0.00650895589992289,-0.00395782526778928,0.0215572818599084,0.17642166911209
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM19,Probable RNA-binding protein 19,39575,-0.00699853630177026,0.0052026017693862,-0.0171956357697672,0.00319856316622668,0.178588673423582
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL36A,Interleukin-36 alpha,39657,-0.00835313987218495,0.00621262000474743,-0.0205298750814899,0.00382359533712001,0.178800175620864
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR4,Toll-like receptor 4,39657,0.00412340398681449,0.00307013673715367,-0.00189406401800671,0.0101408719916357,0.17927735633839
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNW1,Interferon omega-1,39575,-0.00512323498773463,0.00381738633371508,-0.0126053122018162,0.00235884222634692,0.179598063872902
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNR,Tenascin-R,42016,-0.00606052809546176,0.0045294961209039,-0.0149383404924334,0.00281728430150989,0.180914632102066
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.0078280495027952,0.00586084530854178,-0.0193153063075371,0.00365920730194669,0.181690571369325
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00847294852216272,0.00636600941550878,-0.00400442993223448,0.0209503269765599,0.183227514575083
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOP56,Nucleolar protein 56,39575,0.0160702747549393,0.0121189887069414,-0.00768294311066581,0.0398234926205444,0.18485374470954
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH23,Cadherin-23,39929,-0.00381291209950848,0.00289633685768314,-0.00948973234056743,0.00186390814155047,0.188046272045831
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00397377279633146,0.00302685316437044,-0.0019588594058346,0.00990640499849752,0.189264238875769
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN4,Prefoldin subunit 4,39560,-0.00748973361744609,0.00571253942135783,-0.0186863108833074,0.00370684364841525,0.189850078100359
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,39934,0.010548297330285,0.00804753576766742,-0.00522487277434316,0.0263214674349131,0.189969225338475
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00513612059400443,0.00392059195896379,-0.0128204808335735,0.00254823964556461,0.190209863333515
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.00838517936681257,0.00640314823948394,-0.00416499118257595,0.0209353499162011,0.190378877388763
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RETN,Resistin,42105,0.00604051417817317,0.00465078012090912,-0.00307501485880872,0.0151560432151551,0.194028774617601
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.00470014295312805,0.00365068733272828,-0.00245520421901938,0.0118554901252755,0.197958225812368
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00690466729545466,0.00537165284169842,-0.00362377227427425,0.0174331068651836,0.198683056374142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POF1B,Protein POF1B,39657,0.00628739828010479,0.00491505800114682,-0.00334611540214298,0.0159209119623526,0.200849462645815
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPB41L5,Band 4.1-like protein 5,39649,0.00858640711074146,0.00673764151230653,-0.00461937025337933,0.0217921844748623,0.202550766945163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTX2,Neuronal pentraxin-2,39966,-0.00471518556198674,0.0037054304513496,-0.0119778292466319,0.00254745812265847,0.20321912897584
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFRC,Transferrin receptor protein 1,42200,0.00515167739426416,0.00405360701393873,-0.00279339235305575,0.0130967471415841,0.203790507171938
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RELB,Transcription factor RelB,39657,0.00643870327547589,0.00507303881089128,-0.00350445279387102,0.0163818593448228,0.204396286003985
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0145316459098898,0.0114627511226258,-0.0369986381102364,0.00793534629045684,0.204922141670489
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42137,0.00578979525169818,0.00456741976663154,-0.00316234749089963,0.014741937994296,0.204952157068823
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTO1,Protein LTO1 homolog,41913,0.00564513887280469,0.00447078352686305,-0.00311759683984689,0.0144078745854563,0.206728738661851
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.0105311057674102,0.00835707576333991,-0.00584876272873603,0.0269109742635564,0.207644599552722
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00649241721910817,0.00517040306259571,-0.00364157278357941,0.0166264072217958,0.209250880399344
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP1,Retinol-binding protein 1,39649,0.00951275278400963,0.00761013844653604,-0.00540311857120102,0.0244286241392203,0.211322195051662
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,39929,0.00379447142337129,0.00303838054303277,-0.00216075444097294,0.00974969728771552,0.211746964935592
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.0159220948327463,0.0127576123485113,-0.00908282537033581,0.0409270150358284,0.212039771091836
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL22,Interleukin-22,39919,0.00950187518638891,0.00762446031263676,-0.00544206702637915,0.024445817399157,0.212703641267213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TJP3,Tight junction protein ZO-3,39586,-0.00559639694912594,0.00450387180386637,-0.014423985684704,0.00323119178645214,0.214051135921867
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.00935695109183939,0.00753299394324481,-0.00540771703692043,0.0241216192205992,0.214210640737427
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAN,Neurocan core protein,42249,0.00501986899890379,0.00405288723214256,-0.00292378997609562,0.0129635279739032,0.215518363093375
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPEP2,Dipeptidase 2,42070,-0.00402126247643367,0.00325345065556025,-0.0103980257613318,0.00235550080846442,0.216480406371501
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTNL10,Butyrophilin-like protein 10,39560,-0.00532216600574793,0.00431656470207863,-0.013782632821822,0.0031383008103262,0.217615888852906
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.00523948494795628,0.00425475371707951,-0.00309983233751957,0.0135788022334321,0.218178873948034
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0100565679868543,0.0082001595282058,-0.0261288806621376,0.0060157446884291,0.220079408810402
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL19,Interleukin-19,41756,0.00973592110910994,0.00794202958564315,-0.00583045687875063,0.0253022990969705,0.220268343613932
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNPO1,Transportin-1,39757,0.00468632232795046,0.00383853054460251,-0.00283719753947045,0.0122098421953714,0.222163457558452
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFAP2A,Transcription factor AP-2-alpha,39586,0.00785949522790901,0.00644367370615385,-0.00477010523615254,0.0204890956919705,0.222596189365605
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF1,Trefoil factor 1,42084,0.0106134739790049,0.00870344728195661,-0.00644528269363003,0.0276722306516399,0.222692366964019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00392279983519941,0.00323636497275394,-0.00242047551139832,0.0102660751817971,0.225496115315545
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BEX3,Protein BEX3,39560,-0.00606253724586208,0.00506281681300418,-0.0159856581993503,0.00386058370762612,0.231151927611997
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00328536021855501,0.00274434251844038,-0.00866427155469815,0.00209355111758814,0.231277321940923
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.0053001058756198,0.00444267080133822,-0.00340752889500312,0.0140077406462427,0.232894776619149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00457804685473298,0.0038378515771469,-0.0121002359459409,0.00294414223647494,0.232942335861954
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00982782523988747,0.00825021748930314,-0.0259982515189216,0.00634260103914669,0.233592515425048
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.00790924175998626,0.00665444347998905,-0.00513346746079228,0.0209519509807648,0.234631739772452
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOS,Proto-oncogene c-Fos,39539,-0.00464112144942789,0.0039077254985135,-0.0123002634265144,0.00301802052765858,0.234985895879436
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSTL1,Follistatin-related protein 1,39638,0.00298739330095519,0.00251656833055937,-0.00194508062694118,0.00791986722885155,0.235217637351455
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAMDC2,MAM domain-containing protein 2,39958,-0.00456964318788367,0.00385235600854193,-0.0121202609646259,0.00298097458885851,0.235570343282466
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,39560,0.0066763434801789,0.00564131050283594,-0.00438062510537955,0.0177333120657374,0.236647071367434
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.0191903096626914,0.0162534726407924,-0.0126664967132616,0.0510471160386445,0.237746739838865
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANSC4,MANSC domain-containing protein 4,39575,0.00863723594514829,0.0073529763726988,-0.00577459774534135,0.0230490696356379,0.240156868113966
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.0071368893936843,0.00607814865935991,-0.00477628197866112,0.0190500607660297,0.240345232515843
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL6B,Myosin light chain 6B,39649,0.0116061578757644,0.00988680415890596,-0.00777197827569128,0.0309842940272201,0.240458825921903
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00613562470079623,0.00523492423924967,-0.00412482680813313,0.0163960762097256,0.241199216231288
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1R1,Interleukin-1 receptor type 1,42113,-0.00301986574372421,0.00258053138813782,-0.00807770726447433,0.00203797577702591,0.241921188561803
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHPK,Sedoheptulokinase,39757,-0.00505667147837902,0.00432418602861748,-0.0135320760944693,0.00341873313771124,0.242270440507706
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP6,Guanylate-binding protein 6,39575,-0.00565504599060637,0.00483758562414396,-0.0151367138139285,0.00382662183271579,0.242436649751826
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNLZ,DNL-type zinc finger protein,39586,-0.0106850983571235,0.009145941862224,-0.0286111444070826,0.00724094769283552,0.242715779392692
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STEAP4,Metalloreductase STEAP4,39586,0.00920820675991984,0.00788306229644562,-0.00624259534111358,0.0246590088609533,0.242791692359026
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA10,Annexin A10,41839,0.0103426915544361,0.00885792213363251,-0.0070188358274836,0.0277042189363558,0.242980901586995
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKAP12,A-kinase anchor protein 12,39736,-0.00268105240765738,0.00229928158273129,-0.00718764430981071,0.00182553949449595,0.243623577761359
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR2,Toll-like receptor 2,39757,-0.00291182561038998,0.00250409894657243,-0.00781985954567195,0.00199620832489198,0.244925908559837
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.0054696708280507,0.0047316939795803,-0.0147437910280281,0.00380444937192668,0.247720767297903
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL9A1,Collagen alpha-1(IX) chain,42119,-0.00556129834685514,0.00483096552074945,-0.0150299907675241,0.0039073940738138,0.24967961861698
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNN,Tenascin-N,39966,0.00538332212651765,0.00467972789341558,-0.00378894454457689,0.0145555887976122,0.250024197847062
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00576710438909525,0.00501503720359423,-0.00406236852994944,0.01559657730814,0.250184401061164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,39657,-0.00403580123495676,0.00351503375011003,-0.0109252673851724,0.00285366491525891,0.250929696459703
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESPL1,Separin,39560,-0.00663161398386197,0.00577666939484672,-0.0179538859977615,0.0046906580300376,0.250993797460958
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.00266917377422255,0.00232805332823359,-0.00189381074911529,0.00723215829756038,0.251601769640177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP2,Metalloproteinase inhibitor 2,39958,-0.0035367059614274,0.00309031685509262,-0.00959372699740893,0.00252031507455413,0.252462140106523
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADA2,Adenosine deaminase 2,42096,-0.0054138940124156,0.00474564113538928,-0.0147153506377786,0.00388756261294739,0.253967561871785
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.0051498618208619,0.0045161669023202,-0.0037018253076857,0.0140015489494095,0.25417489311655
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,0.00358125785697966,0.00315250429177487,-0.00259765055489909,0.00976016626885841,0.255974951780656
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD2,Bromodomain-containing protein 2,39586,0.00430440091252897,0.00379325764756335,-0.0031303840766952,0.0117391859017531,0.256504640337717
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDHB15,Protocadherin beta-15,39919,-0.00489190823378999,0.00431489763929755,-0.0133491076068132,0.00356529113923321,0.256933842404752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00764872260379521,0.00677134514502925,-0.00562311388046212,0.0209205590880525,0.258681073941067
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLNS1A,Methylosome subunit pICln,39649,0.0040976680540938,0.00363925967940937,-0.00303528091754856,0.0112306170257362,0.26020606582576
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFAP,Glial fibrillary acidic protein,41820,0.00553563389448317,0.00493577628456097,-0.00413848762325633,0.0152097554122227,0.262081603729233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YY1,Transcriptional repressor protein YY1,39657,0.00338313368348142,0.00301674692588185,-0.00252969029124699,0.00929595765820984,0.26212031643725
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.00574094421048683,0.00512577589234936,-0.0157874649594916,0.0043055765385179,0.26273187869587
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00507086227443089,0.00452817712741592,-0.0139460894441661,0.00380436489530432,0.262803619103217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00355869233091635,0.00318385059543266,-0.00268165483613166,0.00979903949796436,0.263701575300817
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.00491536939360809,0.00442119932730922,-0.00375018128791797,0.0135809200751342,0.266259439601928
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSG1,Tryptase gamma,39657,0.00314730564616968,0.00283372757429862,-0.00240680039945561,0.00870141169179498,0.266739215091215
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRRT3,Proline-rich transmembrane protein 3,39638,0.00465366255440496,0.00419019511578478,-0.00355911987253321,0.0128664449813431,0.266761480875129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC1,Sialoadhesin,42185,0.00495468715971536,0.00449911392243019,-0.00386357612824781,0.0137729504476785,0.270803706878661
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL9,Interleukin-9,39757,-0.00668740647004767,0.00607487305893519,-0.0185941576655607,0.00521934472546531,0.270994117761324
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRND,Prion-like protein doppel,39929,0.00581922587767629,0.00529086061768647,-0.0045508609329892,0.0161893126883418,0.271414855113832
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUMF1,Formylglycine-generating enzyme,39657,0.00785259637536164,0.00714561684154191,-0.0061528126340605,0.0218580053847838,0.271818641264077
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HYAL1,Hyaluronidase-1,42077,0.00273836556727154,0.00249611807712729,-0.00215402586389796,0.00763075699844103,0.272639271388486
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCNE1,G1/S-specific cyclin-E1,39657,0.0107625200525708,0.00990736093286877,-0.00865590737585198,0.0301809474809936,0.277363099592878
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.00700578497061462,0.00645756346884288,-0.0196626093695467,0.00565103942831742,0.277991377231173
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPLA2,Acyl-protein thioesterase 2,39586,0.0126734609156539,0.0117648151690074,-0.0103855768156007,0.0357324986469084,0.281399316503308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,0.00797995168888782,0.0074080288205112,-0.00653978479931413,0.0224996881770898,0.28140860905148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00882721249747855,0.00821562315723457,-0.00727540889070121,0.0249298338856583,0.282644014011781
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.0116008122823267,0.0108587333728696,-0.00968230512849767,0.0328839296931512,0.2853902424459
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.00439893146962778,0.00411995286824678,-0.00367617615213591,0.0124740390913915,0.285668569082846
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.0307886610343622,0.028855077143538,-0.0873446122356967,0.0257672901669723,0.285990575846382
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK3,Prostate-specific antigen,39966,0.0132000570989167,0.0123954615604226,-0.0110950475595116,0.037495161757345,0.286939057201596
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPO,Lactoperoxidase,41647,0.00707630511083908,0.00666277127070716,-0.00598272657974695,0.0201353368014251,0.288225226794449
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00758543989605963,0.00715605468410263,-0.0216113070769008,0.00644042728478152,0.289166151552313
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF9,Fibroblast growth factor 9,39539,0.00469826237875584,0.00446036634910974,-0.00404405566549924,0.0134405804230109,0.292210503237878
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCN1,Transcobalamin-1,39806,-0.00403984080432317,0.00385685388829812,-0.0115992744253875,0.00351959281674114,0.294917158699972
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00666026670161477,0.00636283617126135,-0.019131425597287,0.00581089219405748,0.295240101994389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00470966342666222,0.00450647597270747,-0.00412302947984443,0.0135423563331689,0.296004642694308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL24,Interleukin-24,41913,-0.00543677539345387,0.00521958490988027,-0.0156671618168192,0.00479361102991146,0.297611129411405
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00691349249070636,0.00666253721557758,-0.0199720654332384,0.0061450804518257,0.299448127306175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00408386122379074,0.00393896631206775,-0.0118042351954435,0.00363651274786204,0.299854894322874
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS2,"Nitric oxide synthase, inducible",39575,-0.0045187189797963,0.00436151285314407,-0.0130672841719587,0.00402984621236609,0.300204468332192
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGN,Cingulin,39649,0.00418250507135906,0.00405526516758027,-0.00376581465709826,0.0121308247998164,0.302386886116138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00459119769667354,0.00447397115441701,-0.0133601811593309,0.0041777857659838,0.304818875295657
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1D,V-type proton ATPase subunit D,42070,0.00287459467265675,0.00280694208898774,-0.00262701182175922,0.00837620116707273,0.305805547053936
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00798407363545359,0.00782045835547806,-0.0233121720121906,0.00734402474128341,0.307313794728039
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BSND,Barttin,39560,0.00370226331326459,0.00363191241000107,-0.0034162850103375,0.0108208116368667,0.30804974421566
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00334637165647547,0.00329612924650509,-0.00980678497962544,0.0031140416666745,0.310012489442149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WNT9A,Protein Wnt-9a,41913,-0.00319592146126903,0.00315459849983464,-0.00937893452094493,0.00298709159840687,0.311031154989649
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRING1,SREBP regulating gene protein,39560,0.00680155641747959,0.00671911918081832,-0.00636791717692432,0.0199710300118835,0.311431773204561
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRC1,Macrophage mannose receptor 1,39990,0.00309668862910813,0.00307448813724823,-0.00292930811989841,0.00912268537811466,0.313850040571302
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA3G,Semaphorin-3G,39736,0.00495876197906246,0.00492447130022675,-0.00469320176938197,0.0146107257275069,0.31397427929164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6,Interleukin-6,42070,0.0081130225676717,0.00807694569447933,-0.00771779099350779,0.0239438361288512,0.315171782692152
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY2B,Alpha-amylase 2B,41300,-0.0054015689530863,0.00541765439421217,-0.0160201715657422,0.00521703365956955,0.318768496868423
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSAPL1,Proactivator polypeptide-like 1,39930,-0.00539870380003476,0.0054424924406054,-0.0160659889836213,0.00526858138355183,0.321241000762888
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00392219072057753,0.00398933570450564,-0.0117412887014086,0.00389690726025353,0.325545210963928
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00726098080387221,0.007460981094363,-0.00736254214107927,0.0218845037488237,0.330478072748321
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NENF,Neudesin,39919,0.011809282943229,0.0121723840822387,-0.0120485898579589,0.0356671557444169,0.331982447697162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00465355399195937,0.00479941783946776,-0.00475330497339745,0.0140604129573162,0.33225953233125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42040,0.00298735011063395,0.00308196380381929,-0.00305329894485185,0.00902799916611976,0.332412551839604
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00511434777545349,0.00528372312324852,-0.00524174954611361,0.0154704450970206,0.333093697666871
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNC5D,Netrin receptor UNC5D,39657,-0.00272475160506373,0.00282412631731217,-0.00826003918699558,0.00281053597686813,0.334659970513085
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD86,T-lymphocyte activation antigen CD86,39930,0.0031630619021532,0.0032887638038126,-0.00328291515331949,0.0096090389576259,0.336181468831147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PZP,Pregnancy zone protein,39979,0.00341171036538139,0.00359166556443583,-0.00362795414091283,0.0104513748716756,0.342185045294231
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTNNA1,Catenin alpha-1,39586,-0.00347406002600884,0.00366191112627483,-0.0106514058335075,0.00370328578148982,0.342793395711252
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIPK2B,Divergent protein kinase domain 2B,39736,0.00306966548462549,0.00323627942806096,-0.003273442194374,0.00941277316362497,0.342886994903341
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHP1,Calcineurin B homologous protein 1,39586,0.00755620738571585,0.00799202990472687,-0.00810817122754882,0.0232205859989805,0.344440866870191
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00599436537601084,0.00636275803690295,-0.00647664037631894,0.0184653711283406,0.346161321889946
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00360044378780491,0.00382458287796609,-0.00389573865300863,0.0110966262286184,0.346519567569824
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLI2,Zinc finger protein GLI2,39657,-0.0033569958291529,0.0035897591006419,-0.010392923666411,0.00367893200810522,0.3497267441433
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,-0.00259224649885106,0.00277864279537094,-0.0080383863777781,0.00285389338007598,0.350882065622551
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEF,Thyrotroph embryonic factor,39575,0.00432218202644034,0.00463363738753222,-0.00475974725312281,0.0134041113060035,0.350952111734864
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00350174760505647,0.00376199145889049,-0.00387175565436888,0.0108752508644818,0.351965348663605
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DENND2B,DENN domain-containing protein 2B,39575,-0.00493133064111669,0.00530124671280685,-0.0153217741982181,0.00545911291598473,0.352277167796977
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGR,Progesterone receptor,39657,0.0100700599635046,0.010838821877597,-0.0111740309165856,0.0313141508435948,0.352871384208556
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00914259463153309,0.00990700083210392,-0.0102751269993906,0.0285603162624568,0.356109960865221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP4,Caspase-4,39757,-0.0165204677282252,0.0179564202205442,-0.0517150513604919,0.0186741159040415,0.357576320572596
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00743547218963073,0.00809183102713491,-0.00842451662355369,0.0232954610028151,0.358175251518589
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNXB,Tenascin-X,42137,-0.00257502574903832,0.00282818699636565,-0.00811827226191499,0.00296822076383834,0.362582271192612
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALMS1,Alstrom syndrome protein 1,39757,-0.00436610137514156,0.00480417608481064,-0.0137822865013704,0.00505008375108729,0.363468067847159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42248,0.00304941747556687,0.00337255577648924,-0.00356079184635204,0.00965962679748579,0.365912779954935
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GH2,Growth hormone variant,41843,0.0157085535620182,0.0175577224079242,-0.0187045823575132,0.0501216894815496,0.370974113809848
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA2,Ephrin type-A receptor 2,41614,0.00311221003018755,0.00350010252788098,-0.00374799092445917,0.00997241098483427,0.373924494347179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00667498338937673,0.00751806135727235,-0.0214103836496305,0.00806041687087708,0.374635704063444
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00528206760258667,0.00595736335923226,-0.0169584997866819,0.00639436458150856,0.375289407200901
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSLNL,Mesothelin-like protein,39649,-0.00363467613754257,0.0041085633247411,-0.0116874602540351,0.00441810797894999,0.376360007216497
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,39757,0.00383827466267147,0.00435167226114389,-0.00469100296917054,0.0123675522945135,0.377783416100724
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00320294814298148,0.00364992670758515,-0.0103568044898484,0.0039509082038854,0.380210414898261
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00450121321600772,0.00514726155059343,-0.0145898458551708,0.00558741942315539,0.381872114199957
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA10,Ephrin type-A receptor 10,41839,0.00617187813682858,0.0071242670975594,-0.00779168537438784,0.020135441648045,0.386331704239809
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTA2,"Actin, aortic smooth muscle",41900,0.00406397168377685,0.00471554680567417,-0.00517850005534452,0.0133064434228982,0.388799881717955
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42248,0.00390371758378222,0.00453888531660828,-0.00499249763677001,0.0127999328043344,0.389770605367166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUOX2,Dual oxidase 2,41900,0.00651834368142261,0.00759907872145958,-0.00837585061263818,0.0214125379754834,0.391028980854332
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.0053062420092929,0.00618790199427529,-0.0174345299180725,0.00682204589948667,0.39117696075259
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKKL1,Dickkopf-like protein 1,42070,-0.00776350395850087,0.00905859183799321,-0.0255183439609676,0.00999133604396583,0.391442393140445
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,39586,0.0109014721863236,0.0127242571412358,-0.0140380718104986,0.0358410161831458,0.391603276976395
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDA1,DET1- and DDB1-associated protein 1,39575,0.00359729901532735,0.00423708087379916,-0.00470737949731901,0.0119019775279737,0.395897531028095
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASQ2,Calsequestrin-2,39575,0.00433246672697437,0.00514827495093764,-0.00575815217686341,0.0144230856308122,0.400065189529821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRR1B,Cornifin-B,39757,0.00781837452738823,0.00934761871527982,-0.0105029581545602,0.0261397072093367,0.402946247315945
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC123,Cell division cycle protein 123 homolog,39560,0.00567289874017693,0.00679441820533843,-0.00764416094228638,0.0189899584226403,0.403772408588861
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYBB2,Beta-crystallin B2,39929,0.00631756750789629,0.00756967669827449,-0.00851899882072171,0.0211541338365143,0.403966859794878
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.00804238011078239,0.00965859778032863,-0.0269732317602265,0.0108884715386617,0.40505103564579
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERVV_1,,39575,-0.00391452179877524,0.00471499534546826,-0.013155912675893,0.00532686907834255,0.406427868946262
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.00784210537318279,0.00945001685402395,-0.0263641384070697,0.0106799276607042,0.40664098129432
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13,Interleukin-13,41913,-0.00435091437304667,0.00526033004823926,-0.0146611612675956,0.00595933252150228,0.408184931550817
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.0043856800265227,0.0053133992339277,-0.014799942525021,0.0060285824719756,0.409159375521511
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY2A,Pancreatic alpha-amylase,41665,-0.00434889102026652,0.00529059467741568,-0.0147184565880013,0.00602067454746821,0.411089509773687
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDAC8,Histone deacetylase 8,39657,0.00533476893375963,0.00651176729520793,-0.00742829496484791,0.0180978328323672,0.412661137307773
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM132A,Transmembrane protein 132A,39638,0.00556437704358249,0.0067935567047597,-0.00775099409774652,0.0188797481849115,0.412765961360992
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.0026280493411875,0.00321097365458439,-0.00366545902179791,0.00892155770417291,0.413112525346395
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK1,Kallikrein-1,42016,-0.0112640671168553,0.0138228042299126,-0.0383567634074839,0.0158286291737733,0.415149652560384
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL31,Interleukin-31,39657,-0.00489856970914772,0.00601295654558166,-0.0166839645384878,0.00688682512019234,0.415279308880924
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.00290214614612711,0.00357049698883962,-0.00990032024425277,0.00409602795199855,0.416342692894857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00585605207078561,0.00726105558473063,-0.0200877210168576,0.00837561687528642,0.419971230926967
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMMR,Hyaluronan mediated motility receptor,39541,0.00421296313104596,0.00523319297568386,-0.00604409510129441,0.0144700213633863,0.420810402246032
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD160,CD160 antigen,42296,0.00419942429165246,0.00524017304244179,-0.00607131487153345,0.0144701634548384,0.422919582431003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARG2,"Arginase-2, mitochondrial",39919,-0.00365811624650818,0.00456707429662598,-0.0126095818678951,0.00529334937487874,0.423162435422774
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRC1,Protein regulator of cytokinesis 1,39919,0.00381490666531204,0.00477636089578919,-0.00554676069043476,0.0131765740210588,0.424477839749109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00398874131745848,0.00505079495085706,-0.00591081678622136,0.0138882994211383,0.429701843617404
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.00438499038310085,0.00555576295963851,-0.0152742857839923,0.00650430501779063,0.429968712703972
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC7A,C-type lectin domain family 7 member A,42296,-0.00507302866291008,0.00643488080541714,-0.0176853950415277,0.00753933771570752,0.430497440260778
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0046645915654645,0.00594575808697997,-0.0163182774159452,0.00698909428501624,0.43274945820723
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20,Interleukin-20,41913,-0.00395787435454819,0.00505016373016091,-0.0138561952656636,0.0059404465565672,0.433223011305383
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAND5,DAN domain family member 5,39657,-0.00463391930728725,0.00591474916232564,-0.0162268276654455,0.00695898905087101,0.433378784320965
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN15,Tetraspanin-15,39575,-0.0042622160644874,0.00544108897195897,-0.014926750449527,0.00640231832055218,0.433445092156131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C8B,Complement component C8 beta chain,39979,0.00256165929879971,0.00327190286385079,-0.00385127031434783,0.00897458891194725,0.433686596674163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN7,Septin-7,39757,-0.00450032513213832,0.00575652712000996,-0.0157831182873578,0.00678246802308119,0.434361757038148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00229640941788291,0.00294630155065413,-0.00807116045716501,0.00347834162139919,0.435745279561333
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCARE,Photoreceptor cilium actin regulator,39586,-0.00700419907142796,0.00901408360364673,-0.0246718029345756,0.0106634047917196,0.437158737940484
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPEP,Glutamyl aminopeptidase,39575,0.00355867973633698,0.00459129363175113,-0.00544025578189523,0.0125576152545692,0.438301383424704
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF20,Fibroblast growth factor 20,39657,-0.00361452206879602,0.00466784511445147,-0.0127634984931209,0.00553445435552886,0.438743413824241
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA3,GDNF family receptor alpha-3,41989,0.0023245784936746,0.00300868513206642,-0.0035724443651756,0.00822160135252479,0.439759331923817
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00417785835770998,0.00542155284761582,-0.00644838522361703,0.014804101939037,0.440959568008126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSMB,Beta-microseminoprotein,42103,-0.00579718344935305,0.00755502448071967,-0.0206050314315636,0.0090106645328575,0.442899813418679
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAYN,Layilin,41997,-0.00296042831052165,0.00387177255344497,-0.0105491025152738,0.00462824589423049,0.444512311310215
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTTG1,Securin,39757,0.00343256741140497,0.00450247632329439,-0.00539228618225203,0.012257421005062,0.445853396276259
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00256044948545487,0.00337705674528047,-0.00405858173529485,0.0091794807062046,0.448353756345049
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FZD10,Frizzled-10,39649,0.00488387994879869,0.006463030460881,-0.00778365975452807,0.0175514196521254,0.449866736015524
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,-0.0021441932583154,0.00284419609372791,-0.0077188176020221,0.0034304310853913,0.450935193525574
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00514645935390213,0.00685097436365311,-0.00828145039885797,0.0185743691066622,0.452547493228667
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYTH3,Cytohesin-3,39560,0.00590243154809092,0.00791199221971824,-0.00960507320255683,0.0214099362987387,0.455676898267692
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RUVBL1,RuvB-like 1,41843,0.00798922060558476,0.0107199566387445,-0.0130218944063545,0.029000335617524,0.456124078113455
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAEP,Glycodelin,42016,-0.008356155959557,0.0113286860313286,-0.030560380580961,0.013848068661847,0.460764170338743
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00406114850067739,0.00551802848301704,-0.00675418732603602,0.0148764843273908,0.461757022740503
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42119,0.00524950432090646,0.00714769177018328,-0.00875997154865277,0.0192589801904657,0.462697310772699
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY96,Lymphocyte antigen 96,42016,-0.00289536638816542,0.00395384050591581,-0.0106448937797604,0.00485416100342956,0.464003058430518
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALLD,Palladin,39657,-0.00301120832676226,0.00412378665371948,-0.0110938301680524,0.00507141351452793,0.46528055058671
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,39966,-0.00172366493908952,0.00238133422301928,-0.00639108001620732,0.00294375013802827,0.4691891858297
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00605186673326377,0.00836494384719614,-0.0103434232072407,0.0224471566737682,0.469400561461857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00543692596956193,0.00757009741495043,-0.00940046496374091,0.0202743169028648,0.47264248540779
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN7,Tetraspanin-7,39586,-0.00755705586101614,0.0105640898758144,-0.0282626720176124,0.0131485602955801,0.474406004121768
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4C,C-type lectin domain family 4 member C,42119,0.00375436128336809,0.00525363452151455,-0.00654276237880043,0.0140514849455366,0.474855165482767
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.00374153789864875,0.00523677694294637,-0.0140056207068236,0.00652254490952614,0.474949706777115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42185,0.00221422849433523,0.00310612849811604,-0.00387378336197222,0.00830224035064268,0.475945885717387
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLK,STE20-like serine/threonine-protein kinase,39757,-0.00604585736255255,0.00854569683347825,-0.0227954231561699,0.0107037084310648,0.47928681144138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17F,Interleukin-17F,41913,-0.00560995426793998,0.00794407242740003,-0.021180336225644,0.00996042768976408,0.48008784378292
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHC1,SHC-transforming protein 1,39560,-0.00890805035524847,0.0126632232288969,-0.0337279678838864,0.0159118671733894,0.481785085603926
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSD1,Tryptase delta,39934,0.00273668005505697,0.00395684862894693,-0.00501874325767901,0.010492103367793,0.489183115532662
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.00269273417191609,0.0039022151536326,-0.010341075873036,0.00495560752920381,0.490172865346345
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00316954196038112,0.00461020518816723,-0.0122055441291889,0.00586646020842665,0.491778690780817
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.00195627368276955,0.00285586378879386,-0.00364121934326642,0.00755376670880552,0.49335631627248
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00269843361612323,0.00396169902396548,-0.0104633637030956,0.00506649647084911,0.495803261253646
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIFR,Leukemia inhibitory factor receptor,42119,-0.00176294823860884,0.00260147233440978,-0.006861834014052,0.00333593753683432,0.497990481429731
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLB1,"Phospholipase B1, membrane-associated",39929,0.00434513776926817,0.00642156545886267,-0.00824113053010266,0.016931406068639,0.498643294644763
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCB,Calcitonin gene-related peptide 2,39929,0.0029435656226996,0.0043968423022399,-0.00567424528969061,0.0115613765350898,0.503207671380383
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00384649245383631,0.00580956564003725,-0.0152332411083093,0.0075402562006367,0.507923335311847
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRISP2,Cysteine-rich secretory protein 2,42262,-0.00378347350877229,0.00574417305650702,-0.015042052699526,0.00747510568198146,0.51012338116354
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42145,-0.00192231884571954,0.00292198172386733,-0.0076494030244995,0.00380476533306043,0.510625211608193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.00244532414053159,0.00373324265786625,-0.00976247974994944,0.00487183146888627,0.512472811814222
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MN1,Transcriptional activator MN1,39649,-0.00417832670147484,0.00638194329314806,-0.016686935556045,0.00833028215309536,0.512667649041534
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.00212971593487223,0.00325987842514414,-0.00425964577841029,0.00851907764815476,0.513568729979465
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRN1,Neuritin,39934,0.00245040170646678,0.00376314612732931,-0.00492536470309866,0.00982616811603222,0.514957871959392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00481025896761814,0.00738730982153152,-0.0192893862178199,0.00966886828258364,0.514962250540718
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.00483151727433435,0.00744487307621132,-0.00976043395503984,0.0194234685037085,0.516367269312836
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHH,Sonic hedgehog protein,39657,-0.00298555338709108,0.00461398692302177,-0.0120289677562137,0.00605786098203159,0.517602756159961
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00435424813081683,0.00675032935671377,-0.00887639740834216,0.0175848936699758,0.518911087919103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,-0.00320557181384776,0.00497405604845137,-0.0129547216688124,0.00654357804111694,0.519291318079016
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMP,Olfactory marker protein,39586,-0.00332360801325643,0.00519213929272364,-0.0135002010269948,0.00685298500048189,0.522105957528737
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRK1,Protein BRICK1,41839,0.00314952416846304,0.00492138532484914,-0.00649639106824128,0.0127954394051674,0.522205132703434
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBQ1,Hemoglobin subunit theta-1,42262,-0.00424955751472892,0.00665049389271175,-0.017284525544444,0.00878541051498611,0.522844216748432
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCLRE1C,Protein artemis,39560,-0.00210024035559126,0.00329528581483996,-0.00855900055267758,0.00435851984149505,0.523912190114082
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KHDC3L,KH domain-containing protein 3,39560,-0.00462147606932137,0.00726347904286441,-0.0188578949933356,0.00961494285469287,0.524618922122044
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.00236372717469394,0.00372117070997511,-0.00965722176624517,0.00492976741685728,0.52530429691677
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMI,N-myc-interactor,39875,-0.0050134580551058,0.00789413576849953,-0.0204859641613649,0.0104590480511533,0.525384971377017
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNIP4,Kv channel-interacting protein 4,41839,0.00349964170282606,0.00551820861934842,-0.00731604719109684,0.0143153305967489,0.525961998833556
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAT1,Diamine acetyltransferase 1,39575,-0.00331741562499415,0.00523343339402165,-0.0135749450772766,0.00694011382728828,0.526166504723181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENG,Endoglin,42310,0.00118029004541983,0.0018689749582714,-0.00248290087279211,0.00484348096363177,0.527712860952505
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF8,SLAM family member 8,41843,0.00367227151427518,0.00583442419791186,-0.00776319991363207,0.0151077429421824,0.529088548762854
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAPPA,Pappalysin-1,41913,0.00319813809251315,0.00513483922440681,-0.0068661467873242,0.0132624229723505,0.533406119395771
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,0.00988295306475937,0.0158817917427809,-0.0212453587510912,0.0410112648806099,0.533769402959879
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTN4,Alpha-actinin-4,41913,0.00211871221039807,0.0034147630351,-0.00457422333839794,0.00881164775919407,0.534967849494409
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP10,Bone morphogenetic protein 10,39736,0.00187362672808408,0.00305890535993252,-0.00412182777738367,0.00786908123355183,0.540209300126859
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.00167075089370033,0.00275048726075999,-0.00706170592478991,0.00372020413738924,0.543572761550536
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_A,,39934,0.00214493405215989,0.00355146944504936,-0.00481594606013687,0.00910581416445664,0.545884464627119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC39A14,Zinc transporter ZIP14,41839,-0.00220610209412178,0.00365507164400756,-0.0093700425163766,0.00495783832813304,0.546137993197351
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.00212470597867275,0.00354149460329022,-0.00481662344377608,0.00906603540112159,0.548552186280236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.0018459609129377,0.00308468737160475,-0.00789194816128302,0.00420002633540761,0.549566802102741
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSTN,Osteocrin,39649,0.00261304782523697,0.004383954887408,-0.0059795037540827,0.0112055994045566,0.55115532785242
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00320778648937309,0.0053860074040836,-0.0137643610013769,0.00734878802263077,0.551469585730988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.00312504919790601,0.00526671196496532,-0.013447804649238,0.00719770625342602,0.552951026035897
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN2,Contactin-2,42262,0.00279477765089195,0.00476117898060145,-0.00653713315108689,0.0121266884528708,0.557218260281947
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00217615818681329,0.00371450041689483,-0.00510426263030056,0.00945657900392715,0.557984999649654
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00205415714903784,0.00351098883926299,-0.0089356952739933,0.00482738097591763,0.558515938816505
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,42223,0.00402291074320587,0.006890257344913,-0.0094819936528236,0.0175278151392353,0.559327582452555
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00298728687034561,0.0051260543341226,-0.0130343533652259,0.00705977962453469,0.560063243666305
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISM2,Isthmin-2,39966,0.00273730129181769,0.00469903731010957,-0.00647281183599708,0.0119474144196325,0.560225438768234
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN5,Contactin-5,42170,0.00232171170296411,0.00400475602905182,-0.00552761011397746,0.0101710335199057,0.562100525120392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR3,Folate receptor gamma,42132,-0.0120126039009614,0.0207678596347897,-0.0527176087851492,0.0286924009832264,0.56298831808099
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSLP,Thymic stromal lymphopoietin,41900,0.00372173042928213,0.006511325719815,-0.00904046798155527,0.0164839288401195,0.567617573052498
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN3B,Sodium channel subunit beta-3,39586,-0.00287767592550161,0.00504471211353533,-0.0127653116680308,0.00700995981702763,0.568394957953615
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBR1,T-box brain protein 1,39649,0.00293767339807135,0.00519799786390315,-0.00725040241517883,0.0131257492113215,0.57197995806175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00328375737932588,0.00583682088339768,-0.0147239263107853,0.00815641155213357,0.573723238794762
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00347062834278503,0.00617570495486355,-0.0155750100543176,0.00863375336874754,0.574140411280062
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COPE,Coatomer subunit epsilon,41839,0.00281561650518206,0.00502656072875787,-0.00703644252318335,0.0126676755335475,0.57538816466998
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00456786349290306,0.00821995769082851,-0.0115432535811208,0.0206789805669269,0.578424527427758
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00362414790829912,0.00656026725591141,-0.00923397591328724,0.0164822717298855,0.580658811024923
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYB5A,Cytochrome b5,39560,0.0042431375550932,0.0077056055189307,-0.010859849262011,0.0193461243721974,0.581880767478246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC1A4,Neutral amino acid transporter A,39649,0.00302621361771814,0.00550473241087532,-0.00776306190759749,0.0138154891430338,0.582503591941339
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASA1,Ras GTPase-activating protein 1,41839,0.00193171507318822,0.0035319393611928,-0.00499088607474967,0.00885431622112611,0.584437700119405
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF174,Zinc finger protein 174,39657,0.00215919447969843,0.00397732799801153,-0.00563636839640416,0.00995475735580102,0.58722637216086
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PADI2,Protein-arginine deiminase type-2,41913,0.00334939495518453,0.00617211744475625,-0.00874795523653771,0.0154467451469068,0.587369243468977
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPK3A,Uroplakin-3a,39586,-0.00283688348999299,0.00524562776210909,-0.0131183139037268,0.00744454692374081,0.588650100109908
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL33,Interleukin-33,41913,0.00230907928373737,0.00426986825423438,-0.00605986249456201,0.0106780210620368,0.588665059794117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC25A,M-phase inducer phosphatase 1,39560,-0.00234343187333316,0.00433576732210572,-0.0108415358246604,0.00615467207799405,0.588871252643381
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MLLT1,Protein ENL,39560,-0.00387163041611348,0.00718175882676121,-0.0179478777165655,0.0102046168843385,0.589834163414656
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERCC1,DNA excision repair protein ERCC-1,39560,0.00192545196443765,0.00361797977000505,-0.00516578838477226,0.00901669231364755,0.594605327958283
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00152606643616387,0.00288682380971936,-0.00413210823088607,0.00718424110321381,0.597071703874637
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACAN,Aggrecan core protein,41994,0.00156261736544942,0.00295846932513274,-0.00423598251181075,0.00736121724270958,0.597380101606821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDF15,Growth/differentiation factor 15,42310,0.00260616377834502,0.00495042418609019,-0.00709666762639176,0.0123089951830818,0.598582280495521
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.0023187907456463,0.00441169028469757,-0.00632812221236093,0.0109657037036535,0.599175699340095
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.00361674927586001,0.00694872703265123,-0.0100027557081364,0.0172362542598564,0.602731973824847
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA2,Protein disulfide-isomerase A2,39560,0.00221755628265627,0.00432600977126478,-0.00626142286902271,0.0106965354343352,0.608234420116408
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTN3,Myeloblastin,41800,-0.00263542928728171,0.00520958024582798,-0.0128462065691046,0.00757534799454114,0.612948420222651
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC2L,C-type lectin domain family 2 member L,39649,0.00279813332427636,0.00554829307955664,-0.00807652111165466,0.0136727877602074,0.61404428231404
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00238593990324705,0.00473937362105301,-0.0116751122005109,0.00690323239401685,0.614672209766885
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00301271252804597,0.0059940152155382,-0.0147609823505008,0.0087355572944089,0.615241479590553
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00351553258932402,0.00703865529449762,-0.0102802317878913,0.0173112969665394,0.617464779396415
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00182654599544166,0.00367654673783621,-0.00537948561071732,0.00903257760160063,0.619332523032481
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORN4,MORN repeat-containing protein 4,39560,0.00420836320098742,0.00847190020093652,-0.0123965611928482,0.020813287594823,0.619379752303694
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.00190074004124854,0.00382777069765888,-0.00940317060865994,0.00560169052616287,0.619505216690825
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00257109093225625,0.00519159322677348,-0.00760443179221977,0.0127466136567323,0.620439614665301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH4,Cadherin-4,39586,0.00249161455481613,0.00503752038250527,-0.0073819253948942,0.0123651545045265,0.620884407716316
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.00413059070664613,0.00835188133079893,-0.0122390967017198,0.020500278115012,0.620913532134842
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.0092075587726016,0.0186322197695134,-0.0273115919756447,0.0457267095208479,0.621192873045999
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF75D,Zinc finger protein 75D,39757,-0.0032509116347275,0.00661762670673605,-0.0162214599799302,0.00971963671047515,0.623259033207971
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDSN,Corneodesmosin,42246,0.00232381460189943,0.00473713461724063,-0.0069609692478922,0.0116085984516911,0.623750671768998
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXDC1,Plexin domain-containing protein 1,41843,-0.00169401371944859,0.00348893928308754,-0.00853233471430017,0.00514430727540299,0.627302569391176
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PODXL2,Podocalyxin-like protein 2,42181,-0.00149263294903604,0.00309066566221166,-0.0075503376469709,0.00456507174889882,0.629139949772811
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRNN,Cornulin,41749,-0.00348938325546294,0.00728929981457776,-0.0177764108920353,0.0107976443811095,0.632160471078634
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00232864929991065,0.00488464035692068,-0.00724524579965389,0.0119025443994752,0.633564590752972
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10,Interleukin-10,41913,0.00393910571138933,0.00832481265797158,-0.012377527098235,0.0202557385210136,0.636095020566984
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGLON5,IgLON family member 5,39560,-0.00471350808844094,0.0100289720807556,-0.024370293366722,0.0149432771898401,0.638372118695353
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00131855681767319,0.00281911438435411,-0.00684402101100725,0.00420690737566087,0.639993642354748
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTNAP4,Contactin-associated protein-like 4,39649,0.00533810348845161,0.0114353707198096,-0.0170752231223752,0.0277514300992784,0.640647647607435
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00355833322800694,0.00767762823318721,-0.0186064845650539,0.01148981810904,0.643038294038796
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMP,Cartilage oligomeric matrix protein,42042,0.0016589264499554,0.00360390207127771,-0.00540472160974891,0.00872257450965971,0.645298325084724
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00312878951221901,0.0068009857252048,-0.0102011425091824,0.0164587215336204,0.645489864572138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00213868966634659,0.00465073510656794,-0.0112541304752197,0.00697675114252656,0.645623703787034
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00273035310567014,0.00595988080275832,-0.00895101326773617,0.0144117194790764,0.6468737837713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCP11,T-complex protein 11 homolog,39757,-0.00285917672507207,0.00625763504774374,-0.0151241414186498,0.00940578796850566,0.647744551556003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LHB,Lutropin subunit beta,41843,-0.00434999161262395,0.00958367507907828,-0.0231339947676174,0.0144340115423695,0.649911133679685
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.00370200423505017,0.00818707318834033,-0.0197486676841972,0.0123446592140969,0.651150313363424
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,0.00146517828571383,0.00324771174062556,-0.00490033672591227,0.00783069329733992,0.65189603604363
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAM1,Neural cell adhesion molecule 1,42217,0.00159114305579236,0.00353913959475689,-0.00534557054993114,0.00852785666151586,0.653017069421053
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00217491949351627,0.00492247989390442,-0.0118229800855689,0.0074731410985364,0.658617904857711
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCL2,Phosducin-like protein 2,39560,-0.00249159422061365,0.00565221640601204,-0.0135699383763973,0.00858674993516995,0.659354033703262
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.00659371234963324,0.0150068300342941,-0.0360070992168496,0.0228196745175832,0.66039402003351
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.00193691949578764,0.00440984961257166,-0.00670638574485281,0.0105802247364281,0.660504892133865
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.0020256719070307,0.00461734244444278,-0.0110756630981386,0.00702431928407715,0.660880628124665
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPBGL,Trophoblast glycoprotein-like,39649,-0.00192148252997322,0.00440369924100137,-0.0105527330423359,0.00670976798238946,0.662603135860262
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCNA,Proliferating cell nuclear antigen,39560,0.00303353352766365,0.00697895881834522,-0.010645225756293,0.0167122928116203,0.66381162710615
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAGE2A,G antigen 2A,39560,-0.00304109811701587,0.0070744084058955,-0.016906938592571,0.0108247423585393,0.667296380247577
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF830,Zinc finger protein 830,39919,0.00359214300524547,0.00840561980695199,-0.0128828718163804,0.0200671578268714,0.669132429181229
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESR1,Estrogen receptor,39657,0.00263116052640258,0.0061816478085352,-0.00948486917832641,0.0147471902311316,0.670378006790939
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00341413755269511,0.0080848745842442,-0.0192604917378137,0.0124322166324235,0.672823807249721
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MELTF,Melanotransferrin,39958,0.00136747014095233,0.00325763602252204,-0.00501749646319086,0.00775243674509552,0.674658671121172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.00169954565423194,0.00405786722507566,-0.00965296541538023,0.00625387410691636,0.67534899081336
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHGB,Secretogranin-1,42210,0.00190447620906376,0.00457128684728245,-0.00705524601160983,0.0108641984297374,0.676965079432399
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PITHD1,PITH domain-containing protein 1,39539,-0.00347664181606214,0.00836003308072966,-0.0198623066542923,0.012909023022168,0.677517242171419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,39919,0.00241695562792894,0.00581741051008871,-0.00898516897184493,0.0138190802277028,0.6778062405624
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RG,Cytokine receptor common subunit gamma,39919,0.00159677270591048,0.00385287507242973,-0.00595486243605179,0.00914840784787276,0.678562193374544
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCUN1D1,DCN1-like protein 1,39586,-0.00338289703684412,0.00816417413794645,-0.0193846783472192,0.0126188842735309,0.678619479584579
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00284454879865369,0.00687347920481088,-0.0106274704427756,0.016316568040083,0.678996384294474
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00213007575589123,0.00521813785291034,-0.00809747443581303,0.0123576259475955,0.683130336906531
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPT,Microtubule-associated protein tau,41839,0.0023162865140993,0.0057249418156865,-0.00890459944464625,0.0135371724728448,0.685781298193044
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDAC9,Histone deacetylase 9,39586,0.00291895059833454,0.00722470724767673,-0.0112414756071119,0.0170793768037809,0.686203395377431
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00232700949321422,0.00581801827484615,-0.00907630632548423,0.0137303253119127,0.68918921686805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00157521735562972,0.00397732767157917,-0.00937077959192489,0.00622034488066545,0.692076396653852
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAP1,Antigen peptide transporter 1,39757,0.00246208194029229,0.00631211840966785,-0.0099096701426567,0.0148338340232413,0.696502316575097
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN6,Prefoldin subunit 6,39649,0.00273138248618769,0.00702646952691598,-0.0110404977865676,0.016503262758943,0.697485169233978
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,-0.00210553427575574,0.00549448274520317,-0.0128747204563539,0.00866365190484247,0.701572357349228
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CADPS,Calcium-dependent secretion activator 1,39649,-0.00165686083765725,0.00442009370417634,-0.0103202444978429,0.00700652282252838,0.707781119990096
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA5,Annexin A5,41780,0.00122983441882193,0.00329331444772694,-0.00522506189872287,0.00768473073636673,0.708831728471294
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00146399061869594,0.00392403967654504,-0.00622712714733233,0.00915510838472421,0.709094183529118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00199637099254117,0.00537539199540629,-0.00853939731845515,0.0125321393035375,0.710353665559857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVPL,Envoplakin,39757,-0.0013315399196048,0.00361275277059368,-0.00841253534996842,0.00574945551075881,0.712457805500307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL5A1,Collagen alpha-1(V) chain,39736,0.0016316893224785,0.00443899826542736,-0.00706874727775913,0.0103321259227161,0.713193022377892
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1,Integrin beta-1,42167,-0.000835062854348167,0.00228093845081379,-0.0053057022179432,0.00363557650924687,0.714292473468217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.00145299614977148,0.00397521972530292,-0.0092444268113652,0.00633843451182225,0.714735189315332
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00267835250214024,0.00738395818886612,-0.0171509105523178,0.0117942055480374,0.716816559275804
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA11,Carbonic anhydrase-related protein 11,41843,-0.00119288728426672,0.00330574441946871,-0.00767214634642539,0.00528637177789196,0.718215210461284
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00157752375797768,0.00438334395833141,-0.00701383040035188,0.0101688779163072,0.718935915561862
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLN1,Cerebellin-1,39586,-0.00359134894300566,0.0100330474537389,-0.0232561219523338,0.0160734240663225,0.720386146254019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00132035089630848,0.00370275517547824,-0.00857775104024584,0.00593704924762888,0.721407296647072
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NLGN1,Neuroligin-1,39649,-0.00259315667236732,0.00727834120779854,-0.0168587054396525,0.0116723920949178,0.721634677311664
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF6,Fibroblast growth factor 6,39657,0.00150245106554124,0.00422598843800736,-0.00678048627295319,0.00978538840403568,0.722201944603934
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00235992713896606,0.00665352351429953,-0.010680978949061,0.0154008332269931,0.722829702952866
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAGEA3,Melanoma-associated antigen 3,39757,0.00320732561287786,0.00932279862720897,-0.0150653596964517,0.0214800109222074,0.730829950048838
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPT2,Angiopoietin-2,42262,-0.00138919419295337,0.00403893228626465,-0.00930550147403209,0.00652711308812536,0.730888542725283
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL11,Interleukin-11,41913,-0.00221400569618958,0.00659451664212235,-0.0151392583147494,0.0107112469223702,0.737076497966199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH22,Cadherin-22,39757,0.00097487693324189,0.00298240369705886,-0.00487063431299348,0.00682038817947726,0.743767617718016
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTF,Ciliary neurotrophic factor,39586,-0.00120957329962053,0.00374171584326457,-0.00854333635241909,0.00612418975317802,0.746499187447931
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00162916337012032,0.00504371725489181,-0.00825652244946763,0.0115148491897083,0.746694984606219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00137386699735723,0.004263389241548,-0.00973010991079131,0.00698237591607685,0.747271156046198
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTN,Neuroplastin,41843,0.002697861478506,0.00848242048225394,-0.0139276826667117,0.0193234056237237,0.750449552937271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,0.00201117393798203,0.0063703164023897,-0.0104746462107018,0.0144969940866658,0.752228472404237
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD33,Myeloid cell surface antigen CD33,42181,0.00267984241710609,0.00859552939358521,-0.0141673951943209,0.0195270800285331,0.755218853640275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CORO6,Coronin-6,39586,-0.00130041855333229,0.00422802556032223,-0.00958734865156386,0.00698651154489928,0.75841452945852
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD2,T-cell surface antigen CD2,39575,-0.00129457436577654,0.00421046955787594,-0.00954709469921339,0.0069579459676603,0.758494870063005
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZPR1,Zinc finger protein ZPR1,39586,-0.00320774526032494,0.0104351042364252,-0.0236605495637182,0.0172450590430684,0.75854517671647
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB5,Integrin beta-5,42181,0.0012765239055528,0.00415686340195553,-0.00687092836228005,0.00942397617338565,0.758780909747346
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00161518761699281,0.00535434030265136,-0.00887931937620386,0.0121096946101895,0.762917360767032
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM2,Intercellular adhesion molecule 2,42310,-0.00106210021133763,0.00354106655798091,-0.00800259066498021,0.00587839024230496,0.76422904059576
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PI16,Peptidase inhibitor 16,39990,-0.00078133948430276,0.00261214360587488,-0.00590114095181752,0.004338461983212,0.76485537851862
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00173579763021423,0.00582889074667937,-0.0131604234937058,0.00968882823327733,0.765867473690187
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHAD,Chondroadherin,39736,0.00148409470412477,0.00507408455524611,-0.0084611110241576,0.0114293004324071,0.769921112889895
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCLN,Nicalin,41913,0.00162130775986399,0.00554335986254229,-0.00924367757071889,0.0124862930904469,0.769926156286077
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNB2,Ephrin-B2,39649,-0.00182242783719647,0.00626818410843402,-0.0141080686897272,0.0104632130153342,0.771253682647043
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL4,Early placenta insulin-like peptide,39919,0.00150508243142728,0.00521305881298262,-0.00871251284201866,0.0117226777048732,0.772805627825325
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00209188501427582,0.0073825189573334,-0.0165616221706493,0.0123778521420976,0.776908885707358
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTLA,B- and T-lymphocyte attenuator,39560,0.00262454664923912,0.00927492686407468,-0.0155543100043473,0.0208034033028255,0.777203476003717
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00244775445419326,0.00866236252025353,-0.0194259849938902,0.0145304760855037,0.777509006767001
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00147604377992986,0.00523363696900562,-0.00878188467932116,0.0117339722391809,0.777925656929365
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXK,Tyrosine-protein kinase TXK,39757,-0.00220900308520219,0.00792247906047534,-0.0177370620437339,0.0133190558733295,0.780382565225317
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMOD2,Leiomodin-2,39586,0.00184771618726647,0.00665856544912203,-0.0112030720930127,0.0148985044675456,0.781405546363404
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEFL,Neurofilament light polypeptide,41797,0.00140146470173994,0.00512794466691695,-0.00864930684541729,0.0114522362488972,0.784627278067934
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSLN,Mesothelin,42048,0.00171390645051248,0.00628591732673472,-0.0106064915098876,0.0140343044109125,0.785120210907313
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,41839,-0.00159626393711053,0.00585916645978804,-0.0130802301982951,0.00988770232407404,0.78528893616063
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PXDNL,Peroxidasin-like protein,39919,-0.00168797800711706,0.00619688872938929,-0.0138338799167201,0.0104579239024859,0.78532620076032
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRP15,RRP15-like protein,39586,0.00264445855766188,0.00987510442044525,-0.0167107461064108,0.0219996632217346,0.788865657164097
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.00084463959359428,0.00321538747887313,-0.00545751986499705,0.00714679905218561,0.792796072008373
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPT1,Translationally-controlled tumor protein,41913,-0.00180255079565491,0.00693508575676857,-0.0153953188789213,0.0117902172876115,0.794931359821374
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6,Seizure protein 6 homolog,39649,-0.000880118407195575,0.00339285920846027,-0.00753012245577771,0.00576988564138656,0.795329022993204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHD,SH2 domain-containing adapter protein D,39554,0.00228881846281449,0.00892315072256482,-0.0152005569534126,0.0197781938790415,0.797566975611292
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,0.000660440190117185,0.0026136364829009,-0.00446228731636858,0.00578316769660295,0.800512243937025
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCN15,Lipocalin-15,39934,0.00165776477411814,0.00656282619990403,-0.0112053745776938,0.01452090412593,0.800582514104126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.00461068086422271,0.0182878599781912,-0.031233524693032,0.0404548864214775,0.800954495533905
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL25,Interleukin-25,39510,-0.000931695555988888,0.00371971200458156,-0.00822233108496874,0.00635893997299096,0.802224608445729
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB116,Beta-defensin 116,39586,0.00203035077738523,0.00813024163419368,-0.0139049228256344,0.0179656243804048,0.802802201641817
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RLN1,Prorelaxin H1,39934,0.00115257345132435,0.00479565664542086,-0.00824691357370053,0.0105520604763492,0.810073405491132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00170697011974211,0.00710889434255722,-0.0156404030311543,0.01222646279167,0.810243559485873
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JUN,Transcription factor AP-1,41913,0.0012246452321653,0.00522603896943963,-0.00901839114793637,0.011467681612267,0.814728313204547
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",42094,0.00170280820231693,0.00734841933132892,-0.0127000936870878,0.0161057100917216,0.816755577372604
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.000868811499697042,0.00375656784401897,-0.00649406147458014,0.00823168447397423,0.817102390735604
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.00105198839651581,0.00456358130851085,-0.00789263096816546,0.00999660776119708,0.817693375114415
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL21R,Interleukin-21 receptor,39657,-0.00134430317108809,0.00585583654713259,-0.012821742803468,0.0101331364612918,0.8184329838742
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPGN,Epigen,39919,-0.00112830659930618,0.0050153589700947,-0.0109584101806918,0.00870179698207944,0.822006473317636
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00144130180590164,0.00642234326127707,-0.0111464909862014,0.0140290945980047,0.822434617303813
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6L,Seizure 6-like protein,42181,0.000661731946613029,0.00297744416039052,-0.0051740586077524,0.00649752250097846,0.824123926719761
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.00109496823101708,0.00494671853928072,-0.00860060010597314,0.0107905365680073,0.824821347167298
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLHL41,Kelch-like protein 41,39934,-0.00123506620003193,0.00567597238973084,-0.0123599720839044,0.00988983968384052,0.827748187367428
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.00389843479567384,0.0179785700844223,-0.0391364321611415,0.0313395625697938,0.82833860419545
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.00116954204462754,0.00546573605974613,-0.0118823847217299,0.00954330063247487,0.830568933934495
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.000932496937831744,0.00436193920473411,-0.00761690390344711,0.0094818977791106,0.830722307799057
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IKZF2,Zinc finger protein Helios,41843,0.00200313301558394,0.00962853031649506,-0.0168687864047464,0.0208750524359143,0.835199833977603
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO1,Alpha-enolase,42119,-0.00176678313330221,0.0085067754406958,-0.018440062997066,0.0149064967304616,0.835473150285218
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-0.000920838633564549,0.00447809409219744,-0.00969790305427154,0.00785622578714244,0.837082330768066
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIPK1C,Divergent protein kinase domain 1C,39649,0.000895955210732612,0.00455253367989804,-0.00802701080186755,0.00981892122333277,0.843984820320841
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53BP1,TP53-binding protein 1,39657,-0.00178586208474806,0.00930063738396548,-0.0200151113573204,0.0164433871878243,0.847733965191543
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,0.00162805173058478,0.00848439020268797,-0.0150013530666836,0.0182574565278532,0.847832965878633
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00058235757345586,0.00306379955571091,-0.00542268955573752,0.00658740470264924,0.849251706353411
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP2BP,LRP2-binding protein,39649,0.00147576350034617,0.00841913162977484,-0.0150257344940125,0.0179772614947048,0.860857415157283
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORF4L2,Mortality factor 4-like protein 2,39560,-0.000716286133058524,0.00408804857474232,-0.00872886133955346,0.00729628907343642,0.860914184519297
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,0.000856829398059301,0.00490668497300731,-0.00876027314903502,0.0104739319451536,0.861377595627044
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABO,Histo-blood group ABO system transferase,39990,-0.00272964698044794,0.0156851433033412,-0.0334725278549967,0.0280132338941008,0.861846907617665
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMCN2,Hemicentin-2,39721,-0.00105650442928873,0.00627565549308451,-0.0133567891957344,0.0112437803371569,0.86631127464724
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.00213093878929096,0.0128517945182856,-0.0230585784665489,0.0273204560451308,0.868310009227603
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NME3,Nucleoside diphosphate kinase 3,42144,0.000427176115007249,0.00258592714560667,-0.00464124109038183,0.00549559332039633,0.868794828687414
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSCA,Prostate stem cell antigen,39930,0.00460213745347772,0.028129171045319,-0.0505310377953475,0.0597353127023029,0.870043223354875
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0010217050548248,0.00626219697184356,-0.0132956111196382,0.0112522010099886,0.870399288297182
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL3,Interleukin-3,39560,0.00101372492263908,0.00662913686098208,-0.0119793833248858,0.014006833170164,0.8784644983018
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEPACAM2,HEPACAM family member 2,39929,0.000714667971083515,0.0047289493913148,-0.0085540728358935,0.00998340877806053,0.879878886078973
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.000444009218353294,0.00298874154487653,-0.00541392420960471,0.0063019426463113,0.881902575181682
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42070,0.000496643696771486,0.00342907082930039,-0.00622433512865728,0.00721762252220026,0.884844644596088
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PYDC1,Pyrin domain-containing protein 1,39638,0.000632005702672667,0.00446488718647937,-0.0081191731828269,0.00938318458817223,0.887437883540392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KDM3A,Lysine-specific demethylase 3A,39657,-0.001355171695985,0.00958973808859567,-0.0201510583496325,0.0174407149576625,0.887623851091853
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF12,Fibroblast growth factor 12,39657,-0.000641496274445581,0.00490342273916934,-0.0102522048432175,0.00896921229432633,0.895915158744335
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,42081,0.000377897770670795,0.00288877245259262,-0.00528409623641073,0.00603989177775232,0.895922786458602
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOX2,Transcription factor SOX-2,39915,0.000340964863932127,0.00265692122181697,-0.00486660073082914,0.00554853045869339,0.89788946113096
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR1,TGF-beta receptor type-1,39657,0.000297990906273342,0.00237768477945816,-0.00436227126146464,0.00495825307401133,0.900266022040988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLGAP5,Disks large-associated protein 5,39934,-0.000667910805140649,0.00534739690474079,-0.0111488087384326,0.00981298712815131,0.900601834568046
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCIN,Adseverin,39586,0.000979645530653765,0.0079903726533473,-0.0146814848699069,0.0166407759312145,0.902423535764786
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,39649,0.000854459633006365,0.00698022426648946,-0.012826779929313,0.0145356991953257,0.902575367789962
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD4,Sushi domain-containing protein 4,39919,-0.000505582352053014,0.00417317502500835,-0.00868500540106938,0.00767384069696335,0.90357395986929
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK12,Kallikrein-12,41843,0.00171512072806922,0.0144504081483661,-0.0266076792427284,0.0300379206988669,0.905522661721219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDAN1,Codanin-1,39929,0.000276152083158238,0.00236619384958632,-0.00436158786203095,0.00491389202834743,0.907094078078674
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.000682697019990462,0.00585966597260079,-0.012167642326288,0.0108022482863071,0.907252189677738
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,-0.000615636332823562,0.00529026307387464,-0.0109845519576179,0.00975327929197074,0.907360176258879
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBZ,Hemoglobin subunit zeta,39958,0.00135307458123745,0.0116301470949348,-0.0214420137248347,0.0241481628873096,0.907383556752881
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.000798594018672139,0.00706688917821849,-0.0146496968079804,0.0130525087706361,0.910028601071529
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00026367771740083,0.00235140361606271,-0.00434507337008207,0.00487242880488373,0.910717004644907
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.000459335082077308,0.00413456496652815,-0.00856308241647249,0.00764441225231787,0.91154197356099
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAX,Integrin alpha-X,39757,-0.000614111824630159,0.00558756361376348,-0.0115657365076066,0.0103375128583463,0.912485182849247
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHIT1,Chitotriosidase-1,42207,0.00177052548240012,0.0169482119968201,-0.0314479700313672,0.0349890209961674,0.916800453111291
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GJA8,Gap junction alpha-8 protein,39560,-0.000695089826434279,0.00675487816825459,-0.0139346510362133,0.0125444713833447,0.918042708981264
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.000484668194075987,0.0047623128613098,-0.0098188014022432,0.00884946501409123,0.918939831145909
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.000441281830350265,0.0043683635169032,-0.00900327432348053,0.00812071066278,0.919538291990556
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAN,Brevican core protein,42016,-0.000372868265394186,0.00373418482949135,-0.00769187053119722,0.00694613400040885,0.920462797079982
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAG,Myelin-associated glycoprotein,39649,0.000477448223848452,0.00527106959724825,-0.00985384818675811,0.010808744634455,0.927828759170457
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC51B,Organic solute transporter subunit beta,39575,0.000703873978752312,0.00785005214170982,-0.0146822282189989,0.0160899761765036,0.928555161801717
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.000491968440836112,0.00559394560932134,-0.0104721649534337,0.0114561018351059,0.929920766873097
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM171A2,Protein FAM171A2,39934,-0.0014839410957682,0.0169010452471345,-0.0346099897801517,0.0316421075886153,0.930035809932834
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAGLN3,Transgelin-3,39560,0.000543735027778454,0.00649616230527588,-0.0121887430905623,0.0132762131461192,0.93329572170071
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,0.000307790226967723,0.00401987504097572,-0.00757116485334469,0.00818674530728013,0.938969294946444
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRC,Chymotrypsin-C,42122,0.000539161809092586,0.00707083933478296,-0.013319683287082,0.0143980069052672,0.939220172270278
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB7,Integrin beta-7,42262,-0.000352778427581062,0.00499042594926292,-0.0101340132881364,0.00942845643297425,0.94364468238625
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,0.000479882362599316,0.00690620459126177,-0.0130562786362738,0.0140160433614724,0.9446040564555
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLINT1,Clathrin interactor 1,39560,-0.000343663875255771,0.0054094526299573,-0.0109461910299721,0.0102588632794605,0.9493454308273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP350,Centrosome-associated protein 350,39560,0.000245133138297706,0.00395683218180871,-0.00751025793804736,0.00800052421464277,0.950602293116406
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNL2,Interferon lambda-2,39586,-0.000379853703260247,0.00633859840034846,-0.0128035065679432,0.0120437991614227,0.952214800715341
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2,Interleukin-2,41913,-0.000199369909090345,0.00346172109569128,-0.00698434325664525,0.00658560343846456,0.954073918671098
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAD1,Glutamate decarboxylase 1,39560,-0.000160842138192993,0.0028506588804567,-0.00574813354388813,0.00542644926750214,0.955006027563301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.000180357402214983,0.0032880477849672,-0.0066249310607507,0.00626421625632073,0.956256999409261
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HK2,Hexokinase-2,41900,0.000149880558779622,0.00295135208116101,-0.00563476952029595,0.0059345306378552,0.959498647624395
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,0.000163131282296001,0.00327573272797875,-0.00625730486454235,0.00658356742913435,0.960282692229239
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.000172295558415429,0.00354891292836324,-0.00678357378117653,0.00712816489800739,0.961279735688321
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKIV2L,Helicase SKI2W,39575,0.000187241015900869,0.00428180532297761,-0.00820509741713524,0.00857957944893698,0.965120855003394
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRX,Cone-rod homeobox protein,41900,0.000381940616391055,0.01162704274677,-0.0224070631672782,0.0231709444000603,0.97379522911122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,9.20012757558032e-05,0.00287804145177215,-0.00554895996971762,0.00573296252122922,0.974499248680915
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGF,Beta-nerve growth factor,42016,4.12177882805796e-05,0.00131763741920644,-0.00254135155336404,0.0026237871299252,0.975045440765959
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,-9.88673285630646e-05,0.00323090242115487,-0.00643143607402661,0.00623370141690048,0.975588671245899
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TET2,Methylcytosine dioxygenase TET2,39750,-0.000320846782677517,0.0108691729558976,-0.0216244257762367,0.0209827322108817,0.976451218540827
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.000106531011813556,0.00453409939408296,-0.00899336582421616,0.00878030380058905,0.981255437966589
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.000131735249018321,0.00654261016939853,-0.0126917806830028,0.0129552511810394,0.98393600847534
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,-5.60404226139179e-05,0.00327483016712211,-0.00647470755017325,0.00636262670494541,0.98634715106563
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA3,Carbonic anhydrase 3,42287,-0.000108612162271215,0.00635876717787445,-0.0125717958309051,0.0123545715063627,0.986372488848162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,39929,4.89431599993006e-05,0.00331390295980501,-0.00644630664121852,0.00654419296121712,0.988216700746954
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,39894,-4.71023957711345e-05,0.00414679459868125,-0.00817481980918638,0.00808061501764411,0.990937425671785
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-4.00284033970304e-05,0.00363180063126618,-0.00715835764067875,0.00707830083388469,0.991206381311114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF3,Fibroblast growth factor 3,39657,-3.08359764202095e-05,0.0032036893813887,-0.00631006716394206,0.00624839521110164,0.99232053723752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP15,Matrix metalloproteinase-15,39958,4.74771687563148e-05,0.00526781079941928,-0.0102774319981055,0.0103723863356181,0.992809165947329
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP73,Tumor protein p73,39649,2.78546247278243e-05,0.00371311050578328,-0.00724984196660741,0.00730555121606306,0.994014704475933
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELL,L-selectin,39979,-1.82857284152299e-05,0.00252065666282359,-0.00495877278754946,0.004922201330719,0.994212043200758
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANGAP1,Ran GTPase-activating protein 1,41843,-2.19404418703228e-05,0.00521597178900305,-0.0102452451483163,0.0102013642645757,0.99664385498344
